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PREFACE 
The protozoans are the most diverse and amongst the most ancient grcn^ of 
organisms in the eukaiyotic kingdom. Many of their members are parasitic like, those 
belonging to the fiunily, Tiypanosomatidae (Afiican trypanosomes, tiypanosoma cruzi, 
Leishnumia spp.) and tbc genera Plasmodium Eimeria, Babesia, Theileria. Toxoplasma and 
Entamoeba are the cause of important diseases in humans and their domestic liverstock. 
Parasitic infections are a major health problem World wide especially in under developed and 
developing countries. In die recent past WHO has selected six important diseases in tropical 
and subtrc^cal regicms, in i ^ c h human leishmaniasis is second in importance only to malaria, 
as it possesses much greater problem both in treatment and control. Several chemotherapeutic 
agents/drugs against himan leishmaniasis are available but they suffer from serious limitations 
Hke toxic side effect and their mechanism of action poorly imderstood. Recent studies have shown 
ftax immtmotherapy/immuno chemotherapy is much more promising than chemotherapy. 
Recent and past e]q>eriences have indicated ^ t cell surface molecules in 
view of tiieir importance in interaction with the immime system, parasite recognition and 
i^ Ttake and survival in macroptages held a great promise as immunc^)ro{Aylactic/vaccine 
candidate. LPG IM SL major cell sur&ce glycoconjugate of Leishmania parasite and is t h o u ^ 
to play an important role in the biology of the parasite. 
We have isolated the LPG &(Hn promastigotes of UR6 strain, purified, 
characterized and studied its in vitro potential in providing protection against L donovani 
promastigote infection in peritcmeal macrophages. Furthermore, in vivo efficacy of LPG as a 
immunqxx^^lactic agent against L donovani infection in Syrian golden hamsters has also been 
studied. 
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ABSTRACT 
Lipophosphoglycan (LPG) is a major cell surface 
glycoconjugate of Leishmania parasites. This unusual 
qlycoconjugate is present throughout the various phases of growth 
in tfei shmania parasites. The promastigotes plasma membrane 
contains eUoout 1.25 million copies/cell of LPG, accounting for 
atleast 25% of its cell wall. Structurally, LPG is cott^ osed of a 
neutral cap and a variable con^osition of a repeating 
phosphorylated disaccharide units attached via a conserved 
phosphosaccharide core to a phosphatidyl inositol (PI) lipid 
anchor. All LPG molecules contain multiple unit of a backbone 
structure of PO -6-Gal(p l->4)Man oc 1-. These phosphorylated 
4 
disaccharide repeat units are attached by oC- glycosidic linkage. 
The disaccharide repeat units of h- donovani LPG has no 
substitutions in their backbone sequence whereas repeating units 
of L- mexicana LPG has approximately 30% of its galactose 
residues substituted at the C 3 hydroxyl with glucose (Glc) 
residues. The repeating units of the L- major LPG are the most 
con^lex, as more than 85% of the galactose residues are further 
substituted with small saccharide chains containing one to four 
residues of galactose, glucose, or the pentose arabinose. It has 
been demonstrated that the number of repeating units per LPG 
molecule directly depends on the growth stage of promastigotes. 
le average number of repeat units per molecule reported for 
different species are : 16 for L- donovani. 20 for L. mexicana 
and 14 for procyclic, 30 for metacyclic, 36 for amastigotes of L-
-iii-
wnaioL- T^6 overall structure of LPGs isolated from L- donovanj, 
T. iDai^ 2£> and L- mexicana promastigotes are similar, with a 
linear arramgement of caps, repeating units, glycosylated core 
and lyso-alkylglycerol lipid moiety. The most striking 
differences in LPG structure between the Iieishmania species lies 
in the phosphorylated oligosaccharide repeats. 
LPG plays an inportant role in the biology of the parasite 
due to its surface location, its developmental regulation during 
the life cycle and the reduce virulence of the LPG-deficient 
organisms. A variety of functions and activities of LPG in the 
mammalian host have been experimentally demonstrated or 
suggested. These include, involvelment in attachment and entry of 
promastigotes into mammalian macrophages, protection of parasite 
within phagolysosomal coTt5)artment and as a recognition molecule 
for the T-lymphocyte dependent immune responses characteristic 
of leishmaniasis. LPG is an inhibitor of protein kinase C, 
inhibitor of oxidative burst, inhibitor of viral fusion, signal 
transduction euid scavenger of oxygen free radicals. 
Lipophosphoglycan has also been proposed to induce a protective 
immune response in mice and therefore, it is considered to be a 
candidate vaccine against leishmaniasis. 
In recent years, the promastigote cell surface has received 
considerable attention in view of its in^ xjrtance in interaction 
with the immune system and for parasite recognition, uptake euid 
survival in macrophages. The cell surface glycoconjugate, 
lipophosphoglycan (LPG) has been isolated, purified and 
characterized from Leishmanip parasites of different species. 
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However, no attempt has been made to study the LPG from non-
pathogenic strains. Hence, LPG from promastigotes of non-
pathogenic strain UR6 was isolated, purified, characterized and 
its potential as immunoprophylactic agent and/or candidate 
vaccine against experimental visceral leishmaniasis was 
evaluated. I'solation of LPG was carried out using different 
organic solvent mixtures. Crude LPG was purified by size-
exclusion, and hydrophobic affinity chromatography. The elution 
profile of LPG from Sephadex G-200 is indicating that LPG 
fractions eluted just after void volume, suggesting that it is a 
high molecular weight molecule. Single broad peak was obtained 
indicating the heterogeneous nature of LPG. The desaltation of 
LPG molecule which is eluted from Sephadex G-200 was necessary 
+ ++ 
for removal of unwanted salts like, EDTA, NH , Mg etc. These 
4 
salts were found to interfere in further purification and 
characterization studies. LPG purified by conventional methods 
failed to remove LPG-associated protein contaminants as they were 
tightly bound to LPG. These associated proteins were removed by 
the treatment with proteinase K enzyme and protein/peptide free 
LPG was obtained after purification from octyl Sepharose column. 
From 25.0 ml (27.0 gm) packed cells, about 150 mg of crude LPG 
was obtained. This on partial purification yielded 31 mg of 
partially purified LPG which on octyl Sepharose CL-4B column gave 
a yield of about 15.0 mg of pure LPG. Characterization of 
purified LPG was carried out by thin layer chromatography (TLC) , 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and NMR 
Bpectroscopy. The mobility of purified LPG on silica gel G coatad 
plate in the solvent mixture 1-propanol/pyridine/H 0 (1:1:1, 
v/v) is shown a single diffuse spot. The R value of LPG in this 
solvent system was found to be about 0.66+0.02, which is close to 
0,62 reported earlier for the L- donovani promastigotes LPG of 
pathogenic strain. The purity of LPG molecule was assessed by 
SDS-PAGE followed by periodic acid schiffs (PAS) staining. On PAS 
staining of gel, LPG was the only carbohydrate staining species 
observed as it migrated as a single diffused band. The molecular 
weight of UR6 LPG obtained by the migration of standard proteins 
on SDS-PAGE, was found to be in the rauige of 20-25 kDa. One 
1 
dimensional H - NMR and two dimensional COSY NMR studies were 
carried out for structural characterization of the LPG molecule. 
The signal at ^  5.52 ppm was unambiguously assined to H-1 of 
mannose emd connectivities could be traced out as cross pesOc to 
the H-2 ( fi" 3.71 ppm) and H-3 (5 3.53 ppm) respectively. 
Similarly, the signal at £ 4.47 ppm Ccui be unambiguously assinged 
to H-1 proton of galactose auid connectivities could be traced out 
for H-2 (63.54 ppm) and H-3 (63.83 ppm) respectively. Further, 
connectivities could not traced out due to the in phase 
properties of diagonal pesdc. Hence, it is suggested that LPG 
molecule is obtained after final purification was pure. The LPG 
satrples are devoid of any protein contaminants which was 
supported by the NMR spectroscopy as no signal of any -NH was 
2 
found during NMR studies except carbohyrates corresponding peaks 
VI-
vere observed. 
The protective potential of lu. donovani LPG, against II.. 
^-^pvani infection in peritoneal macrophages has been studied. 
The studies demonstrate that UR6 LPG inhibits binding of 
promastigotes of Dd8 strain to peritoneal macrophages in a 
concentration dependent manner. For 10 ng/ml LPG about 50% 
inhibition of attachment to peritoneal macrophages was obse rved. 
This inhibitory activity was enhanced from 60% to 78%, when the 
LPG concentration was increased from 50 ng/ml to 100 ng/ml, 
respectively. A maximum inhibition of about 85-90% was observed 
for 1000 ng/ml of LPG. No further enhancement in inhibition with 
increase in LPG concentration upto 2000 ng/ml was observed. 
Similar results were also observed when LPG was incorporated into 
small unilamellar vesicle (SUV) containing cholesterol. 
Furthermore, UR6 LPG provided a significant protection (about 85-
90%) in peritoneal macrophages against promastigotes infection. 
This study is also supported by previous study (Kelleher eL al., 
1995) that LPG was unable to corr^ letely block . attachment 
of promastigotes to macrophages, suggesting the involvement of 
other ligands supporting the earlier observation that the domain 
of LPG which is involved in binding of promastigotes to the 
macrophages, is conserved in the promastigotes LPG of both the 
Dd8 auid UR6 strains of L. donovani,, 
In order to look into the possibility whether LPG mediated 
protection in macrophages system against L^ donovani was either 
due to inhibition of attachment of prcxnastigotes to macrophages 
-vix-
or killing of ainastigotes inside the macrophages, studies with 
pre and post treatment of macrophages with UR6 LPG were carried 
out. It was observed that the peritoneal macrophages which were 
treated with LPG before being challenged with promastigotes 
provided significant protection against L^ donovani infection. 
However, those macrophages which were first challenged with 
promastigotes amd then treated with LPG provided similar pattern 
of infection as observed that for control. These observations, 
suggest that pretreatment of peritoneal macrophages is necessary 
for achieving protection which depends on the inhibition of 
attachment of promastigotes to peritoneal macrophages. 
In vivo efficacy of LPG molecules against visceral 
leishmaniasis was evaluated in susceptible golden hamsters using 
LPG alone or incorporated in liposomes. Pretreatment of hamsters 
with LPG anywhere between 10-28 days prior to infection did 
provide significamt protection against lu^ donovani infection. The 
group of einimals receiving LPG alone (10 >jg/animal) showed a 
relatively low protection of about 22-25% . The protective 
efficacy of LPG was enhanced significantly on its incorporation 
in liposomes. LPG incorporated in cholesterol containing 
multilamellar liposomses provided 40 percent protection whereas 
LPG incorporated in small unilamellar vesicles (SUV) provided 
about 65-70 percent protection. This protection was more than 
double as conpared to LPG alone. Furthermore, for incorporation 
of LPG in negatively charged liposomes as similar percent 
-Vlll-
protection as that for neutral liposomes was observed. Studies on 
concentration dependence of liposomised LPG in protecting hamster 
against k.. donovanj infection showed that a single dose of 20 
;ig/animal of liposomised LPG incorporated in SUV provided a 
maximum protection of about 68 percent. The effectivenss of 
liposome incorporated LPG coitpared to LPG alone in protection 
against L^ donovanj in hamsters can be due to induction of an 
effective T-cell response. This possiblity is indicated from the 
fact that increased percent protection was observed on increasing 
the pretreatment schedule with liposomised LPG from 2 days to 21 
days. 
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CHAPTER 1 
LEISHMANIASIS: 
AN OVERVIEW 
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Parasitic infections are a major health problem worid wide cspeciall>' in under 
(Jcvcloped and developing countries. Several factors which are responsible for increasing parasitic 
diseases arc population crowding, poor sanitation and health education, inadequate control of 
parasite vectors and reservoirs of infection, population migration and lastly- development of 
j^ sistance towards agents drugs used for control of these diseases or vectors. In Ac recent past the 
\ '^orld Health Organisation (WHO) has selected six important parasitic diseases in tropical and 
subtropical regions of the world for inclusion in its specific programme for research and training. 
It can be said that amongst the selected parasitic diseases, human leishmaniasis is second in 
importance only to malaria, as it possesses much greater problem both in treatment and control, 
leishmaniasis is a general name given to Ac disease caused b> infection with any member of the 
genus Leishmania. The current survey by WHO showed that about 12 million people are thought 
to be infected world wide with more tfum 400,000 new cases ]^ )pearing each year (WHO, 1984; 
Anon, 1990) and approximately- 350 million people arc at risk (WHO, 1990; Ashford et al, 1992) 
HISTORY OF THE PARASITE: 
Leishmaniasis includes a group of unicellular organism inhabiting macrophages of 
\aidbme hosts as an obligate parasite. They are transmitted fi-om one host to another by a vector, 
sandfly' {Phlebotomus spp). The natural hosts of Leishmania spp. are lizards, and other mammals, 
particularly canine, rodents, and primates including man. 
The human leishmaniasis was first reported in 188S by Cunningham in histological 
sections of oriental sore. The parasite was first named as Piroplasma dono\'ani, which was 
subsequently changed to Leishmania donavani by Ross in 1903 (Zuckerman and Lainson, 1977) 
after its discoverers, Leishman and Donovan who reported the oiiganism independently, Leishman 
in 1900 fi-om London and Donovan in 1903 fi-om Madras (Peters, 1988). Wright (1903) named 
the causative agent of oriental sore as Helcosoma tropica (Zuckerman and Lainson, 1977). 
Borcrvsky (1988) and Wi^t (1903), gavr an accurate descrqjtion of its morphology and was named 
Leishmania tropica by Luhe in 1906. Nicolle (1908) established ttie Tiypanosomatid nature of Z,. 
donovani and L tropica, and also gave tfie name L. infantam to tfie parasite which caused infantOe 
Kala-azar. The Russian workers Yakimoff and Schockov in 1915 described L. tropica and L. 
major, the causative agent of zoonotic cutaneous leishmaniasis (Zuckerman and Lainson, 1977). 
Leishmania braziliensis was discovered in 1913 by Vianna and Muniz and Medina discovered L. 
enriettii in 1948 in Panama state (Zuckerman and Lainson, 1977). The western hemisphere parasites 
were classified into two major groups of Z,. mexicana and L. braziliensis complexcd (Lainson and 
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Sbow, 1972). Visceral leishmaniasis was discovered in America in 1913 and the causative parasite 
was named L chagasi by Margues Dacunha and Chagas in 1937 (Zuckerman and I^ainsoa 1977). 
GEOGRAPHICAL DISTRIBinriON: 
LeisAmama i/onovtjm is a causative agent of Kala-azar or visceral Idshmaniasis. It 
B widel\ distributed in Europe (Portugal, Spain, Italy, Malta, Greece, and Southern Russia), Africa, 
(Morocco, AlgOTa, Tunisia, Libya, Abyssinia, Sudan, Northern Kenya, Nigeria) Asia (India, China, 
Turkistan etc.) and in South America. 
Leishmania tropica has bc«i reported fiom Africa (mainl>' Mediterranean sea) Europe 
(Spain, ItaK, France, and Greece), Asia (Syria, Palestine, Armenia, Southern Russia, Iraq, Iran, 
Arabia, Tuildstan, India, Indo-China and China), and Australia (Northern (Queensland). 
Leishmania Brazihensis (Vianna) has been reported from Brazil, Peru, Paraguay, 
Argentina, Uruguay, BoKia, Venezuela, Ecuador, Colombia, Panama, Costa Rica, Mexico and 
South as weD as Central America. 
In btdia, tfie first available record of leishmaniasis was in 1862, and the disease was 
known as " Jwar Vikar" in the local language of tfie district Jessore and took a total of 75,000 Hves 
in three years (Sengupta, 1944). The disease is now highl} endemic in the states of Bengal 
(Jayaraman, 1988X Orissa (Satyavati and Nando, 1987), Bihar (Thakur, 1984) and North west India 
(Naik etal., 1979). Few cases have also been reported from Gujarat (Gajwani et al., lS>67),Kashmir 
(Jacob and Kalra,1951), Himachal Pradesh (Gupta and Bhatia, 1975), ChandigaA (Naik et al., 
1979), Madras (Sivaprakasam et al., 1988), Mussourie (Chand et al., 1988), Delhi and Uttar 
Pradesh (Kapur et al, 1979). 
TAXONOMY': 
The gmus Leishmania belong to the Phylum: protozoa, Subphylum: plasmodroma, 
class: Mastigophora, Subclass: Zoomastigina, Order: Protomonadina, Family: Trypanosomatidae. 
Genus: Leishmania, Species: donovani, major, tropica, mexicana, etc. 
Simi^ ified and traditiona] classifbalion of leishmaniasis based on clinical manifestations 
are as follows. 
1. Visceral leishmaniasis or Kala-azar: L. donovani, a chronic and ofren fatal disease which affects 
tiie macrophages of flie liver, spleen, bone marrow and lymphnode. 
2.Ciitaneous leishmaniasis or Oriental Sore: L. major, L.tropica. L. mexicana, and/., aethiopica, 
HMch les&ict flidr infection to dermal tissues only. This disease produces skin ulcers which leave 
•n unsigjitly scare on healing. New World cutaneous leishmaniasis (NWCL) tends to be more 
severe and chronic than Old World cutaneous leishmaniasis (OWCL). Difiuse cutaneous 
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leishmaniasis (DCL) caases wide spread thickening of skin. • -* -^ -^ -'^ ^ ^ J IS 
3 Mucocutaneous leishmaniasis or Espundia: L braziliensis, which replicates primarily in 
mucous tissues and causes gross disfigurements. This affects mucosal region of nose, ear and 
mouth (Marr et a!., 1978). The details of clinical taxonomy is summarized in Table 1. The 
laxonomv of genus Leishmania was based primaril)' on clinical factors, differences in de\ elopmental 
vectors and xirulence in experimental host. Since these criteria provide insufficient basis of 
classification, hence, techniques like monoclonal antibod}' (mAb) typing, recognising specific 
antieens and species specific probes (McMahon et a/.. 1982), isoenz\'me analysis (Kreutzer, 1980), 
DNA buo>ant densit> (Chance et ai., 1974) and restriction cndonucleases analysis of niKlear and 
mitochondrial DNA (Arnot et ai, 1981) have recently been used. The most common and so far 
most successful DNA identification method imoKes the use of kinetoplast DNA. It has about 10^ 
base pairs of mitochondrial DNA, including approximately 10-20000 highly reiterated mini 
sequences of 500-2500 base pairs, used for identification of the species. (Barker, 1987) 
MORPHOLOGY: 
The Leishmania species are unicellular protozoa that exist in two distinct 
morphological forms. The flagellated promastigotes form, resides in the midgut and hindgut of 
alimentary tract of their insect vector (Sandflies). The parasite exists extracellularly as the flagellated, 
motile promastigote (Kilhck-kendrick and Robertson, 1977). Promastigotes, measure 15 to 20 um 
in length and 2 to 3 um in width. The fully developed ones are long slender spindle shaped bod\ 
They are monoflagellated parasite having nucleus, kinetoplast and eosinophilic vacuole etc. 
The iKwiflagellated amastigote form is spherical or ovoid 2-4 um along the longitudinal 
axis. It contains a central rod shaped kinetoplast and axoneme which represents the root of the 
nonfunctional flageUum (Zuckerman and Lainson, 1977; Chang, 1983). The different morphological 
form of promastigotes and their developmental sites are described in (table 2) (L.L Walter et ai. 
1993) 
LIFE CYCLE OF LEISHMANIA PARASITE : 
The life cycle of Leishmania parasite consists of tuo different stages. In the first stage, 
the parasite lives as an extracellular flagellated promastigote form in the hindgxn and midgut of 
alimentary tract of its insect vector, wiiile in Ae second stage, as amastigote form residing in the cells 
of mononuclear jAagocnic cells of the reticuloendothelial system of the mammalian host. The 
disease occurs when the insect vector (Phlcbotomus argcnlipcs) bites a healthy htmian host and 
injects the extracellular promastigotes into the blood stream. There, they encounter complement 
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TABLE 1. TAXONOMY' OF LEJSHMAMA SPECIES KNOWN TO INTECT 
MAN 
Species Disease 
Ldshnumia donovani 
L.d. donovani 
L.d. infantum' 
L.d. chagasf 
Leishmania major 
Leishmania tropica 
Leishmania aethiopica 
Letshmania mexicana 
L.m. mexicana 
L.m. amazonensis' 
L.m. pifanoi 
L.m. garnhami 
Leishmama braziliensb 
L.m. venezuelensis 
L.h. braziliensis 
L.b. guyanensis 
L.b. panamanensis 
Leishmania peruvana 
Visceral (Kala-azar) 
Infantile Visceral 
Cutancoxis 
Cutaneous 
Cutaneous 
Diffuse cutaneous 
Cutaneous 
Cutaneous 
Cutaneous 
Cutaneous 
Cutaneous 
Mucocutaneous 
Cutaneous 
Cutaneous 
Cutaneous 
* Some consider these to be separate species. 
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Tablc 2. Proposed dcsipnaiion o^ Lciilmwiua forms in ihc sand fly 
put and developmental sites. 
DciipisiJon-name Locoiion in put 
AM Amasiipoic 
PI First stumpy promasiigoic 
P2 Second stumpy promasiigotc 
P3 Third stumpy promastigoic 
Frcc-swjmming phase* 
Nl Elongate ncciomonad promastigotc 
N2 Spalulate ncciomonad promasiigote 
N3 Short ncciomonad promasiigote 
N4 Ncciomonad p2r:imasiiE0ic 
N5 Mciacyclic ncciomonad promastigoic 
Attached phase** 
HO Pear-shaped hzptomonad promasii-
gote 
HI Elongate haptomonad promasiigote 
Blood meal' 
Uloodmcal 
P>loodmeal 
DIoodmcal 
liloodmeal, midgul, 
hindgui 
Uloodincal. hindgut 
Midpul,' forcpul? 
Midgut,' forcgul? 
Midgul, forcgut 
Hindizui, forcgul 
llimlcui. siomodcal 
v::lvc7 
H2 Spalulate haptomonad promasiigote Hindr.".!'. 
H3 Short haptomonad promasiigote Siomodcal valve 
H4 Haptomonad paramastigoic HiiuiiMii, forcgul 
• The bloodmcal is surrounded by the pcriirophic membrane. 
•• Parasites with a free flagcllum in the lumen of ihc midgut, i-indgul 
or forcgul. 
* In t'h. papotasi. ihis form of Lr. panamcnsis dcvcic.s inside the 
retained pcriirophic sac. 
" Parasites coloni7C the cuiicular lining of the hindpui or forcgul and 
are attached bv a modified Ibtcllum. 
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-^ijbodies and phagoc>1ic ceDs, all of which can kill promastigote (Hoover et al., 1985; Pearson e/ 
al 1983)- As many as SCWo of the promastigotcs are effectively killed by such mechanisms (Lewis 
•nd Peters, 1977). Shortl>- thereafter, the survivors can be found within the phagocytic cells, both 
ffPUtixxivik and mononuclear phagoc)ics. Different factors contribute to the attachment and uptake 
of flie parasites into approiMiate host cells. Long term survival is possible onl>^  in cells of macrophage 
famih'. 
When infected sandfh' takes blood meal, the infective promastigotes form present in 
its pharvTix enter into the blood stream of the vertebrate host. Once tiiis is inside the blood stream 
of the vertebrate host, promastigotes are phagocytosed by the mononuclear phagocytic cells of the 
host and transform into amastigotes which then begin replicating by binary fission within 
rrfiagolysosomes. The host cells lyse, releasing five amastigotes. These amastigotes then infect the 
odier cdb (^een, livw, bone marrow and lyn^h nodes) of reticuloendo-thelial system (Chatteijee 
*/ al., 1957; Ghosh et al., 1987). 
The amastigotes are ingested by the sandfi>' during a blood meal fi^om an infected 
vertebrate host The parasite migrates to the midgut of the sandfly, wiiere the amastigotes transform 
into promastigotes within 3-4 days. The flagellated parasite then gradually migrates forward to the 
pharynx by the fourth and fifth days. The transformation of amastigote to promastigote takes place 
in approximatdy one week (Figure -1). The promastigotes attach itself to the epithetial ceD lining of 
the midgut of the sandfly and multiph'. These are avirulent promastigotes. When promastigotes 
eventually cease dividing, tfiey detach fi'om the epithelial cells and migrate to tfie mouth part of the 
insect and these are termed as metacyclic promastigotes which are virulent form of the parasite 
ji(Sacks, 1988). The promastigotes need a basic environment (pH 7.0 to 7.S) with low temp^ature 
(24 ± 2*C) for powlfa. In contrast, the amastigotes perform dieir metabobc proc«s&, survival and 
multiplication at (pH 5.0 to 5.5) and high tenq>erature of 37*0 in 5% CO, (Chang et a/., 1985). 
HOST PARASITE INTERACTIONS. 
There are several factors which regulate the attachment of promastigotes to tiie 
phagocytic cells. Initiall>', infection is dependent on the abilit}' of promastigotes and later on 
amastigotes. Some problems are invdved during interactioit, Kke, homogeneity of promastigotes 
population (Sacks and Peikins, 1984; 1985), differentiation and activation of host cell receptors (Tait 
and Sadcs, 1988), parasite differentiation from non-infective to infective stage in the alimentary canal 
of the midgut of sandfly (Sacks, 1990). In tpitc of fiiese problems, parasites do succeed in 
developing infecticm in host ceOs. The Leishmania promastigotes bind and are internalize by all 
phagocytes, but ttiey survive only in macrophages and less mature mcmocytes. Interaction of 
Leishmania promastigotes with macrophages is a receptor mediated event. The promastigotes bind 
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Figure 1: Life cycle of Leishmania donovani showing reticuloendothelial system, distribution of 
Leishmania in Kala-azar and sandfly cycle (Chatterjee, 1957). 
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dirccth' to macrophage receptors or through the intervention of the host factors, i.e., complement 
fcocp^ois (CRI/CR 3X mannose-fiicose receptor (MFR) and fibroncctin receptor (FnR) (Mosser and 
Edelsoa 1984; 1985; 1987; Russell et aJ., 1989). Promastigotes may utilize several different 
macrophage receptors depending on tfie parasite species and developmental stage and on the 
presence or absence of serum. In the presence of serum, however, the promastigotes surface b 
opsonized with comfJcmOTt component such as C3b and iC3b, and promastigotes uptake occurs via 
(he conplement receptors CRl or CR3 (da Silva et al., 1989; Mosser et al., 1992). The host parasite 
attachment in the presence of scrum factors of Ae mammalian host, may also involve, natural 
antibodies, oxida^ metabobtes, and digestive fluids or secretory products of salivary glands of die 
sandOy vectors. 
It has been demonstrated tfiat surface molectiles of parasite Uke 63kDa glycoprotein 
(gp63) and hpophosphogjycan (LPG), bind directfy to a number of nucrophage receptors in the 
absence of serum (Handman and Coding 198S; Chang and Chang. 1986; Russell and WiDielm, 
1986) (Fig. 2). Purified gp63 has been shown to bind to tfie macrophage receptors as its binding to 
macroirfiage was blocked with anti-CR3 monoclonal antibodies (Russell and Wright, 1988). Thus, 
the binding of ap63 is mediated by CR3 receptor of Ae macrophages (Russell, 1990). The binding 
of LPG to macrophages was first demonstrated by Handman and Coding, 1985. Differential 
inhibition of individual members of tfie macrophage receptor indicated that CR3 and p'*"** were 
primarily responsible for LPG binding (Talamas-Rohana et al., 1990). LPG imdergoes extensKr 
elongation during differentiation of procychc im)mastigotes to the metacycUc promastigotes. This 
alteration leads to increased complement resistance of Leishmania parasites and a thick coat is 
formed on tfie parasite surface (7nm in log phase-17nm in stationary phage) (Sacks and da siha, 
1987', Pimenta et al, 1989; da Silva et al, 1989). The MFR of macrophage ma> also binds to the 
LPG and help in parasite phagocytosis. It has been observed fiiat lectins like receptors are present 
in the midgut of sandfly that act as hemag^utinins and are inhibited by only three sugars 
(galactosamine, gjhjcosamine, mannosamane). The i^osphoiylated tetrasaccharides, effectively inhibit 
(>70%) Ae binding of procyclic promastigotes to P. papatasi (Pimenta et al, 1992). LPG has been 
shown to be a bgand to tfie sandfly midgut epifiidium as only L. major strain having complete 
procyclic LPG was found to be attached to Ae xmigisi of Aeir natural vector, P. Papatasi, vvWe 
Leishmania of otf)CT ^ )ecies Hke, L. donovani, L. h'opica and L. amazonensis failed to attach to the 
epithelium cell lining of midgut of P. papatasi. Ckmtraiy of Ais, P. argentipes a natural vector of 
L. donovani supported Ae growA of L. donovani, L. major, L. tropica and L. amazonensis 
promastigotes in Ae epiAelium of sandfly midgut. FurAermore, L. donovani mutant deficient in 
LPG failed to attach to Ae midgut of Ais sandfly. The multiple ^ linked galactose residue of L. 
mcgor LPG was found to be responsible for Ae attachment to Ae cpiAeHal ccB line of midgut of P. 
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Figure 2: Recq)tor ligand interactions between Leishmania major promastigotes and human 
macrof^ iages. The two m^or cell surface glycoconjugatcs, LPG and gp63 are depicted 
as controlling the attachment of di£ferent developmental stages of promastigotes on 
which Ae e^ qjression of the LPG is developmentaUy modified. Multiple interactions 
might be required for subsequent events associated with receptor activation and 
internalization (Tait and Sacks, 1988). 
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ijcipatasi and w^ found to be species specific. Conlrasl to this the P. argentipcs midgut possesses 
a receptor for relalKely conserved oligosaccharides or lectin like' molecules of procyclic LPG of 
different species of Leishmania parasites. These observation suggesting that LPG is a ligand to the 
sandfl\ midgut epithelium and plays an important role in host parasite interaction (Pimenta ct a/.. 
1994; Volf e;a!., 1994; Sacks and Turco, 1995). Acid phosphatase is also a cell surface molecule 
and reported to be secreted in the culture medium, (Dwyer and Gottlieb, 1985; Glew et al., 1988) 
Two form of acid phosphatase are present, a membrane boimd, tartrate resistant and other a 
secretory acid phosphatase. They are antigenically distinct aiKl exist as multiple isoenzNines present 
in both stages of most Leishmania spp. It has been shoun that acid phosphatases dephosphory late 
certain pbosphoUpids and phosphoproteins which may provide the parasite a source of energ\ as 
inorganic pbosphste for growth. Leishmania spp. possess a superoxide dismutase which converts 
Oi' to H;0,, which can diffuse into the extracellular spaces and kill Leishmania parasites. 
Promastigotes are generaUy more sensitive tfian amastigotes to Hp^and 0;(MurTa>, 1981; Pearson 
et al., 1983). Thtis, this cctoenzyme is thou^t to protect Leishmania spp. by interfering with 
regulatory mechanism of the macrophages that produces microbicidal free radicals (Glew et al., 
1988). 
The mechanism of host resistance and susceptibilit\- are dependent on the THI/ TH 2 
t)pe response and macrophage-cytokine interactions. The resistance correlates with the T^ 1 cell 
response, while susceptibility correlates with a TH 2 cell response (Maingon et al., 1995; Kemp el 
al., 1996). Production of IFN-y by THI cells has been found to be essential for macrophage 
activation, microbial clearance, healing and protective immunit)' in Leishmania infection (Belose\ic 
et al., 1989). Conversely, nonhealing response in susceptible mice have been related to the 
cxjxession of the TH 2 subset and the production of cytokines such as IL-4 and IL-10 (Heinzel et al., 
1989; Locksley et al., 1991). IL-12 and IFN-Y are known to be associated with the healing process 
and also play an important role in immunity against human \isceral leihmaniasis (Ghalib et al.. 
1995). The production of both IL-12 and IFN-y is inhibited by IL-10. It has also been demonstrated 
that the disriq^ ticm of IL-4 gene can confer protective immunit>' by TH 1 type immime response, as 
determined by positive DTH and IFN-y production (Satoskar et al., 1995). In addition, jM-oduction 
of nitric oxide has been found to be most likely an effector mechanism for parasite killing. (Bhakuni 
etal., 1996; Stefani et a!., 1994; Bogdanet al., 1993). 
PATHOGENESIS AND SYMPTOMS: 
Leishmania is an obligate intracellular parasite that cause a broad spectrum of 
diseases in man and other animals, ranging frran self-healing skin ulcers to a &ta] visceral infection 
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Tbe Leisfmania parasite after entering the host, invades the cells of the reticuloendoAcUal s>stem 
where it resides and multiplies. Thus, the parasites are distributed all over the bod> and arc 
particularly fouKl in tissues rich in reticuloendothelial cells. They multq>l>' in tfie reticuloendothelial 
cells, spcciall>' Ae macrophages in spleen, liver, lymph nodes and bone marrow, which become 
heavily parasitized. The initial infection and the appearance of the clinical manifestations arc 
generally observed from three weeks to six months (Thakur, 1984), but the incubation period may 
extend upto 2-9 years (Faust and RusseD, 1964). Earl>' stage of visceral leishmaniasis is characterized 
by malaise, headache, and fever occurring at irregular intervals later becoming regular and 
accompanied by chills and sweating. Chronic visceral leishmaniasis {Mtxluces marked enlargement 
of liver and spleen (hepalosplecnomcgaly). The spleen is more enlarged as con^pared to bvcr. The 
other synqjtoms are high fever, pyrexia, ^nq^hadenopathy, anaemia, die skin over the body becomes 
dry, rough and harsh and is often pigmented (darkened) (Sen Gupta et al, 1956; KhaUd et al. 
1990). The hair terKls to be brittle and fall off. There is a rerversal of normal albumin-globulin ratio. 
In the active stage of disease, ttie peripheral blood (T/B cell) ratio is also reversed (Rezai et al 
1977). Kala-azar patients are also found to have a defective cellular immunity, as detected through 
skin test (Manson Bahr, 1%1). Lesions in the bnmchi and Ixmgs, intestinal ulcers and hemonhages 
in the intonal organs are also reported to occur simultaneous!}'. In the later stage of disease the skin 
usually becomes Hack in cdour and Ihoe is continuous high fever, justifying the name of the disease 
'Kala-azar* (Black sickness). If patients are untreated, 75-95% die within a period of two vears. 
Deatfi in Kala-azar is always due to secondary infections, such as amoebic or bacillary dysentery 
pneumonia, pulmonary tuberculosis, cancerum oris and other septic infection (Nag and Ghosh. 
1955). Due to &e suppressed immune system tuberculosis and AIDS are opportunistic infection in 
Kala-azar patients (Fuzibet er a/., 1988, TDRNewsNo. 36, 1991). 
In about 20% of Indian Kala-azar patients, there are non-ulcerative nodular cutaneous 
lesioiEs known as post Kala-azar dermal leishmaniasis (PKDL), generally occurring one or two years 
after the completion of sodiiun stibogluconate treatment. PKDL lesions have also been found in 
some spontaneously cured Kala-azar cases (Rees and Kagar, 1987; Chessborough, 1988). 
DIAGNOSIS OF KALA-AZAR: 
Clinical diagnosis of the kala azar on the basis of signs and symptoms (prolonged 
fever, hepatospleenomegaly, abdominal distension, pallor, anorexia, anaemia, leucopaenia, 
thrombocytopaenia and t^perglobulinemia, etc.) is very difficult because tfiese symptoms may also 
be present due to other diseases. Therefore, parasitological confirmation before treatment is 
essoitiaL Parasites may be demonstrated in ttie aspirates of ^leen, bone marrow and \ympYi nodes 
Hie dononstralion of tfie Leishmania parasites by (direct evidence mediod) blood smears or blood 
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c„lm« and b,ot«> of Ihe parasitized tissues is possible and biops> of bone raanow and spleen are 
still used today. Although spleen aspuation is a high risk technique and thetc is no consensus on its 
use, however, because of its supertor sensitivity it is the prefetred method Tlte bone marrow 
puncmre, wh.ch is widely practiced, is less hazardous and easy to perfom, than spleen aspirates is 
„ore patnM and labour extensive. Bone marrow aspitated samples .re cuUured ,n v„.o for 
propaganon of the patasite and also smeared on microslides for microscopic exammat.on Blood 
smear, are generally negative because of low levels of circulating paras.tes Blood culture method 
is time^onsummg, and less sensitive. Therefore, it is neither preferred nor used now a davs 
A number of serological, immunological and DNA based techniques are now being appHed 
foMhe dragnostsofKala-azar Inmost ^delya^Ued immunological test in leishma^asThas 
been the letshmamn or Montenegro's skm test. Which is usually positive in CL and MCL ., is 
negative in acute VL and most cases of PKDL but becomes positive after recoverv It is also 
ne^uvemDCL Tl.leishn,aninreacUonisnots,«c.esspecinc(ShowandLainson, ,967 197^ 
.975; Southgate and Manson Bahr. ,967). TU skin test could be used for e v L o n 'for l e 
effecfve mm-umzation w,4 killed I e , r * ^ „ . ,,,^^^^^ ^ ,^ ^, 
letshmamazatton applied in the control of cutaneous leishmaniasis (Kadim e, a, im) SomI 
serolo^caJ tes^ based on specific antibody or amigens present in the sen™, such as' EUSA. hav 
been develop Tins is widely used and is most suitable and sensitive technique for d e t e l n of 
Kala-azar. EUSA has the adv^tage of being usefi.1 for both antigen and a n t i l v Z T Z l ^ 
D^-blot EUSA test ts similar to ELISA but the ant.gens are used on pa^r^Tpl^ su^^^"! 
detect an«bod> which is then v,sual.zed usmg antiglobuhns labelled w«h enzvmes (Voll ^ ^ 
°'^«°°^-"='hod based on parasne DNA are very useful butsiui face a number of 
hmnanonsas,,,«,u.resspecmcDNApobeand«^sUca.edinstr.™entfacihuesRecentlvat^^^ 
soph^rcated polymerase chain reacon (PCR) t^hnique, is being used for detection of K I Z 
<^e^ ,9S8; Audy. . , . , . , 1992) U, PCR, a spec.fic target DNA fiagmen, ts l ^ Z 
amphfied from total DNA or RNA of given organism using a thennostT^NA p K , l ™ Z 
ohg.^».deprime.sflankmgthe.a,getsi.e. .he s,«tfic.y of the p m n e r s : ^ ™ : 
other DNA sequences are not^plified during amplification -ntemain advantage ofPCR is J Z 
^^hasnofieldapphcanonsmcethe.echni,uerequiresl.gh Skill and also sophtstrcat^ 
IMMUNITY TO THE VISCERAL LEISHMANIASIS: 
In human infections, the specific immune resp«ise to Ihe pathogen mav be of v.„t 
un^nanceforhostdefenseAninappropria. response may not ^ ZTL^:!:^ 
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proteclion, h may even contribute to the pathology of disease. After infection with Leishmaia 
parasites, hunians often develop immunit> to reinfection. The protective inunimity against both 
VEceral (Skov and Twohy, 1974 a;b) and cutaneous leishmaniasis (Preston and Dumonde 1976) is 
n T-ccD mediated process. Generally Ac killing of amastigotes inside the macrophages requires the 
release of T-ccIl factors that lead to activation of the macrophages and produce more of the lethal 
substances which eventually kill tfie parasites. If T-cell activation and lymphokine production does 
not occur, tfien tfie macrophages will not be able to kill the parasites (Lciw, 1990). T-lymphocytes 
can recognise antigens associated witft class I and class IIMHC molecules i.e. CD8* and CD4* T-
cclls respectively, on the surface of accessory or antigen presenting cells (APCs). Leishmanial 
antigen has beoi demonstrated on the surface of infected macrophages (Farah et al., 1975; Berman 
and Dwyer, 1981; Handman and Hocking, 1982), but it has not been associated with the 
concomitant expression of class II molecules. 
The production of co-stimulatoiy &ctors, including IL-1, IL-2, IFN y by the accessory 
cdls promote antigen spodiSc lymphocyte activation (Unanue, 1984; Kaye, 1987; Unanue and Allen, 
1987; WeavCT and l^ianue, 1990; Kaye et al., 1991). An adherent cell populations (macrophages) 
have been found to be associated with immunosuppression in leishmaniasis (Scott and Farrell, 1981; 
Reiner and Malemude 1984; 1985; Murray et al., 1986). Impairment of tfie immune response has 
been found to be associated with inability of macrophages to produce IL-2 upon specific or 
mitogenic stimulation (Reiner and Finke, 1983; Cillari et al., 1986; Murra>' et al., 1987). 
An antigen qiecific unresponsiveness is common during active visceral leishmaniasis. 
It is associated with reduced IFN-y and IL-2 production (Carvalho et al., 1984a; Kaye et al., 1991). 
However, the absence of these co-stimulatory factors in chronic infected mice with L. donovani 
resulted in Ae £uhire of providing tfie necessary signals to activate IFN-y producing T-ceDs. So far, 
IL-1 has be«i identified as co-stimulatory factor for activation of TH2 ccHs, but not Tgl cells which 
induced TH2 cell proliferation and disease exacerbation. (Kurt Jones et al., 1987). Freund's 
conqdete at^ uvant is a potent stimulator of THI cells (Gun and maurer, 1989X which can promote 
a protectiMs Ksgoosc against PT3, a T-cclls qntope derived hom the primary structure of L. major 
gp63 (Jardim et al, 1990). PT3 i& found to activate IL-2 and DFN-y producing T-cells in presence 
of adjuvant, while PT3 alone is able to induce TH2 cell and these cells produced more IL-1. 
Therefore, disease exacerbation and protection depend on the e^qnession of TH2 and TQI cells, 
respectively (Fig. 3). 
Humoral Immunity: 
Immune responses, including antibody, conqrfement and {rfuigocytes, particqwites 
n die destruction of promastigotes tfiat enter tfie body. The local production of antibody at the site 
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Macrophage 
Figure 3: The development of antigen-specific responses by T-ccIl subset in humans infected 
widi Leishmania depends upon balance of THj and THj cells which arc responsible 
for disease resistance and disease exacerbation. In addition, cytokines produced localh 
by non specific cells may provide an environment tiiat favours development of cither 
TH, or TH2 responses (Kemp et al., 1996). 
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of infection have been shown by presence of plasma cells in leishmanial lesions (Stahur et al., 1970) 
A few smdies had revealed the i^ xxiucUon of IgG 1, IgG3, IgE and IgA during the course of infection 
of leishmaniasis (EL-Amin et al., 1986; Lunch et al., 1986). Clinically, non-healing visceral 
leishmaniasis have been associated with high immunoglobulin levels and negative DTH, while 
bealing or cured individuals display strong DTH and low levels of antibody (Turk and Br>ceson, 
1971). Antibodies may also influence the course of infection by directly affecting parasile-
macrophage interactions. The potential protective functions of antibodies have also been 
demonstrated in vivo (Anderson et al., 1983). A monoclonal anlibocK' against a surface glycoi^otein 
(M-2) ofL mexicana has been shown to be protective, if inoculated into the footpads of BALB c 
mice along with parasites. Vaccination with M-2 (glycoprotein) plus adjm-ant also induce jM o^tection, 
wiiich is associated with increased antibod)' levels (Champsi and McMahon-Pratu 1988. Reiner and 
Lockslcy, 1995; Liew and O'Donnell, 1993). 
Cellular immone response; 
Not only hum(M<il immunity plays a role in Leishmania infection but cell mediated 
immunity also plays a major role in protection. The more protective imimune response for the 
resolution of Leishmania infection \s the cellular reactions (Pearson et al, 1983; Liew, 1986; 1989). 
Control of the infection is influenced by the induction of immune responses in \arious T-cell 
subpopulations. There may be preferential induction of protective T-cell reactions. The protective 
T-cell secretes y -interferon (IFN-^), which is a potent activator of macrophage microbicidal activity 
(Liew, 1989). Although interferon acts by stimulating macrophages to activate antimicrobial activilv, 
but other hmphokines are, also necessary for tlie efficacy of interferon (Davis et al, 1988). During 
early infection, all types of lymphokines are produced, but as infection progresses, either the 
protective or the disease-p-omoting responses take fwecedence (Scott et al, 1988). Recently it has 
been demonstrated that a balance between TH 1 and TH2 cells is responsible for disease exacerbation 
or resisitance (Kemp et al, 1996) (Figure 3). 
(I) QYHS" T cells mediated immunity-: 
The T-cells conferring protection or counter protection primarily belong to the CD4" 
T-ccU subset (Mitchell era/., 1981; Liew era/., 1982: Louise/a/., 1982: Gorczynski, 1985). CD8* 
T-cell plays a protective role in leishmaniasis. Administration of anti CD4 "monoclonal antibodies 
increases resistance to L major (Titus et al., 1985; Hill et al, 1989) while administration of anti 
CD8*monoclonal antibodies exaceibated infection in vivo condition in mice (Farrell et al, 1989). 
A protective role of CDS* T-cell subset during L. donovani infection is fotmd wliich is associated 
with the inhibition of parasite growth in hepatic nodules (Mc Ebrath et al, 1988). However, CDS* 
T-cclls can produce IFN-y upon specific stimulation (Kaufinann 1988; Salgame et al, 1992), and 
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jclivate macrophages lo kill Leishmania parasiies (Smith et ai, 1991). 
m) CD4* T-<ells mediated immunity: 
The resistance and susccptibilit> of the parasites are mediated by at least tvso different 
CD^* T-cell subsets (Scott,1989, Liew,1989). These are the THI and T,;2 CD4* T-cell subsets wtich 
arc morphologically identical, but functionally distinguishable, on the basis of cytokines productioa 
(Mosmann et ai, 1986; Cheminski et al., 1987). THI cells produce IFN-y and IL-2, and mediate 
DTH and IgG2a antibody pwtxluction, while 1^ cells jwoduces IL-4 and IL-5, and promote IgE and 
IgGl production but do not mediate DTH. Several other c>lokines including IL-3 and GTanuloc>le-
macrophage colony- stimulating factor (GMCSF) are produced in varying amounts by both cell 
tvpes. Based on the \'arious studies on the Leishmania resistant and susceptible mice it has been 
suggested that the T^l cells have a protective role and TH2 cells arc counter protective The 
protective T-ccll lines and clcmcs secreted IFK-Y and IL-2, while the counter protective T-ccll lines 
and clones secreted IL-4 and IL-5. Healing and resistance arc invariably associated with IFN-y and 
IL-2 sccrctiML and susceptibilitv- and non-healing with IL-4 and IL-5 production. The IL-3, wiiich 
is produced by both THI and TH2 cells, has been shown to be counter protective (Scott et al, 1989; 
Muller and Louis, 1989, Alexander and Russell, 1992; RoUinghoff, 1990). 
m ) L>iDphoIdDes/c>1okines mediated immanit}-: 
Killing o{ Leishmania parasites by IFN-y and TNF-a in activated macrophages 
have been demonstrated. TNF-a and IFN-y act s>'nergistically lo activate macrophages leading 
to the killing o{Leishmania parasites (Liew et al, 1990; Paul, 1993). The leishmanial protection 
mediated by IFN-y has been shov^ ii to be inhibited by IL-3 (Liew e/a/., 1989). Prelreatment 
of macrophage with IL-4 inhibits macrophage activation and parasite killing mediated b> IFN-y 
, while treatment of infected macrophages suggested that IL-4 enhances IFN-y mediated 
leishmanicidal acti\it) (Phillipes et al, 1990). Thus, interplay between IL-4 and IFN-y in inducing 
macrophage for leishmanicidal aclivit) is very complex. IL-4 act s>-nergisiicall\ with IFN-y lo 
promote maao];rfuge activation resulting in release of TNF-a, which activates the leishmanicidal 
acti\it> of macrophages (Solbach et al, 1991). 
Recent studies have suggested thai IFN-y has a capacity' to enhance host defense 
in euthjinic animals (Murray, 1988; 1994). Afltileishmanial acti\'ity in vitro or in vivo in cuthymic 
mice can be induced by regulated T-ccUs or can be modulated b>' IFN-y (Murray et ai, 1993,1995; 
Murray, 1995; Tumang et ai, 1994; Liew et a/., 1990). IFN-^  can directly activate macrophages in 
vivo regardless of the hosfs comi^anent of T-ocUs and indicates that CD4 *or CD8 'T-cclls can act 
with IFN-7 to activate intracellular microbial activity. Based on these findings it was suggested that 
fw most T-ccll-deficient patients, including AIDS patients, with preserved CDS *cclls, an adjunctive 
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therapy v^ iib IFN-y should be explored for opportunistic intracellular infection. 
In addition to IFN- ,^ in vho responsiveness to exogenous administration of other 
cytokines like. TNF-a , IL-1, IL-2, IL-7, IL-12 and GM-CSF also appears to require participation 
of host T-ccUs for optimal induction of antitximor or non-Niral antimicrobial acti\'it\ (Murray et al., 
1993; 1995; Murray and Hariprasad. 1995; Brunda el al., 1993; Hock et al., 1991, North et al., 
1988; Aukermane/ al., 1990). 
IL-10, a TH2 type associated cytokine, inhibits antigen-specific cellular responses in 
active \-isceral leishmaniasis. It has been shown to induce many inhibitory effects on IFN-y 
production and fiinction on the macrophage capacity of antigen presentation and cytotoxicity 
(Moore et al., 1990; Bogdan et al., 1991; De Waal MaleM et al., 1991). IL-10 \^^ shown to inhibit 
human lymphocyte IFN-y production, by suppressing NK-cell stimulating factor. 
IL-12 is a pluripotent cytokine that interacts with NK and T-cells to play a central role 
in the initiation and maintenance of THI responses and IFN^ production and is associated wifli cure 
of L major infections (Hcinzel et al., 1993; ScotL 1993; Sypek et al., 1993; Chan et al., 1991). The 
production of IFN-y by THI cells appears to be essential for macrophage acti\'ation, microbial 
clearance, healing and protective immunity in leishmanial infection (Belose\'ic et al., 1989). The 
production of IL-12p40 by PBMC &XMn treated patients has been reported to be markedly reduced 
by addition of anti-IFN-'^  (Kubin et al,1994). The production of these two cytokines after successful 
treatment was foimd to be interdependent. This proxides evidence that IL-12 and IFN-y are 
associated with healing process and could play an important role in immunity against human visceral 
leishmaniasis (Finkehnan et al., 1994; Zhang et al, 1994; Ghalib et al., 1995; Murray et al., 1995; 
Kemp et al., 1996, Tremblay et al. 1996, Milon et al, 1995, Solbach and Laskay, 1995) Figure 4. 
(h) Reacthe Oxygen Species: 
The toxic metabohtes of oxygen, superoxide (OV), singlet oxygen ("O )^ the hydroxy! 
radical(OH) and most especially hydrogen peroxide (HP3) ha\e been thought to be responsible for 
macrophage leishmanicidal activitj' (Murray, 1981; Pearson et al., 1982; da Silva et al., 1989) 
Evidence for this view point arose because of studies that demonstrated that amastigotes of Z. 
donavani and metacyclic promastigotes of L. major survived better than, and triggered the 
macro{ i^age respiratory burst only weakly compared with, log p i^ase promastigotes This ability was 
also attributable to amiastigotes having higher levels of glutathione peroxidase, superoxide and 
catalase than prcMnastigotes (Murray, 1982; Pearson et al, 1983). Intracellular amastigotes are also 
citable of down-regulating the macrophage oxygen-depeiKknt microbicidal potential (BuchmuUer-
Rouiller and MaucL 1987). Nevertheless, there has been increasing evidence from several studies 
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Figure 4: How the immune system fi^ils Leishmania parasiles: 
1. Leishmania parasites proliferate inside tfie oigaiieDes of ceOs, vihcn they t^ 
b^ nond file reach of antibodies. Macrophages ingest Leishmania oi]ganisms a| 
hold them in vesicles called endosomes. Many organisms trapped in endos(»9% 
are later destroyed by en^mes from lysosomes. Leishmania parasites, howev* 
survive and multiply in the endosomes. (Paul, 1993). 
2. Class n MHC molecules produced by the infected macrophage bind to peptif 
from the parasite. The MHC moleciile carries the peptide to cell surface] 
3. CD4* T ceOs that have complementary receptor mofecules are activated by ^ 
peptides class n complex and by the B7 molecfde on the surface of ^ 
macrophage. 
4. The activated T cells secrete certain cytokines that bind to receptors on if 
macrophage, h response the macrophage i^oduces TNF, NO and other facttf^  
that Idll the parasites. 
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fltfl ox)^n-independenl mechanisms are capable of killing Leishmanicr, not onh' are L. donavani, 
I. mexicana, and L. major resistant to oxjgen radicals (Pearson et a!., 1982; Mallinson and 
Coombs, 1989b), but the>' can be killed by macrophages deficient in the production of oxygen 
meUbolites (Murray and Cartelli, 1983; Scott et al, 1985). 
Recently a new mechanism of macrophage anti-leishmanial killing has been 
characterized as a novd metabolic patfiway synthesizing nitric oxides [nitric oxide (NO), nitrite oxide 
(NO'j) and nitrate oxide (NO",)] from L-arginine witfi L-citniDine as a co-product (Green et al., 
1990; Licw et a!., 1990a,b). 
Nitric oxide is derived from the guanidinonitrogen of L-aiginine and molecular oxygen in 
a reaction catafyzod by tfie ai^me nitric oxide synthase (NOS) (Palmer et al., 1987; Marietta et al., 
1988; Hlbbs et al., 1988). Nitric oxide has been shown to play an important role in the killing of the 
protozoan parasites of Leishmania species (Licw and Cox, 1991; Mauel et al, 1991; Roach et al, 
1991; Bogdan et al., 1993; Paiil et al, 1993; Stefani et al, 1994). Macrophage NO mediated killing 
of L. m(gor has bea\ shown to be induced by TNF-a acting syneigisticalh' with IFN-7 (Liew et al, 
\S90a). This biochemical pathways, as well as anti Leishmania activity-, is inhibited in the presence 
of D-aigjnine and N-monomethy L-ai^ ginine (liew et al, 1990b; James and Hibbs 1990). 
TREATMENT OF LEISHMANIASIS: 
The Worid Health Organization (WHO) estimates 12 millon cases of leishmaniasis 
woridwide, witfi annual figures of one million for visceral leishmaniasis (VL) and three million for 
cutaneous Idshmaniasb (CL) (Anon, 1990). Cutaneous leishmaniasis is a self healing and relativeh 
benign disease but visceral leishmaniasis or kala-azar, is a wide ^xread. severe and often fatal 
disease in the absence of specific chemotherapy. Several chemotherapeutic agents against himian 
visceral leishmaniasis are available. 
CHEMOTHERAPY OF LEISHMANIASIS: 
Antimonials Drugs: 
The antimonial d n ^ are most suitable for chemotfaer^y of leishmaniasis. These are 
known to be tissue specific in tfieir action. The>' accumulate most r^dh ' in liver where their 
efficacy is higher as compared to tiiat in spleen (Collins et al., 1992). The antimonial drugs are 
divided into two main groups: trivalent and pentavalent antimonials. Trivalent antimonial (urea 
itabamine) is now rarely used for fte treatment of leishmaniasis. Pentavalent antimonials are as 
follows: 
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PeatavaleDl aatimoDials: 
Xhe important pentavalent drugs are . 
n) Sodium stibogluconate (Pentostam) 
(II) Meglumine antimonate (Glucantime) 
(HI) Ncostibosan (Ethyl stibamine) 
(TV) Urca stibamine (Coibostibamine, stiborea) and deriN-atixcs of stibanilic acid such as stibacetia 
Among these, sodium stibogluconate and meglumine antimonate are drugs of choice 
till date. Sodium stibogluconate (Pentostam Sb*) dcN'clopedby Wellcome foundation. UK. in 1925 
was first used in China wth great success. Pentostam is more potent and well tolerated antimonial 
drug (Berman, 1988: Thakur et al., 1988). which is used for visceral leishmaniasis (Black et al., 
1977; Chulay et al, 1988; Thakur et al., 1988; 1990). The recommended dose of Sb' is 10-20 
mgkg/day (im or iv) for 20-40 days depending on the geographical distribution and, body 
sur^ce area of patients and also to reduce unresponsiveoess to the dnig (Thakur et al., 1988; 1989; 
OUiaro and Bryceson, 1993;Chulay et al., 1983; Chance, 1995). 
The drawback of Pentavalent antimonial is their rapid excretion by the kidneys, 
which is about 60-80% within six hrs of administration. This leads to acute toxicity, perhaps due to 
the production of trivalent metabolites, which increases in proportion with dose and duration 
(Bryceson, 1987). Besides incomplete cure, the usual side effects are vcMniting. diarrhoea, abdominal 
pain, anorexia, malaise, itching, fever, dizziness, headache, cardiotoxicit>- and nephrotoxicity with 
pentostam have also been reported (Chulay et al., 1985; Ree et al., 1985; Karen et al., 1987). 
In cutaneous leishmaniasis (CL), the parasites are relativeh insensitive to 
antimonials, as the concentration of the drug tends to be more in hver and spleen (Br>'ceson, 
1987),than reaching in desired concentration to skin(Thakur and Kumar, 1990; Herwaldt and 
Berman, 1992). Mucocutaneous leishmaniasis (MCL) is relatively poor responder to antimonials, 
possibl> due to the site of infection, poor immuoe response and partial dn^ resistance to antimonials 
(Grogl,1989). 
Meglumine antimoniaie (Glucantime" )^ is equally well accepted for American 
leishmaniasis (Chulay etal., 1988: McGrcvy and Morsden, 1986). The recommended dose and 
schedule is summarized in table 3. 
Aromatic Diamidines: 
The search for alternatives to antimony therapy, led to the disco\'ery of some 
aromatic diamidines, such as stilbamidine (Ashley et al., 1942), fax'droxystilbamidine (Kagan et al., 
1987), and pentamidine (Ashley et al., 1946; Ashley and Harris, 1946: Pastier, 1962). In 1944. 
stilbamidine was used for treatment of kala-azar in Mediterranean region. It has se\'eral side effects, 
viz. lowering of blood ];^ essure, respirat<My disorder, neurotoxicity and trigeminal neur(^thy 
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(KapicT et a!., 1942). Hydroxystilbamidine being stable and less loxic was preferred over 
stilbamidinc (Sen Gupta, 1950; Snape, 1952). 
pentamidine: 
Pentamidine is the drug of choice for treating Kala-azar patients, w-ho have failed 
to respond to antimony therapv' (Jha 1983). Pantamidine is less toxic than stilbamidinc and can be 
administered intramuscularly. It is more effectixe against visceral leishmaniasis than cutaneous 
leishmaniasis and mucocutaneous leishmaniasis (Stcck, 1974; Iyer, 1985). The recommetKkd dose, 
mode of action and various side effects are summarized in table 3. 
Antifungal antibiotics: 
(I) Amphotericin-B: 
Amphotericin B desoxycholate is a polyene antil>iotic. It is effecti\'e against cutaneous 
and mucocutaneous leishmaniasis, (Sampio et ai, 1985). Amfdiotericin B is 400 times as potent 
as sodium stibogluconate in infected hamsters and monkeys. Amphotericin B is formulated as a 
colloidal suspension uhich is administered as a slow intravenous infusion. Its usefiilness is limited 
b> ad\'erse reactions including anaphylaxis, thrombocytopaenia, flushing, generalized pain, 
convulsions, chills, fever, phlebitis, anaemia, anorexia, decreased renal tubular and glomerular 
function and h>pokaIaemia in about one-third of patients treated (Bryceson, 1978) It has therefore, 
never been considered a satisfactory first line drug for leishmaniasis and there is little e\'idence of 
its use in visceral leishmaniasis (Thakur, \99l:MisbTzetai., 1992). Amphotericin B tried at ven 
low dose administration on alternate days, with a shorter schedule was found to be more effecthe 
with moderate ioxicit> (Mishrae/ a/., 1994; Thakur et ai, 1994; 1996). 
Amphotericin B \s still of considerable interest because of its mode of actioa It binds 
to sterols in the plasma membrane, forming pores and leakage of ions. It binds preferentially to 24 
substituted sterols such as ergosterol, which i& the major cell membrane sterol of Leishmania parasite 
but not of mammalian cell membranes (Barman, 1991). To a lesser extent it binds to cholesterol 
in human membranes, and this leads to its toxicit\-. (Lianos-cuentas et al, 1991). The major 
advancement has been the new formulations of amphotericin B >\ith lipids (Pearson, et al, 1996) 
Liposomal amphotericin B(AmBisome, Vestar, San, Dimas, CA, USA) wus developed b> 
incorporating amphotericin B into Uposomes made of phos|4)atid\1choline, cholesterol, and disteTo\i 
I^sphatidyi ^ cerol. Pharmaoddnetic data, indicates that AmBisome (Lipos<»i]al am]:^taicin B) 
is well suited for the treatment of visceral leishmaniasis. It has been used successfully in patient with 
visceral leishmaniasis unresponsive to standard treatment (Davidson et a/.,1994;1996, Seamon et al 
1995). Ami^ iocil is a mixture of amphotericinB with cholesterol sulphate (a 1:1 molar ratio) 
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•hown lo be effective against visceral leishmaniasis(Dielze era/., 1993; 1995). 
0) }Ceioconiao\e: 
This drug has been used to treat cutaneous and visceral leishmaniasis (Bennan, 1988; 
Sunder et at., 1990; Wali et al, 1990). Like pentamidine and amphotericin B, Ketoconazole was 
jko found effective in antimony resistant cases (Bennan, 1982; Scott ei al, 1992; Wali el ai, 
1990; Sunder et al., 1990). The major side effects of the drug are vomiting, nausea and hepatic 
l-^ jcit\'. Itraconazole is safer than ketoconazole and has a more favorable phannacokinetic profile. 
,^cing retained in skin for up to two weeks. 
Other Antlleishmanial Drugs 
(I) Levamisole: 
In flie chronic fonns of L. tropica infection, good tfierapeutic response by levamisole 
gi clinical trial has been reported by Butier, (1978) and abo against L. mexicana in mice (Grimaldi 
et al., 1980; Rezai et al., 1988). 
(U) Aminosldfne : 
Aminosidine (Parcmamyan) is an antibiotic of amino-glycoside famih'. It is available 
•s an injectable formulation given either by intramuscular injection or intravenous infusion. 
Aminosidine is Hghty' effective gainst visceralizing species and Old Worid cutaneous leishmaniasis, 
but susceptibilitv' varies in different leishmanial species of New Worid cutaneous leishmaniasis. 
Aminosidine is foimd to be highly active against antimony resistant strains. It is nearh six fold and 
more than 600 fold active than sodium stibo^uconate against L. mexicana and L. major. 
respectively. Aminosidine is a safe, well tolerated effective "first line' alternative to pentavalent 
antimony for the treatment of native and unresponsive visceral leishmaniasis (ODiaro and Bryceson, 
1993). 
Although chemotherapy has been available for many years but it is not sufficient 
to cue the patients of leishmaniasis. The d n ^ are faii1> toxic, duration of treatment is undefined, 
mechanism of action is poorly understood and tiieir success rate is variable and pardculariy poor in 
immunodepressed individuals most notabl>' in patients with acquired immunodeficiency s>'ndrome 
(AIDS). Visceral leishmaniasis (VL) has now been established as an HTV-associated infectiorL 
The immunopathological picture in VUHIV infections is different. Patients witfi VL and HTV 
nfections have defecting cell mediated immunity. They need prolonged treatment witti antimonials 
nd are Habie to idq»e. Hie recent epidemics dfVL, parasite resistance to antimony, and the poor 
response in patients suffering fi'om HIV infection has increased the urgency of new theiapy or 
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j , ^ for leishmaniasis. 
The success of any chemotherapeutic regimen is oAen depend on the potential or 
Ijtcnt immunological response by the infected host. Successful chemotherapy of leishmaniasis 
in human results in the generation of antigen-specific T-cells and delayed type h>persensitrvit\' 
(DTH). ^^ Tien the patients have defective immune response, chemotherapy tends to be 
ineffective (Rizzi ef al, 1988). 
The macrophage is an essential cell for Leishmania donovani, because it is the 
only ceD in which the Leishmania species repbcate during mammalian infection. Therefore, an 
jjternative a^ iproach to therapy of visceral leishmaniasis would be to take tfie advantage of the host 
macrophages. -Macrophages have been implicated in host defense against tumors and various 
ailracdhilar and exlracdhilar pafliogois. The effective control of Leishmania infection in both mice 
aid human has been shown to occur ^ough cytokine induced macrophage activation (Green et 
al, 1991; Murray, 1990; 1994a; 1994b). 
Two new immunodierapeutic jqjproaches in VL have been explored treatment 
with IFN-7 alone or treatment with IFN- y phis conventional antileishmanial drugs. The appeal of 
the latter regimen stems firom its potential to simuhaneoust}' attack intraceOular L. donovani by 
different mechanisms: one utilizing direct toxicit>' to the protozoan witii the parasitized 
macrophage (antimony) and tfie other involving effects on the macrophage itself (Murray, 
1990;1994). The studies have demonstrated that IFN-y enhances both in vitro and in VA'O 
antileishmania} effects of sodium stibo^uconate (Murray et al., 1988). Recently a successful trials 
of combined therapy of IFN-y and antimony has been earned out in Indian kala-azar patients 
(Sunder et al., 1994; Shyam et al., 1995). It was observed that patients who were earlier 
unresponsive to antimonials were foimd to be cured with this immunochemotfaerapeutic regimen. 
Successful clinical studies with GM-CSF have also been reported, aMiou^ the efiBcacy of this 
cytokine is mostly related to the reversal of neutropenia (Badaro et al., 1994; 1995). 
IMMUNOTHERAPY: 
Immunotherapy is comparatively better than chemother<q)y. It directh' induces ceU 
mediated immune rc^xxise. Vaiious immunopotentiator, inchiding Bacillus calmette-Guerin (BCG) 
(Forticr et al., 1987), BCG phis promastigotcs (castes et al, 1989), levamisole (Rezai et al, 1988 
Xcyctosporin A (Bogdan et al, 1989), C. parvum (MB, 1987 Xand ghican (Cook et al., 1980) have 
been used to modify Ae course of Leishmania infection. These immunopotentiators have an ability 
- 2 5 -
10 aclivaie macrophages non-specifically. The complex inimunopotentialors like BCG and C. 
panum have been excluded from genera] human usage because of their undesirable side effects. The 
recombinant c>tokines are more effective, more controlled and have negligible side effects against 
leishmania infection. Several cytokines have been tested in models for intervention of visceral 
leishmaniasis, including IFN-y (Murraj' et al., 1988), IL-1 (Cuny and Kaye, 1992), IL-2 (Murra) 
eial; 1993), TNfF-a (Tumang et al., 1994), GM-CSF (Murray ct al., 1995) and IL-12 (Murray and 
Harijxasad, 1995). Success has been variable and precise mode of action is difficult to determine 
in some cases. The effective c\lokine therapy requires the presence of T-ceUs or other c\lokines. 
The complexit>' of experimental cytokine therz^' is particularly evident from recent studies on IL-
12.The n--12 can significantly reduce liver parasite burden and recipients of IL-12 indicate the 
presence of CD4-^  and CDS* T-cells, NK-ceUs and endogenous IL-2, TNFa and IFN-y (Murray and 
Hariprasad, 1995). Therefore, number of workers ha\'e suggested that immunological inter\ention 
of disease in combination with chemotherapy is much better than chemotherap> or immunotherapy 
alone. 
VACCINATION: 
Vaccination against leishmaniasis has a long histon, (Alexander, 1988b). From 
as early as the 19th centmy, and as recently as 1990, living organisms have been used for 
vaccination (Peters e/a/, 1990). Vaccination with L. arabtea against L major infection observed 
exacerbated lesion grovMh. Experimental studies using subcutaneous \ accination with heat-killed 
or radio-attenuated parasites have also often resulted in disease exacerbation following challenge 
of infective parasites (Liew el al., 1985b). Thus, these studies were not useful as a vaccine in 
humans. After several years, Scientists prompted to lr>' and use killed parasites, with or without 
adjiA'ant, as \'accines. or as an immunotherapeutic agents. These studies have shown some light in 
the progress of developncnt of vaccine, which is not sufficient and still lot is to be done. In order 
to limit the de\'elopment of a candidate \'accine, it should consists immunologically characterized, 
purified antigen or its deri\atives. Studies have shown that apart from parasite membrane antigens, 
soluble DOD-membrane antigens can also induce protection (Handman and Mitchell, 1985, Russell 
and Alexander, 1988, Scott et al., 1989). There are two t>pes of vaccines, (I) 'first generation' 
vaccines are con^wsed of heat killed or radio-attenuated parasites with or without adjmant and (ii) 
the second generation' vaccines have different recombinant molecules, either parasite fiactions or 
genetically constructed b\ removing virtilent genes or bacteria carrying and e^ qn^ essing leishmanial 
genes wiiich are avirulent At present the "first goieration" vaccines are at various stages of Phase 
I (safet)'), n (reactivity) or m (efficacy) trials in htJtmans. In contrast second generation' vaccines 
arc only in the preclinical state^odabber, 1989; 1995; Kaye etal. 1995) (Table 4) 
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TABLE 4 
PoKntial Uishmaniaui vaccines currently being JerelopeJ 
Current Jeielopuient stage Reference 
Clinical trials , n PARASITE WITH OR NVITIIOLT DCG L-li iCal tnalS 
^ I „fex{caiia ±BCG, L. braziliensis+BCG Field efficacy, 
I, major ± BCG* 
Mixed Leishmania strains 
^. aniazonensis 
| j \ t VACCINF5 
Rcconihinjnt Leishm.inici (OMFR/TS ' ) 
Recombinant bacteria 
Sulmonella-irpfiJ 
DCG-VT63 
Recombinant virus 
\'accinia-ep-16 
OtriNKD SLDLMTS 
r-ep63 ' 
LclF 
LACK 
OTHERS 
dp70-72 
Synthetic peptides 
immune responses 
Safttv, immunogcncciiv 
(Phase I-l l) 
Efficacy 
Preparation, Phase I-II 
Immune responses 
Prc-clinical development 
Development and animal 
testing 
In-vivo immunization (mice, 
docs) 
Preparation and mouse 
vaccination 
Preparation and animal 
testini: 
Primate studies 
Prc-clinical development 
Animal studies 
Mice and m-%iirn human 
ceils 
Mice and 
in-vitro human cells 
Gene cloned and protein 
expressed 
Animal studies 
Convit ei al. (19S7), 
Castes et al. (1994) 
Bahar/'/fl/. (1993) 
See Antunes et al. (198| 
K. Mar/ochi 
(unpubl. obs.) 
Mcndonca et al. (1995" 
Cmzei al. (1991). 
R. G. Titus el a!. 
(1995) 
Vang^-/ a I. (1990) 
Conncll et al. (1993) 
McMahon-Pratt et al. 
(1993) 
G. Grimaldi 
(unpubl. obs.) 
Russo et III. (1991) 
SU-ikv et al. (1994) 
Moueneau et ai (199 
Roafati el al. 
(unpubl. obs.) 
Rjchamin et al. (199j 
Jardim et al. (1990) 
'Field efficao trials arc undcrwav in Iran. Pakistan and Sudan. 
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The 'second generation' vaccine candidates can be divided into three categories: (I) live 
yjiccine (ii) defined subunits and (iii) crude fractions. It is possible to produce stable mutants wWch, 
at least, would cause an abortive infection, if inoculated into human (Cruz et al., 1991). An other 
attcn^t to develop an oral vaccine against leishmaniasis, a Salmonella typhimurium that expresses 
the L mcgor, promastigote surface protein gp63 has been constructed. It is found that the construct 
^ staHe, czpaiAz of oqpressing ttie protein and could induce Tgl type response in mice (Yang et al., 
1990). Another important development is the construction of recombinant BCG carrying gp63, 
^ c h has shown to protect mice against L. maxicana infection (Connel et al, 1993). 
Defined recombinant subunit and synthetic vaccines have been shown to induce protection 
in experimental animals. Various recombinant proteins or synthetic peptides, like r-gp63 (gp63 
expressed inf. co/i) or vaiious synthetic peptides of gp63 have represented T-ccll epitopes and have 
also induced partial protection (Russo et al., 1991; Jardim et al., 1991). Anodier recombinant 
protein of L braziliensis (LeIF), stimulates human Tgl-type ceDs and induces IL-12 production by 
normal peTq)heral monocytes, in vitro. A protein of L. major, Leishmania homologue of receptors 
for activated C kinase (LACK) which could activate protein kinase C, was used as protective T-ceD 
done against infection (Rivas et al., 1991; Mougneau et al, 1994). Russell and Alexander (1988) 
reconstituted crude Ag or purified Ag (gp63) into liposomes and then inocubted into CBA/Ca CM-
BALB^ c mice, both by subcutaneous and intraperitoneal routes. They observed complete protection 
in CBA'Ca mice,when administered by both routes and poor protection in BALB c mice. 
Handman and NfitcheD (1985) reported successful vaccination of BALB/c mice with 
purified L major LPG. Interestingly, sohible LPG that lacked the phosphatidylinositol anchor 
induced a disease exacerbation. Similar protection against L. mexicana in CBA'Ca mice is also 
rqxxted with honK^ous LPG, wWch is constituted into lqx>somes (Russell and Alexander, 1988). 
Purified LPG fi-om L. major reconstituted into liposomes with or without C. Parvum when 
inoculated into BALB/c mice jwior to infection resulted in survival of animals (McConville et al., 
1987). The protective efficacy of LPG has been speculated to be due to some peptides/proteins 
associated wifli LPG. There are several proteins which are tighth' associated with LPG, such as the 
Bprotein andK\fP-ll. Theseprotdns are highfy immunogenic in nature which lack NH; terminal 
signal peptides (Jardim et al, 1991; 1995; FKnn et al, 1994). These peptides are responsible for 
the T-cell response to LPG (Jardim et al, 1991; Moll et al, 1989). Jaffe and colleagues have 
isdated and purified a protein which is associated from L. donovani LPG molecules. This protein 
protect mice against cutaneous as well as, visco^al leishmaniasis (Rachamim and Jaffe, 1993). 
AUKN^ recoit vacdne litoature is a^ a^ilable in abundence and many antigens have 
been studied, ttte advants^ es and disadvantages of each qjproach for vaccine development have been 
discussed above but molecular vaccine development are open to question. 
CHAPTER 2 
LIPOPHOSHOGLYCAN: 
THE STORY SO FAR IN LEISHMANIASIS 
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The protozoan are the most diverse and amongst tfic most ancient group of organisms 
ill the cukaiyotic kingdom (Sogin et al., 1989). Many of their members are parasitic, Kke, those 
tj^ onging to the family Tiypanosomatidae (African trypanosomcs, Trypanosoma cruzi, Leishmania 
mp.) and the genera Plasmodium, Eimeria, Babesia, Theileria, rcaoplasma and Entamoeba, and 
fgz the cause of important diseases in humans and their domestic Hver stock. These parasites express 
cell surface glycoconjugates. Gfycoconjugates on the cell surface of these oi^ ganisms play a crucial 
role in determining parasite survival and infectKit>' (McConville and Ferguson, 1993). Such as, 
leishmania spp., gnnving in culture produce a polysaccharide or gjycoconjiigate, called the Excreted 
Factor (EF) (Schnur et al., 1972). It occurs on the parasite ceD surface as weD as in the culture 
medium and is the major antigenic ^coconjugate released from the surface of leishmanial parasite 
(Schnur et al., 1977; Slutzky et al., 1979; El-on et al., 1979). Excreted factor is immunologically 
active substance and species-specific (Schnur et al., 1972). EFs are responsible for parasite infection 
for host macrophages (Handman and Greenblatt, 1977). Excreted factors are also produced by 
intracellular amastigotes (Schnur et al., 1972). EFs from Leishmania tropica and Leishmania 
doncvaru share a common carrier protein, identified as rabbit serum albumin (Slutzky- et al, 1979). 
Excreted factors contains about 45.6% ^ucose, 39.9*'/o galactose, 14.2% mannose and a trace amount 
cjf ^ucosamine (Shitzky and Greenblatt, 1979). The molecular w^ht of tfie excreted factor ranged 
between 15-30 kDa. 
Excreted factor is organized into three categories: the first category is called cell 
associated, i.e. it forms ver>' tight complex with albumin in the medium and can be dissociated b> 
trcatmoit wifli TCA into two frs^m^nts, one having a molecular wei^t of about 61,000 (without and 
leishmania activity) and the other having, a molecular weight of about 18, (XX) (with no anti-rabbit 
jctivily) (Shitzl^ et al., 1979). This form of excreted factor has a properly to react with certain lectins 
and also show positive reaction with periodic acid-schiffs stain and is called Upophosphoglycan. The 
second categoiy is the sohible secreted form of excreted factor wliich arc isolated and purified from 
promastigotes. They are highly negatively chai^ ged polysaccharide. These appear to be 
immunok)gk:aIly idoitical substance, as secreted acid phosphatase by L. donovani, L. tropica and L. 
mexicana (Bates et al., 1990; Jaffe et al, 1989; 1990, Ilg et al, 1991). The third categoiy of 
exotted fiictor is an extracellular phospho^can (exPGX which is purified from culture medium of 
L donovani (Grds et al, 1992). Their structural characterization indicates tfiat they consist of the 
foBowing stnicturc: (CAP) (P04-6GaI (pi->4) man al ) ] 10-11. The cap contains one of the several 
•nanneutral(^gosaccharides, most abimdant is tfie branched trisaccharide Gal (pi—>4) [Man (a 1-
2)] Man (al). ExPG is identical to LPG except tfiat it lacks ttie Iqnd anchor and the 
phosphosaccharide core, with lesser number of repeating units as conqiared to LPG (Fig. 5). The 
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Figure 5: Summaiy of sccrctoiy products from promastigotcs (a) and amasdgotes of L 
mexicana (b). (Ferguson et al. 1994). 
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loshmanial excreted fiactor contains terminal non reducing galactose residues (Slutzky and Grecnblatt, 
1982). This galactose residue is found to be immxinodominant sugar in these excreted factor. 
Importance of cell-surface Glycoconjugates: 
1. The cell surface ^coconjugates play a key role in the survival of the Leishmania parasite 
throughout its Kfe cycle. It protects the parasite in the gut of the sandfly where the oiganism could 
be susceptible to digestive engines. 
2. It protects Ac parasite in die bloodstream of the vertebrate host where ttiey transiently exist and 
would be exposed to die lytic complement padiway. 
3. hi flie jrfiagrfysosome of tfie host macrophages where die parasite would be vulnerable to hydrolytic 
enzymes and the microbicidal oxidative burst 
4. It is possible diat Excreted factors promote immunity to leishmanial infection, such a general £F 
could provide a broad spectrum of protection, whereas the species-specific EF would onl>' protect 
j^ainst a single species (S lut^ et al, 1979) 
5. Interaction of excreted factor with macrophages may be helpful. 
A number of functions have been suggested for excreted factor; it inhibits the activity 
cf lysosomal -^g^ Iactosidase of macrophages (El-On et al, 1980). The excreted factor may be eidier 
a substrate fai mammalian lysosomal p-galactosidase or a competitive inhibitor of the enzyme. The 
excreted factors isolated from the culture fluid in wWch L. tropica and L. donovani were grown 
precipitated C-reactive protein. (Pritchard et al., 1985). It has also been demonstrated that 
letshmanial exoeted factor binds to C-reactive protein which may have a significance in host defense 
against these oiganisms. 
LIPOPHOSPHOGLYCAN (LPG): 
The lipophosphoglycan is a major cell surface gtycoconjugate of the Leishmania parasites. 
It is expressed preferentiall>' during die latter part of the logaridimic growth phase and during 
stationao' i*ase, and is finally released into the culture medium (King et al, 1987). It is observed diat 
the presoKe of albumin in the medium enhances the rate of release of LPG from ceQs. It is postulated 
that the lipid moiety of LPG interacts with hydrophobic binding site on albumin (King et al, 1987) 
and dns interactian frdlitates die released of LPG into medium. It is a heterogeneous lipid containing 
polysaccharide molecule (Turco and Descoteaux, 1992). The molecular wei^t of acidic 
gtycoconjugate is found to be in die range of 15,000-30,000 (Turco et al, 1984) and later it was 
found to be between 10-20 kDa of LPG (King et al., 1987). LPG is tiioug^t to pla^ ' an important 
lofe in die biology of the parasite due to its surfMx kx^ation, its developmental regulatiixi during the 
life cycle and the reduced virulence of tfic LPG deficient oiganisms (EDiay et al, 1990; 
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Xlov\!nviDc et aJ., 1992). A variety of functions and activities of LPG in mammalian host have been 
«N y^rimentaIIy demonstrated or suggested. These include involvement in attachment and detachment 
V )Me>3fi>' midgut, attachment and entiy of promastigotes into mammalian macrophages, protection 
^^Virssiie witfrai tfic { i^^ dysosomal conq)artment, inhibitor of PKC, inhibitor of oxidative burst and 
ik.*\xs^r^ of oxygen metabolites, inhibitor of chemotactic activity and as a recognition molecule for 
the l^^mphocyte-dependent immune re^xinses characteristic of leishmaniasis (Handman and Goding, 
^^^«^. Tolson et al, 1990; Turco, 1990; 1993; MoD et al., 1989; Descoteaux and Turco, 1992; 
W^^T^a et al., 1992; 1994; Sacks el al., 1995; Sacks and Turco, 1995; Panaro et al, 1995). In the 
%^ K v^ Ttfiese functions, tfie knowledge of biological actions of LPG may be useful in order to prepare 
* ^iKvine gainst hiunan leishmaniasis. 
^t>^lKrrURE OF LIPOPHOSPHOGLYCAN: 
^ ^^« (^p|>osphoglycan of promastigotes: 
The promastigotes ofaIlL€if^/ndma parasites produced LPG (King ^/a/., 1987; Pimenta 
•'^ '^  ^^ AcliLs, 1991). The general structiire of LPG molecule consists of four domains (Figure 6): 
^^ • rtK}sphatid>1inositol lipid anchor, 
^^ * rttosphosaccharide core, 
^ * txpcating phosphoiylated disaccharide region, and 
^^ * ^nnall oligosaccharide cap structure. 
^ V l^pid anchor of LPG: 
The polysaccharide portion of LPG is anchored by the unusual phosholipid derivative viz. 
*"'^ '^ '-«*lkyl-2-lyso-phosphatidyl(niyo) inositol (Oiiandi et al, 1987; McConville et al, 1987, Dg 
*Vv(inA$ et al 1992). The aliphatic chain of LPG in L. major, L. donavani and L. mexicana is 
^''^'^csi by ctfiCT linkage to caibon-l of the glycerol backbone. It can be either a Q4 or Cjt saturated 
'^^•^•Khed hydrocarbon (McConville etoi., 1987). The molar ratio in alkyl Kso-PI anchor chains 
•• ^^ **r>sl to be 73% and 21% for Cj^  and Cja, respective^. 
•* ^^Itosphosaccharide Core of LPG: 
The Phosphosaccharide core of LPG is attached to the inositol of the lipid anchor. The 
* '^*'"*'ft core consists of an unacet>dated glucosamine, two mannose, a galactose -6- phosphate, a 
•"^^"IHTanose, and a galactofuranose (Turco et al, 1989; McConville et al, 1990, Dg Thomas et 
'^ ^ ^"*a2). LPG possesses the Man (al->4 Glc N (a l->6) myoinositoM-P04 motif. The LPG 
** ^V x\t' £ donavani (Thomas et a/., 1992) and L. mexicana (Dg Thomas et al, 1992) possess a 
' ^ ^ ^ ' ^ 1 - a 1- phosphate attached via jAo^Aodiester linkage to the C« hydroxyl of tfie proximal 
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jj^ annosc residue. The L. mexicana LPG resembles that of L. donovani LPG having 
l^ iosphosaccharide core in which Man 2 is always substituted with Glcp alPO^. A substantial 
pavsr^^^ of L mtjbr LPG contains an identical gjucosyl-al-phosphate substitution. The Gal (al-3) 
(3al unit of the phosphosaccharide core has been found to be the epitope for circulating antibodies 
in patients with leishmaniasis (Avila and Garcia , 1988; Avila and Towbin, 1988; Towbin el al, 
1987). 
The repeating Units of LPG: 
op 
All IJPG molecules contain mvitiple units,phosphof^ted dasicchande repeat ofP04-6Gai 
(Pl->4 )Man (al) (Hg Thomas et al., 1990, Turco et al., 1987). These phosphoiylated disaccharide 
repeat units are attached by a-glycosidic linkage. The disaccharide repeat units of Z,. donovani LPG 
has no substitutions in their backbone sequence whereas repeating units of L. mexicana LPG has 
j^proximatdy 30% of its galactose residues substituted at the C, faydroxyl witfi glucose (Glc) residues 
(Hg etal., 1992). Tlie repeating units of tfie L. mq/or LPG are the most complex, as more than 85% 
of the galactose residues are further substituted with small saccharide side chains containing one to 
four residues of galactose, ^ ucose, or tfie pentose arabinose (McConviDe et al., 1990). Thus, die extra 
Glc ofL. mexicana and the extra Gal, Glc andAraofL. mq/br are always linked to the 3-
pofiition of ttK Gal residue of the phosphosaccharides repeat units (Thomas et al., 1992). It has been 
demonstrated that the number of repeating units per LPG molecule directly depends on the growth 
stage of promastigote. The svera^ numbo' of repeat unit&^mdecule reported for different species are: 
16 for L. donovani, 20 for L. mexicana and 14 for procycHc, 30 for metacycUc, 36 for amastigotes 
of Z.. major. (Kdleher et al., 1994). 
The Cap oligosaccharide of LPG: 
The LPG mokcule is tominated by the nonreducing neutral digosaccharides or molecules 
ike galactose or mannose. Although the LPG of I . major possesses the most complicated series of 
tcpeM6i\g units but it is capped with the simplest structure, conasting exchisively- of the disaccharide 
Man (al-2) Man (al) (McConviDe et al., 1990). The most abundant terminal oligosaccharide of I. 
donovanimdL mexicana LPG are the branched trisaccharide Gal (P1-4) [man (a 1-2)] Man (a 1) 
(Thomas et al., 1992; Ilg et al., 1992). In Ae L. major LPG, tfie C ^ stnicture is predominanth' Man 
al-2-Man, whereasinZ. mexicana and L. donovani LPG, the Cap structures are mainl>' Man a 1—> 
2Man, Man al->2Man al->2Man, and Man a l - > 2[Gal pl->4] Man. (Thomas et a/., 1992). 
The ratio of the oligosaccharide CMp& Man a l - > 2 Man, Man a l->2[Gal pi->4p^lan, 
Man aI->2 Man a 1-^2 Man, Man a I~>2 Man a I->2 [Gal pI->4J Man and Gal pl~>4 Man 
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is found to be 20:52:6:5:16. It is also observed that the ratio of cap species to total repeat units are 
found to be (1:12 and 1:25 for fH-oc>clic and metacyclic LPG respectively (McConville et al., 1992). 
The overall structure of LPGs isolated from L donovani (Thomas et al., 1992), L major 
(McConville et al.., 1990) and L mexicana (Ug et al.., 1992) promastigotes arc similar, with a linear 
arrangement of caps, repealing units, glucosylated core and lyso-alk>lglycerol lipid moiety (Figure 7). 
The most striking difference in LPG structure bctA e^en the Leishmania species lies in the 
pbosphorylated ohgosaccharide repeats. The L. donovani LPG possesses simplest, phosphorylated 
oligosaccharide repeat unit, where as in Z,. maxicana LPG, about one in five of the repeats is a 
trisaccharide with the structure Glc p->3[PO<^]Gal pi—>4 Man al- and L major LPG is the most 
complex structure (McConville et al, 1987, 1990). The L major phosphorylated disaccharide 
repeats are branched, ^^ t^h more than 85% substitution at the 3C position of Gal with di, tri and 
tclrasaccharide (McConville et al, 1990; 1992). 
Structural analysis of LPG from several species of Leishmania have shown complete 
conservation of the hpid anchor, extensive conservation of the phosphosaccharide core, variabiUt>' of 
sugar composition and sequeiKC in the repeating i4K>sphoiylated saccharide units aiKl the cap structure 
(Ug et al, 1992; McConville et al, 1990; Orlandi et al.,\9%l, Thomas et al, 1992). The three-
dimensicmal solution structure of the repeating PO/6 Gal (pi->4)Man al-disaccharide unit of LPG 
derived from L donovani has recently been determined (HcHnans et al, 1992 ). The molecular 
modeling stud> showed that each of the stable conformers of the Man ( al)PO/6Gal linkage exists 
in a different configuration \\ithin the same LPG molecule. The torsional oscillations allow the LPG 
molecule to omtract or expand in a manner reminiscent of a slink} spring, resulting in a molecule 
whose length can range from 90A*'(fiiUy contracted) to 160A°(fiilly expanded), assuming an average 
of 16 repeat unit (Homans et al, 1992). 
DEVELOPMENTAL MODIFICATION OF LPG METACYCLOGENTSIS: 
The most significant propert\- of LPG is its structural modification accompanying the process 
of mctacyclogenesis (Sacks et al, 1985; 1987). Structural comparison of LPG isolated from 
logarithmic and stationar\ phase promastigotes of L major rc\'ealed that lyso-l-O-
alkyl];4K)S|4iatidyliiK>sitol hpid anchor, and the phosphosaccharide core are conserved (Sacks et al, 
1990) Figure 8. The most striking changes that occur during mctacyclogenesis are as follows: 
(I) An apfM'oximate doubling in the average number of repeat units per molecule . 
(U) Decrease in the relative abundance ofside chains of^Gal or Gal pi-3Gaipi and a corresponding 
increase in repeat units with either no side chains or with side chains of Arap al-2 Gal p. 
(m) A decrease in the frequency with which the glycohpid zaAxx is substituted with a single glucose 
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Figure 7: Structure of LPG from tfircc promastigotes species of Leishmania grown in log to 
late log phase of growth (Turco and Dcscotcaux, 1992). 
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(X'l phosphate residue. 
The surface metacyclic promastigote contains densefy packed filamentous structures, 
which are JIO nm in thickness. In contrast, the loganthnucaO> gro^ Mi, non infectious nectomonad 
promastigotes have a thin gjyocalyx which is 10 nm in thickness. This variability is due to tfie 
(Jififerential ejq>ression in the LPG in these two stages. A striking dififerencc in the repeating 
nhoq)ho(>lated disaccharide composition in Ae two stages of LPG fi"om L major has been observed 
(Sacks et al, 1985; 1990). The repeat units of LPG obtained from logarithmically L. major and L. 
donavani contain terminal galactose residue, whereas, LPG in metacyclic grown form possess 
Arabinose and ^cose residues. The galactose residues are responsible for the agglutinability with 
peanut agglutinin, while in metacyclic promastigotes, the repeat units terminate predominanth with 
Aia and to a lesser cdoit wi^ ^ - ^ residues, which are not ligands for the lectin (Sacks et al, 1990; 
Turco et al, 1987; Volf ^/ al, 1994; McConviDe et al., 1991; 1992). However, the terminal 
galactose residue present in the cap oligosaccharide of LPG isolated from noninfectious parasites 
is absent in metacycbc LPG. Such changes in LPG structure may have profoimd implications on its 
functions and suggest that it ma>' have an important role in die regulation of the life cycle of 
Leishmania parasites. Therefore, the reduction in terminal!}' exposed galactose residues controls the 
st^-specific adhesion of developing promastigotes to the sandfly midgut (Pimenta er a/., 1992; 
Sacks and Turco, 1995). In vitro binding of LPG to nddgai could be completely inhibited with 
procyclic LPG or wifli purified repeat units containing side chains terminating in galactose, but not 
with metacyclic LPG or the metacyclic specific repeat units witti arabinose - capped side chains. 
Recent studies have revealed an identical modification of the LPG during in vivo 
metacyclogenesis. (Davies et al, 1990; Lang et al, 1991; Sandva et al, 1995). The Procychc LPG 
detected by day 3 on a small proportion (18%) of procyclic and nectomonad is formed in the 
abdominal midgut. By day 5, virtually all promastigotes in the midgut expressed high levels (90-
100%) of procyclic LPG on their surface, and a few begin to exhibit internal staining for metacyclic 
LPG. In contrast, 2% metacyclic LPG is present on da>' 5, 4(y% on day 7 and 60-70<^ b on da) 10, 
in the mi^ut to?, pc^asi (Saraiva et al, 1995). Even at 15 days, rou^ily 30-40% parasites in the 
gut have not differentiated to metacyctic form. However, complete metacyclogenesis is rareh 
achieved in culture (da Silva and Sacks, 1987). 
The developmental modification of LPG m^' be important in the binding of 
promastigotes to receptors in die sandfly midgut as well as on human macrophages and in increasing 
Ihe resistance of metacyclic promastigotes to con:q)lement me(fiated lysis (McConville et al, 1992; 
Camara et al, 1995). The expression of LPG on newly transformed promastigotes is found to 
beddayod anditcoiidnotbedetected iq>to3 days. It is possibkfliat delay is a consequence of time 
re<iuired for syndesis and surface expression of LPG after tnnsfonnation. Ahematively, since the 
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expression of LPG coincides with the morphogenesis of nectomonad forms, it is possible that its 
biosynthesis does not occur during tfie transformation of amastigotes to procyclic promastigotes. 
Xherefore, it has been si^ested that delayed c;q)ression of LPG on developing promastigotes would 
fgmx against the role of LPG in protecting the parasites from tfie proteolytic enzymes in the midgut 
of the sandfly vector (Dilon andLane, 1993; Saraiva et al, 1995). 
Species Specific LPG Polymorphisms and Vector Competence; 
The sandfly alimentary tract can pose a number of potential barriers to tiKe 
complete development of transmissible infection in the vector. The death and loss of Leishmania 
pomastigotes occur in an ina{)propriate vector, due to presence of proteolytic enzymes \ ^ c h are 
seoeted for the digestion of the infective meal (Schlein and Romano, 1986; Borovisky and Schlein, 
1987). Proteolytic activity could be modified by released gfycocoiyugate. Since shed glycoconjugate 
contains laige amounts of LPG, hence LPG polymnplusms mig t^ be driven by species variations and 
gpecificities of digestive en^mes in the sand^ gut 
The majority of experiments involving infection of sandflies with parasite strains 
whidi they do not nonnaIl>' transmit in nature have been carried out with P. papatasi. and a closely 
idated spoaes^ P. dubcxqui, are the natural vectors of Z,. major and do not transmit an> odter species 
(Sacks et al, 1994). It has been shown tfiat P. Papatasi supports the fuD growth and development 
of L. major in high frequency whereas tins is unsuitable for the development of L. donovani, L. 
infantum, L. tropica, L. braziliensis and L. amazonensis (Adler and Theodor, 1927; Heyneman, 
1963). P. Sergenti, a natural vector of L. tropica is able to support experimental infection wifli L. 
tropica but not of Z.. infantum and L. major. 
It is possible that LPG polymoiphism might be driven by heterogeneity in parasite 
recognition sites expressed on midgut epithelial cells of different sandfly species. It is observed that 
procyclic promastigote of L. major is attached only to the epittiehum of midgut of its vector P. 
papatasi, while promastigotes of other species £sil to attach to epithelium midgut of diis vector. 
Identical differences in binding are observed after using LPG mc^ule from each of die ^)ecies. 
The ability of Z.. major LPG to mediate procyclic attachment is probably determined 
by a unique a i^ect of its stnicture tiiat the multq)le ^-1-3 side chain-linked terminal galactose residues 
per mcdecule are Kspaos^ for binding. The LPG molecules of tlK other species are also examined, 
in these terminally exposed galactose residues are either absent mtirely, or restricted to the single 
neutral oqjpingolgosacdiaride e?q)ressing tfie branched trisacdutride. Gal pi->4 (Man a l->2) Man. 
This suggests diat the putative receptors oo P. pcqKitasi midguts are either hi^ily specific for pi-3 
linked galactose residues, or as is more Ukely the case, dependent on recognition of multiple ligands 
for staUe binding to occur. Therefore, P. papatasi may lack recqytors for LPG of other Leishmania 
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-pp. These LPGs might mediate significant binding to midguts of their natiiral or at least permissive 
ygctor. Similarf)', procydic promastigotes or purified procyclic LPG of Z.. donovani show a significant 
jod comparable binding to tfic P. argentipes midguts, which is natural vector of Indian L. donovani 
iifectioa OthCT Species, L major, L amazonensis or the LPGs of these species show comparatively 
^ bincfing to midgut of P. argentipes. Thus, P. argentipes midgut possess a receptor, lacking in P. 
papatasi, for relatively conserved oligosaccharide on LPG. The observed significant differences in 
LPG mediated binding aigue tfiat the alimentaiy tracts of at least some Phlebotomine vectors are 
functionally diverse, and midgut therefore, provide the evolutionary drive for LPG structural 
polymorphisms. 
LIPOPHOSPHOGLYCAN OF AMASTIGOTES ; 
All the detail information regarding the structure of LPG has been obtained fi-oro 
Leishmania promastigotes. The presence of LPG has also been examined in the amastigotes of L. 
doncMmi, L. major and L. mexicana but distinguish features have been obtained The L. donovani 
amastigotes apparently can not synthesize LPG, as at least a 10^  fold down-regulation in LPG was 
found corresponding to less tfian 100 molecuIes/ceD and L. mexicana lO* fold down-regulation 
summarised in taUe S. b an another report, it has been shown diat L. major amastigotes express LPG 
diat is both bkxivsivkiSfy and antigenically distinct firom tfiat of promastigotes (Turco et al, 1991; 
Moodj' et al.., 1991; Glaser et al.., 1991). Like promastigote LPG, tiie amastigotes LPG also consists 
of maint>' drree domain: The lipid anchor, hexasaccharide core and phosphogl>'can. The structure of 
the anchor, the core and the phosphogtycan were detcnuined by monosaccharide and linkage 
analysis, fast atom-bombardment mass spectrcmietry, one dimensional 'H NMR spectroscopy, and 
exo^cosidases microsequencing (Mood>'er a/., 1993). Amastigotes YPG consists of galactose, 
g^cose, maimose, ^ucosamine and inositol monosaccharides in a molar ratio of 51:30:24:1:1. 
Amastigotes LPG lacks arabinose. The bpid anchor consists four types of alkyl chain with length of 
24A 220, 20: and 26:0 carbon atoms in tfte molar ratio 68:18:8:6. The phosphate is present at 4% 
w/w of total carbohydrates content (Moody et al., 1991). It is found tiiat amastigotes LPG belongs 
to a polydisperse funily of molecules, showing a band spaiming region of Mr 55-100 kDa (Glaser 
et al, 1991; Moody et al., 1993). Therefore, the LPG of amastigotes possess a larger molecular 
wei^t than promastigotes, while ejqiressing at a lower copy number/cell. The average number of 
repeat units per molecule is 36 (McConville et al., 1992; Moody et al., 1993). Amastigotes LPG 
consisls of PO4 6Ga]pi-4Man a 1 repeats which are eiflier unsubstituted 70% or substituted 30% 
at tfie 3-C position of tfie Gal residues with (^osaccharide side diain containing pmaanfy of Gal 
and Glc (Moody et al, 1993). 
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XABLE 5: 
pf^ernainatioD of tipophosphoglycan io Leishmania 
Ifithmania spp. Promasiigotes (molecules cell ') Amastigotes (molecules cell"') 
Log phase Stai. Phase 
I, mexicana 1 x 10* 1.3-2 x 10* <10-' 
L. major 1.4x10* 1.1-5x10* 2x10^ 
L.dono\ani 3.3x10* 2.5-5.6x10* <10' 
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LPG from amastigote and promastlgote fonns of L. major have many commo 
l^y r^^ clcristjcs, such as: 
n TlK wnastjgotes LPG was extracted by same protocol as the LPG from promastigotes, indicating 
Ihe siiTular sohibility properties. 
«) /Unastigotes LPG is susceptible both to nitrous acid deamination and PI-PLC treatment. 
iij) The PI-PLC released PG from amastigotes LPG was found to have a similar structure to the 
promastigotes counterparts. 
jyf\ The amastigotes PG contains phosphate and was siisceptible to mild acid hydrolysis. 
During amastigote to promastigote transfonnation, the amastigote specific form of LPG 
g^gppcaa after subculture for 48hr, whereas, during promastigote to amastigote transformation, the 
ynastigote-q>ecific form of LPG was detected after about 12 hr (Glaser et al., 1991) The qiiantities 
of (he I. mq/or amastigotes version of LPG appear to be much less tfian the promastigote counterpart. 
The hig^ molecular wei^t phospho^can appears to be located in the himen of the flagellar pocket 
of amastigotes as seen in tfie mouse lesion and may be secreted frt>m diere into the lumen of the 
parasitophorous vacuole of die parasitized macrophages. LPG was undetectable in lysates of either 
amastigotes or infected macrophages (Bahr et al., 1993). In both L. mexicana and L. donavani 
amastigotes a& compare to L. major (McConviDe and Blackwell, 1991), the expression of LPG is 
down regulated at least 1000 fold In agreement with several recent studies (Turco and Sacks, 1991; 
CMascr et al, 1991) small amounts of LPG about 2 x Itf molecule&/cell are detectable in L. major 
amastigotes (Bahr et al, 1993). Finally, the amastigote surface is devoid of LPG as judged by 
immunofluorescence and immuno-clectron microscopy in L. mexicana (Bahr et al, 1993), wWle it 
was detected on the cdl surface of L. major (Kellehere et al, 1995). FunctionaIl>', amastigotes LPG 
ii diflerent tfian promastigotes LPG due to low expression of LPG molecules^ccD. It play a protective 
role in amastigotes against macrophage lysosomal enzymes (Bahr et al, 1993). 
BIOSYNTHESIS OF LPG; 
LPG is an essential molecule for the survival of Leishmania parasites as it progresses throi^ 
out fte varimis {biases of its Hfe cycle. The biosynthesis of LPG is as follows: 
(1) Synthesis of the PI lipid anchor region: 
Atocugh LPG posses a lyso-l-0-aIk\i-PI anchor, its synthesis may involve formation 
ofl-O alcy4-2-«cyl-PI precursor. Leishmania parasites possess significant amount of l-O-aIkyl-2-
acyl phospholqnds, but not lyso-alkyl frfiosirfiolipids (Wassef et al., 1985). The lyso-
•D i^pho j^bo^sids are known to be cytotoxic for Leishmania (Actnbuig and Gercken, 1987) as well 
as odiff eidcafyotic ceSs (Hoffinan e/a/., 1984). On tfie basis of OACT eukaiyotic system, it has been 
suggested tkat an ctfier phospholipid synthesis mi^t be initiated by acjlation of Cj of glycolytic 
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g^ teniwdiatc, suiA as dfihydroxyacetonephosphatc (DHAP). A key enzyme, believed to be involved 
in ether lipid synthesis is dihydroxy acetone f^osphate acjltransferase which has been reported in 
leishmania glycosomes (pcroxisomeXHart and Opperdoes, 1984). The acyl group may then be 
replaced with a fatty alcohol. Leishmania parasite do incorporate fatty alcohols in ettier 
pho )^hobpids (Hcrrman and Gcrcken, 1980). The resultant alkyl dihydroxyacetonephosphate mi^t 
then be reduced with NADPH and ac>1ated at the Sn-2 position forming l-O-aIkyl-2-acyl 
phosphatidic acid. The latter may activate the CDP-deri\'ative by CTP and then condensed with 
mj'oinositol to fonn l-Oalkyl-2-acyl-PL 
(II) Assembly of the Core-PI region; 
The pathway of corc-PI synthesis can be derived from flie recently elucidated 
structures of the GIPLs isolated from LewAmoma spp. (McConville and Bacic, 1989; 1990; 
McConville and Blackwell, 1991; McConville et al, 1990) and from details of GPI anchor 
assembly in African trypanosomes (Daeing et al., 1990; Menon et al., 1990). 
^ Leishmania species, addition affile first mannose residue to Glc-N-PI presumably 
would yield Man( a 1~>4) Glc N-PI, a precursor to LPG. The addition of the second mannose 
residue is at a branch point in the biosynthetic pathway of leishmanial GPI anchors. In the synthesis 
of the GPI anchor of gp63 (Schneider et al, 1990) the second mannose would form Man ( a 1-
> 6) Man ( a 1~>4) Glc N-PI, whereas in LPG, it would yield Man ( a l-->3) Man ( a l->4) 
Glc-NPL In LPG biosynthesis, three galactose residues tiien would be added, one of which is Ac 
g l^actofriranose. 
(III) Polymerization of repeating units: 
An in vitro membrane system from L. donovani capable of synthesizing LPG 
iqjcating units has been shown (Carver and Turco, 1991). The galactose and maimose residues of 
the LPG repeating units of L. donovani are bdieved to be added from their respective nucleotide-
sugar donors sequentially and directly to LPG (Figure 9). The mannos>i-phosphoiyl dolichol might 
participate as a maraiosyl donor in core-PI synfliesis but no such evidence was found regarding the 
possible involvement in the repeating unit assembly. It is suggested that guanosine diphosphate 
(GDP)-Man donates mannose-1-phosphate (Carver and Turco, 1991; 1992X thereby conserving 
the a-anomcric configuration of file maimosyl phosphate bond. Tlius, the rq)eating units of LPG 
appears to be polymerized by the individual alternating transfer of galactose and maimose-1-
phoqjhate residues from fiieir nucleotide derK'atives. It has been demonstrated that the assembly of 
fiiese repeating units of fiie LPG of promastigole occurs in fiie golgj body (Bates et al, 1990) and it 
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|jas been confinned using monensin. an inhibitor of golgi ftinciioa The addition of other hexoses 
ihat comprise side chains of the LPG repeating units of Z.. major and L. mexicana has not been 
examined. One of the key enz)me glycosyltransferases was discovered from L. major such as a 
putative arabinos> Itransferase. The arabinos) Itransferase may be an important regulatory enz}'me in 
metacyclogenesis in L. major (Ngetal, 1996; Opat e/o/. 1996). 
An LPG deficient strain of Z. major has been identified which is unable to form the first 
repeat unit due to a defect in the transfer of the gal residue (McConville and Romans. 1992). This 
strain express two highly truncated LPG structures on its cell surface (GIPL-4 and GIPL-6) and is 
unable to survive in mammalian macrophages (Handman et ai, 1986). 
COTC-Pl 
r GDP-Man 
GMP 
Initiation of Polvmerization 
Man-P-Core-PI 
r 
UDP-Gal Completion of initial disacchride unit 
UDP 
Gal-Man-P-Core-PI 
[UDP-Gal-GDP-Man]n 
[UDP ^ GMPJn 
(Gal-Man-P)n-Gal-Man-P-Core-Pl 
PohTOerization 
r 
GDP-Man Initiation of Cap formation 
> GMP 
Man-P-(Gal-Man-P)n-Gal-Man-P-Core-PI 
- UDP-Gal'GDP-Man 
Man 
.1 
UDP/GDP Cap formation 
Gal-Man-P(Gal-Man-P)n-Gal-Man-P-Core-PI 
Figure9 is the proposed pathway of assembly of the repeating imits and capping oligosaccharides 
of the L donovani LPG. The core structure is Gal ( a l->6) Gal ( a l->3) Galf (pi—>3> 
Man-< a l->3) Man ( a l->4) GkN ( a l->6) and PI is h-so-l-O-alkyi phosphatidylinositol 
(Turco & Descosteaux, 1992). 
IV. Synthesis of capping Oligosaccharides 
Not all but one of the cap structures elucidated from various leishmanial LPGs 
contain aMan ( a l->2)Man ( a 1) at the reducing end. It is therefore, tempting to speculate on the 
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existencc of a Man ( a 1~>2) mannosyl transferase. The activit)' of this enzyme would result in 
tfic signal for cessation of LPG elongation with the formation of a chain terminating Man ( a 1,2) 
)v!an- a l containing cap oligosaccharide. As metacyclogenesis is accompaiued by an apfproxinuite 
joubIii% in AK size of LPG, a chain terminating mannosyl transferase may prove to be one of tfie key 
regulatory enzymes in LPG biosynthesis. 
The major GIPL species jq^ pcar to have a relatively low turnover rate (Proudfoot et 
al., 1995X in contrast to LPG, which is activdy shed from the cell surface and has a h i ^ turn over 
rate (Handman et al., 1984; King et al., I9i7). The rate of LPG shedding is increased wlien 
par^ ates are grown in the presence of serum albumin, which contains a hydrophobic pocket (King 
et al., 1987), and die shed material retains Ac lysoaflcyl PI Kpid moiety (Ilg et al., 1992). This is 
consistent with a non-enzymatic mechanism of release of LPG which pass out of the plasma 
membrane as either monomers or micdies. This property is probably a reflecti(Hi of the weak 
aoacjimatf of LPG to die outer leaflet of the i^ asma membrane via a sin^e aliphatic dudn and may 
be important in allowing die rqnd e^qiression of new LPG structures on die ceD surface during 
parasite development (McConville and Ferguson, 1993). 
DEFECT IN LPG BIOSYNTHESIS: 
LPG-deficient strains of Leishmarda have provided evidence that LPG is essential for 
pnxnastigotes infectKity in die mammalian host (Handman et al, 1986; Elhay et al, 1990; McNeel> 
and Turco, 1990). These strains are avinilent in mice and are rapidly killed in die phagolysosome of 
in vitro infected macrophages. It has been demonstrated diat intraceSular survival of diese strains 
can be prolonged if exogenous LPG is inserted into the promastigote plasma membrane (Handman 
et al, 1986; McNceh' and Turco 1990). fo tins regard, LPG is thou^t to prevent c<xnplement 
mediated lysis of promastigote in the blood stream of the host (Puentes et al, 1988), in mediating 
die initial attachment of promastigotes to die macrophage (Handman and Goding, 1985; Puentes et 
al., 1988; da Silva etal., 1989, Talamas-Rohana et al., 1990), and also to protect the parasite from 
faydrt^ytic enzymes and the oxidative burst in the phagolysosome (El-oner a/., 1980; Chen er a/., 
1989;McNed^' and Turco, 1990). The defect of LPG biosyndiesis has shown that a mutaticm occur 
k the p 1 -4 galactos>1transferase, wiiich is involved in fonning the first repeat unit (McConviDe and 
Ifamans, 1992). Alternative possibilities, involving an impairment in intracellular vesicle tran^xnt or 
a defect in UDP-Gal synthesis or transport are unlikely, as all diese Gal ccmtaining GIPLa, are still 
expressed in higji copy number at the cdl sur&ce (McConville and Bacic, 1989). 
The protocol for isolating mutants defecting in die biosyndiesis of an abundant ceD 
surface LPG was developed (McConviDe, 1$>91; Turco and Dcscoteaux, 1992; McConviDe and 
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Pfgrnxon, 1993; Qg et aJ., 1994). LPG is the only major ceD surface molecule of Lci&hmania parasites 
«^Bch terminates in p-linked galactose, and is recognised by kctin^ricin agglutinin (King and Turco, 
jogg). Since mutations in any LPG bios>'nthetic step, kads to the absence of terminal p-linked 
^gdosyl residues, attached to the parasite, selection against ricin binding should lead to the recovery 
of a wide spectrum of mutation. 
It is observed tfiat R2D2 mutant synthesized a truncated LPG in the glycan core 
fcaott, tni was defective in a step involving addition of galactofiiranos^ (Gal^ ) tfiere in (Hung and 
Tureo, 1993; Descoteaux er fl/., 1993; Ryan etaL, 1993; Descoteaux et al., 1995; Beverley and 
Turco, 1995). This type of LPG is called LPGl. The defect in biosyntfiesis of LPGl may be 
fincfional genetic complementation in Leishmania parasites. Thus LPGl represents a class of gene 
oicodbig LPGl biosynthetic en2ymcs. It is shown tfiat the LPG made in LPG 1 transfected R2D2 
gtrain was of full lengtti and identical to wild-type LPG in structure (Beverley and Turco, 1995). 
The second class of LPG mutants are those which have defective 
ccn j^artmoitaHzation and LPG assonbly. They are synthesized as truncated LPG containing only the 
^ c a n core and lipid anchor and lacking repeating units (McNeely et al, 1990; Descoteaux et al, 
1995). This type of LPG was called LPG2. The accumulation of a truncated LPG core in C3PO 
indicated a defect in the addition of the first mannose phosphate residue (Descoteaux et al, 1995). 
Howerver, C3PO microsomal membranes catalysed the addition of repeating unit onto endogenous 
LPG glycan core acceptors, approaching neariy 65% of wfld type levels. The LPG syntfiesized in 
vitro was of the same size and structure, as that made by wild-type microsomal membranes. These 
studies indicate that, despite of its LPG- phenotype, C3PO contained all flie enzymes necessary to 
make LPG. Since loss of cellular compartmentalization occurs in preparation of microsomal 
metiibranes, it was concluded tfiat LPG2 could afifect the localization or compartmentalization of a 
key LPG biosynthetic precursor or en^me. 
Most probably, LPG2 mediates transport of an essential LPG precursor or 
biosynthetic enzyme into the secretoiy netwoiic Interesting fliere are several proteins which are 
tightly associated with LPG, such as the B protein and KMP-11. Thej' are strong '^ immunogenic 
protein, ^uch lack typical NHj- teimiiud signal peptides (Jardims et al, 1991; 1995; Flinn et al, 
\99A; Pimenta et al, 1994). Since putatrvely LPG deficient Knes show alteration in the surface 
locafizatioQ of B protein (Smith and Rangarajan, 1995), there could be an LPG-coiq)led patfiway for 
trandooatinn of ttiese protdns into the secretory network invdving LPG2. The various roles of LPG2 
have rapiicated iegardit\g tfie graeiic studies, in the Leishmasnia infectious cyd^. In both L. donavani 
and L. mcgor, LPG mutants showed aheralions in virulence, as assessed l^ survival in host 
macrofrfiages and modulation of tfie immune response (Handman et al, 1986; McNeety and 
Turco, 1990; Cappai et al, 1994; Reiner et al., 1994). Thus, the requirement of LPG2 and the 
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/jisaccharide phosphate repeats is essentia] for successfid intracellular parasitism oi Leishmania has 
been genetically proven (Dcscoteaux et al., 1995, Beverly and Turco,1995 ). These studies could 
p[C\,vk a usefiil enliy into flie intracellular macromolecular sorting and transport in Leishmania SPP. 
GLYCOSYLPHOSPHATIDYLINOSITOL: 
The g^colipids of Leishmania parasites belong to tfie class of gl>coinositol 
pho^holipids (GIPL) and they exhibit partial structural homology to the phosphatidylinositol wWch 
contains ^ 'colq)id membrane anchors of several eukaiyotic proteins and the lipid moiety of L. mcgor 
lipophosphogjycan (Rosen et al., 1988; 1989; Elhay et al., 1988). The structural analysis of diese 
^yccSpid& have in(ficated close resemblance to the phosphosaccharide core phosphatidylinositol region 
of LPG of different Leishmania spp (see Table 6). Particulariy, the L. mcgor GIPLs, have a smaD 
mannose and galactose containing gleans which are glycosidicaDy linked by an unacetylated 
glucosamine residues to either l-0-alkyl-2-ac)1-PI or lyso-l-O-alkyl-PL The glycan parts of these 
mdecules are con^^ely identical to the analogous portions of LPG (McConville et al, 1987; 1990; 
Schneider et al, 1990; McConville and Bacic,1989; 1990). 
The g^coinositol phospholipids (GIPLs) of L. donavani promastigotes are non-
galactosylated and synthesize GIPLs containing one to four mannose residues in abundance. The I. 
donavani amastjgotes (HPLs, contains one to three mannose residues, which are structurally different 
fixjm promastigote GIPLs and appear to be precursors of the glycol^ nd anchors of proteins (Fig. 10). 
The plasma membrane of the amastigotes, also contains a number of glycosphingolipids which arc 
apparently acqiiired from tfie mammalian host (McConville and Blackwell, 1991). All newly 
synthesized GIPL-3 and P-GIPL-3 arc rapidly utilized for LPG anchors (Proudfoot et al, 1995). 
According to autfior, flie supply of GIPL-3 and/ or P-GIPL-3 in L. major strain is closely matched 
by their rate of utilization as LPG/anchOTs. However, in some Leishmania strains, GIPL-3 and or P-
GIPL-3 are found at relatively hig^ abundance on the cell surface (McConville and Bacic, 1989; 
McConville et al, 1990; 1993). ft is possibly due to the regulation of a putative a l->6 
galactosyltraiisferase that converts GIPL-2 into GIPL-3. 
CcD surface LPG have a relatively r ^ d turnover, as compared to GIPL. The GIPLs 
have been observed to be more stable ^ coconjugate than LPG (Proudfoot et al, 1995). The higji 
turnover of LPG is due to the rapid shedding of molecules from the ccD surface (Handman et al., 
1984; King et al, 1987). The shedding of LPG appears to be a stochastic biophysical event, based 
on monomers of LPG molecules leaving the plasma membrane spontaneously. The shedded LPG 
moleciiles have shorter alkyl chains and thus are more polar than the cell associated LPGs (Jig et 
a/., 1992). The stability of tiie GIPLs containing alkyl-PI Iqrid moieties is consistent wifc tfiis 
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Trpe-2 6IPLS 
Table 6 
turn SUuctute 
Ml M*na1-4GlcN\-6Pt 
Tyt«-1 6IPI 
M2 M»ncfl-<^ 
M}na1-<GlcN1-ePt 
M3 Man(3n-2Minon-6 
M»nort-4GlcNl-6Pl 
M 2 Uvitf-4QcNa1-6P1 
U»nort-3' 
GlPl-1 |yUnffl-«GlcNQl-6PI 
&ali^-3Manal-3 
&K-2 Mnal-4GlcKaf1-6PI 
Gala1-3G«t^-3M«nal-3 
OPL-3 Minon-4aeNon-6PI 
Glial-6Cjiai-3Ga)ig9l-3Manai-3 
GIPL-A Minal-4GfcNor1-6PI 
C»i;j i-3Gjia1-3G»l^Si-3Minai-3' 
Glcort—TO4 
LFGp g Manoi-^GIcNMiysoPi 
Gi!art-oG<lcn-3Cali]?l-3Minan~3 
CiPt-^* Minal-4GicNcrl-6/>wPI 
l«l»«jl—ro<—6G»l en-6G»lal -3GJl;pi -3Minai -3 ' 
Ocff i—TO, 
Gft'L-S' ( Mina1-«GicNflf1-«i>»P1 
Mmcrt—«),—6G».'al-6GJla1-3Gil/p1-3Minon-3 ' 
Hytirid type GIPLs 
M«nal~6 
•"^ Uinafl-iCkm-iPt 
M»non-3' 
*•* |yUnal-4acNl-6Pl 
Manoi-3'^ 
HHfHfHi-n, 
Mancrl-6^ | 
B^ ^MS Maoal-4GlcN1-6PI 
Mancn~3 
Lmt/or L nnunt LiaiV'V* 
m (p) (p) (A) 
• • 
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GiPLs Glycosphingotipidj 
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Figure 10: Schematic representations of the ccQ surface of different developmental stages of 
Leishmania spp.: The cell surface of Leishmania parasites is coated by a more 
conqdex gjtycocalyx which also diffo* in the different developmental stages. The surface 
t^ycocalyx of promastigotes s t ^ contains several abimdant GPI-anchor proteins, LPG 
and low mc^ ecidar^ nass (iflLs. Ute surface expression of LPG and the major surface 
{^ycoprotein is greatly down regulated in the intracellular amastigote stage (McConviDe 
and Ferguson, 1993). 
- 4 9 -
observation as ihey are much less polar compared to LPGs. Presumably, the Lyso-GIPL species are 
also sufficiently non-polar to be stable and are associated with the plasma membranes. The 
difference in turaover of these t>vo classes of surface molecules may reflect their different functions. 
The high turn over of LPG molecules are required to allow the expression of new LPG structures 
on the parasite cell surface during their de\'elopment within the sandfly midgut (McCon\-ille el al., 
1992). This turnover is thought to be important in regulating the attachment and subsequent 
detachment of promastigotes from epithelial cells along the midgut (Pimenla et al, 1992: Sacks et 
al., 1995). In contrast. Ae slow turnover of the GIPLs is critical in maintaining a jffotective surface 
on glycocalx-x during and after the differentiation of promastigotes to amastigoles y>iien the levels of 
LPG and GPI-anchored proteins arc drastically diminished (McCoville and BlackweU, 1991; Winter 
et ai, 1994; Bahr et al., 1993; Chneider et al., 1993). GIPL also plays an important role in host-
parasite interactions (Proudfoot and Liew, 1995, Jacobson, 1995; Bates, 1995, Aebiscber, 1994). 
Glycosyl-phosphatidyl inositol (GPI) membrane anchor proteins; 
The glycosvl phosphatidNlinositol (GPI) anchors are used to anchor proteins to the outer 
plasma membrane. They can be considered as part of an alternative anchoring mechanism to the 
transmembrane polypeptide domain of t>pe-l membrane proteins. Se\'eral workers have analv'zed the 
strxicturcs and functions of different eukaryotic GPI anchor proteins (Ferguson and Williams, 1988: 
Low, 1989; Cross, 1990; Thomas et al., 1990, Ferguson, 1991; 1992 b; Ferguson et al 1994: 
McCon\ilIe, 1991; Ttirco and Descoteaux, 1992). The GPI anchoring proteins are mostly present 
at the cell surface of the protozoan parasite, while in mammalian cells, it constitutes only a limited 
distribution of cell surface jwioteins. Although some of the plasma membrane {MX)tcins of the parasitic 
protozoa use transmembrane pol>peptide anchors (Table 7 and Fig. 11). 
All of these surface molecules are placed in GPI famih because ihey contain the 
structural motif Man a l->4 Glc N a l->6 PI. All GPI-anchor proteins contain common core 
structure of ethanolamine-P04-6 Man a l->2 Man a l->6Man a l->4 GlcN a l->6 PI. Some 
of the GPLs also contain Man a l->6 Man a l->4 Glc N a l->6 PI motif and arc called the type-1 
GIPLs. Those which diverge from the GPI-anchor core structure by containing a Man a l->3 Man 
a l->4 GlcN a l->6 PI motif are called t^pe-2, GIPLs. The LPGs structure arc also based on a 
conserved type-2 GIPL core (McConville and Ferguson, 1993). Those which contain the a l->6 
and a 1—>3 structural feature are called hybrid t>pe GIPLs. 
The Upid moieties of the parasite anchors can also vary in a species and stage- specific 
manner. These anchors contain dim>Tistoylglycerol (in VSG), lyso-1-O-stearoylglyccrol (in PARP) 
and alk>'lac>1glycerol (in Leshmania gp63, and T. cruzi IG7 antigen). The Leishmania i»-omastigote 
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Figure 11: A comparison of transmembrane and GPI-anchorcd proteins, the type-1 
transmembrane spans the phospholipid bilayer vAale GPI-anchored protein does not 
(McConville and Ferguson, 1993). 
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suxiace contains about 3-5 million copies of LPG (Turco, 1992), which terminate in neutral mannose 
residues about 20 nm from the cell surface. Together witti about half a million GPI-anchored 
^coproteins also occur (manily gpd3). The LPGs protrude above a dense surface gjycocalyx of about 
10 million copies of GIPLs (McConville et al, 1993, 1990; McConville and Blackwell, 1991). 
The Afiican ttypanosonK procycBc surface contains neither LPGs nor GIPLs. However, 
tfie major surface macromolecule is a glycoprotein called PARP. It is expressed in around 5 million 
copies/cell. Structurally to African tiypanosome has a pofyanionic rod domain made \xp of Ghi-Pro 
repeats, a GPI-anchor and mannose residues in tfie form of N-hnked oligosaccharide about 18 imi 
fiom the manbrane (Richardson etal, 1989; Clayton and Mowatt, 1989; Roditi et at., 1989). These 
features are quite similar to tiie Leishmania LPG, in terms of dimension, charge, density and ottier 
general physico-chemical properties. 
The various function for GPI-protein anchors have been descnbed, particularly in 
manmialian and protozoan systems and were reviewed by many investigators (Cross, 1990b; 
Ferguson, 1991; 1992b) (see table 8). It has been suggested tfutt sonae basic functions are common 
to hi^er and lower eukaryotes, while otfier may represent species specific adaptations that may be 
advantageous to eitfier uniceDular or metazoan organisms. 
Surface glycoprotein (GP63): 
The major surface protein of Leishmania is referred as gp63. It is a ^ coprotein of 
63,000 \fr containing a GPI manbrane anchor (Bordier, 1987; Button and McMaster, 1988; Bouvier 
et a/., 1989; Qiaudhuri et aJ., 1989) and has been reported to be expressed in promastigotes of diverse 
species of Leishmania. It has been demonstrated, to be expressed, in both promastigotes and 
amastigotes life stages of L. major (Frommel et al., 1990) and L. mexicana (Medina Acosta et al., 
1989); however, aO strains may not express an amastigotes form of gp63 (Schneider et al., 1S^2). It 
has been demonstrated that gp63 constitute about 1% of the total cellular proteins or half million 
copies/ccn (Bordier, 1987). 
GP63 has been shown to be a metalloproteinase (Bouvier et al., 1989; Chaudhuri et al., 
1989X with a wide range of pH activity (pH 6-10) and has been reported to hydrolyse non-specifical}>' 
a variety of substrates including casein, azocasein, gelatin, albumin, hemoglobin and fibrinogen 
(Chaudhuri et al., 1989; 1990; Bouvier et al., 1989; 1990; Russell and Cross, 1990; Tzinia and 
Soteriadou, 1991). GP63 shares several c i^aracterislics with tfie membranes of the matrix 
nKtaBoproleinase finnily (Nagase Barrett and Woesdsner, 1992) including degradation of components 
citbc extracellular matrix, such »s, fibrinogen, location at the cell surface, requirement for Zn^ and 
sequence sindlarity of die proposed active site, inhibition of the proteinase activity by chelating agents 
and a 2- macFogM>ulin (Heumann et al., 1989X secretion as a btent from of tfie enzyme and tiie 
-sa-
lable 8: Functions of GPI in mammalian and protozoan cells 
f l -SCnONS MAMMALIAN PROTOZOAN CELLS 
CELLS 
Attachment of protein to plasma 
membrane -\-
Associaixon in membrane micro 
domains 
Intracellular sorting _j. 
Transmembrane signaling via GPI 
clusters 
Endocytosis via non-clathrin coated 
pits (potocytosis) 
High surface expressionlow 
turnover rates 
+ 
+ + 
+ + 
Selectne release of protein by GPl-
PLC 
+ + 
High surface packing _ _j_ 
Contribution of surface glycocalyx _ j _ 
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jctivation by mercmia] compounds (Button et al, 1993). 
The genomic organization of gp63 coding genes in the subgenus Leishmania have 
shown vajious degree of complexity: a tandem array of 6 genes in L. major (Button et al, 1989), a 
cluster of 7 tandem genes with at least 3 dispersed genes in L. donovani (Webb, Button and 
McMastCT, 1991X 4 tandeml>' repeated genes plus 14 genes in L. Chagasi (Roberts et al, 1993) and, 
2 clusters of 4 and 5 tandem genes respectively together with one separated gene in L. mexicana 
(Medina-Acosta and Russell, 1993a). 
Th: translated amino acid sequence analysis of Z.. major showed tfiat it contains about 
602 arvino acid in precursor protein consisting of an NHj- terminal signal peptide of 39 amino acids 
for membrane faiigeting, a proregion of 61 amino acids, the mature protein of 477 amino acids 
containing ^cosylation and putative catalytic sites, and a CCX)H- terminal signal peptide of 20-25 
amino acids for GPI attachment (Button and McMaster, 1988). Recent studies have reported that 
certain gp63 genes exhibit stage-specific expression (Ramamoorthy et al, 1992; Medina-Acosta et 
aJ., 1993) such as the L mexicana amastigotes form of gp63 exists as a soluble metalloproteinase in 
an acidic lysosomal compartment (Bg, Harbecke and Overath, 1993). 
C3^ 63 has also be^ dononstrated to be a major antigen recognized following infection 
by Leishmania in botti experimental animals and humans. Peripheral T cells from a panel of patients 
with New Worid Cutaneous leishmaniasis (NWCL) responded to recombinant gp63 (r gp63) and 
human T-ceD lines. Thus, it was conferred that they specifically reacted with rgp63 (Button , Reiner 
and McMaster, 1991; Russo et al, 1991). FurthOTnore, gp63 specific T-ccIIs that developed in vivo 
during a naturally acquired infection reacted with gp63 &om diverse species of Leishmania (Button, 
Reiner and McMaster, 1991; Russo et al, 1991). The T-ceD response to gp63 in cogenic mouse 
strains were shown to be under ttie genetic control of specific MHC Class D aDeles (Lopez et al, 
1991). 
FUNCTIONS OF LEG: 
The overall stnicture of LPG and its highly unusual domains indicate that LPG should 
have several important fimctions, in the life cycle of the Leishmania (Table 9). Evidences have been 
provided for a surpnnn^ large number of potential activities tfiat enable the promastigote to survive 
and flourish in the bydrolytic environments. 
EXTRACELLULAR FUNCTION: 
Function in SaadOy-Ldshmania interactions: 
LPG plays an important role in sandfly-parasite interactions. During tfie differentiation 
en 
<m 
u 
t% 
C 
o 
i = 
o 
c 
u 
%/* 
o 
•^  
^ 
- * e7» 
a> 
a> 
CM 
E TS 
2 S «^  
o 
o 
«/1 
2 g :z 2 1 ^ ? 
C 3 
o» (7> 
_ • — r ; _ - o 6 j _ -
ro . o c -c: i» 
_- —• * _ •• 5? ^ 
if! «?> -• „ — -^ ™ ^ - ^ . £f " H 6 . . S o» 
c C - , c j - a o c — 
u O — c c en u 
c= E 
0 o 
0 » — CT» 
0 1 o ) a r t 
o) o .— <n _ 
CT> CT» _ * . • 
~^ ^" m ; « 
. fO 
—^ — at — cj 
IV n QJ 
0 1 a> 
a. oj 5 5 5 
> , > . ^ ro - O 
U CJ u ' ^ U 
:= z c y c 
2 2 C (S J^ 
o 
c 
e 
o 
..3 
o 
£1 
o 
5 S 
•o -g 
o 
c 
c 3 
3 3 
3 3 
c a. 
S ^ 
T 3 - O 
ra 
o 
c 
0 
< J 
J O 
o 
51 
It 
o 
E 
o 
t 
s 
Is 
ill 
o 
£ " c §5- = 
a. 
o 
il^ ^sB 
i l r l 
sifiMi 
€» O . 
T 3 
C 
aa 
— " f? 
E 5 2 2 
o c c^ *^  
S 2 ^ o 3 
c «» c w 
o <J E u c 
2 - e £ 5 
^ I - 3 " 
0 1 v V I 
" !2 =^  f " * q - J 
o. S -o 
5 = 1 III 
O C3. O 
g " O " O 
5 I I 
"8 ^ ^ 
-^ jz r: 
Is 
o o Is 
o> cz 
isi 
- 5 6 -
and multiplication of promastigote form of Leishmania parasites that take place in the midgut of 
sandfly, Phlebotomus and Lutzomyia spp, the nwjor ph>-sical change which occurs during 
inctac>x:Iogenests is fte stnictural modification of LPG (Sacks et al., 1985). The importance of these 
modifications with respect to the successful survival of ttic parasite within tfie mammalian host has 
been reported (Sacks, 1989; Turco, 1990). Furtfiermore, the possiWit)' of these deviclopmentall)' 
linked structural changes in controlling the attachment and detachment of maturing promastigotes 
fi-om midgut epithelial cells has also been speculated (Turco, 1990). The attachment of procyclic 
promastigotes to epithelium cell lining of its vector is due to the presence of specific recq)tors on the 
qxthdium cefl lining of sandfly. These receptore bind to the LPG molecule of parasites. For example, 
the multiple p-Knked galactose residues of L. major LPG is thought to be resp(xisible for the 
attachment of P. papatasi, while other q>ecics of sandfly midgut possess reccptOTs of relatively 
conserved oligosaccharides or lectin like' (Pimenta et a!., 1994). These lectin like receptors bind to 
the LPG of procyclic promastigotes. Letshnama parasites e?q>ress tcvo major cell surface molecules, 
LPG and glycoprotein 63(gp63), during their development A laige amount of procyclic LPG is found 
on ttte surface of epithelial cells of the sand fly gut wall In contrast, despite its abundant «q)ression 
on promastigotes, gp63 is not detected on fte gut cell waD. LPG deficient strain (R2D2, a mutant 
strain of L. donejvanf) Med to attach to the midgut of the sandfly. The absence of the metacyclic LPG 
on the gut waD suggest diat the modified version of the LPG docs not bind to these cells and 
consequentf}' allows infecting parasite to move forward after their maturation. Hence, LPG is the ke>' 
determinant which is responsible for attachment and detachment of promastigotes to the sandfly 
midgut and its migration to ttie mouth part (Pimenta et al., 1994). 
FUNCTION IN BLOOD STREAM : 
Complement activation and resistance to complement mediated damages: 
During inoculation and infection of macrophages in human blood stream, promastigotes 
are exposed to the potential lytic effects of normal serum (Joiner, 1988). It appears that die 
devdopmoitaDy regulated modifications of IPG represents the major resistance mechanism (Savaira 
et al. ,1995; Pkneota et al., 1992). Promastigotes of all Leishmania species fi-om log-phase cultures 
(nonnnfective) are extrone^' sensitive to ccniq)lement mediated lysis. The stationary phase metacyclic 
promastigotes display an increased resistance to lysis by activation of complement (Franke et al., 
1985). It has been suggested that the laiger LPG molecules on metac}'clic promastigotes are 
icsponsiUe for tfwr resistance to complement mediated lysis. LPG undeigoes extensive modifications 
during metacydogenesis v^ liich includes elongation of flic molecule due to an iq>proximate two fold 
increase in the phosphodisaccharide repeats and reduction in tenninal e;q>osed galactose residues. 
Therefore, elongation of LPG controls flie complement mediated lysis. This is supported by flie 
- 5 7 -
^j,servation that in L major, most of C5b-9 complexes were spontaneously released from the 
-jejacycHc promastigotes surface. This action precludes their insertion into the membrane and death 
of the parasite (Puentes et al., 1990). The kala-azar serum show's a strong reactivit) with a LPG-
dcficient mutant of L. donovani and little rcactivit>' with wild-type promastigotes which confirmed that 
(he humoral response associated with kala-azar does not contribute to immunity (Karp et al, 1991). 
Attachment of Host Macrophages: 
Since Leishmania parasites infect primarily mononuclear phagocytic cells, attachment 
(^paraale to potential host cdls require specific recognition molecules on the surface of bott\ parasites 
tnd macrophages. The glycoprotein gp63 (Bouvier et al., 1985; 1987) and UPG present on tiiic 
surface of all the Leishmania species, have been implicated as tfie main parasite Ugands (Handman 
and Coding, 1985, Russell etal, 1986; 1988) whereas CRI, CR3 and Mannosc-Fucose receptor 
(MFR) and 1^50^ 95 represent the corresponding macrophage receptors (Wilson et al., 1986; 1988; 
Talamas-Rohana et al. 1990). In L. major, the LPG of metacycKc promastigotes is believed to serve 
as a recqjtor for fee tfiird component of complement (C3X which is ttien converted to C3b and C3bi 
by activation of tfie classical pathway of complement activation and the subsequent CR-1 mediated 
binding and internalization. The utilization favour of boA QU and 013 receptors are implicated to 
Ae survival of Leishmania promastigotes becuase they pfxxnote phagocytosis without triggering the 
oxidative burst (^'rigjit and Siverstein, 1983). 
Studies have fiirther demonstrated that attachment of L. major promastigotes to 
raacrophiges is inhibited b> the Fab fragment of an anti L. major LPG antibod)', suggesting that LPG 
is a parasite recqjtor for macrojAages (Handman et al., 1985). The binding of purified L. major LPG 
to macrophage and nonmacrophage cells has been shown to be temperature dependent. Based on 
these studies two mechanisms of binding have been proposed: a specific mechanism in which the 
cartx^drate part of the molecule binds to a macrophage receptor, and a non-specific mechanism in 
which the lipid of LPG interacts with membrane of the cells, probabh through insertion into the lipid 
bilayer. In contrast to L. major, L. donavani LPG and its dcl^dated derivative have been shown to 
bind to a variety to different ccD types in a temperature-dependent manner (Tolson et al., 1990). 
Talamas-Rohana et al. (1990) have shown that the binding of Z. mexicana LPG to 
macroph^ies is mediated b>' ttte C-diains (tf tiie both CR3 and, 150/95 receptors wliich belong to the 
CD18 iiacc&j of integrins. The binding site of LPG on CR3 has been observed to be distinct from the 
binding site of C3bL These binding studies strongly suggested a role for LPG in the attachment of 
promastigotes to macrophages (Elhay et al,., 1990). 
- 5 8 -
LMTI.ACELLII.AR FUNCTIONS: 
Intracellular sun'h al in host pbagofysosome . 
The Leishmania parasites have adapted to sursive in the highlx destructive 
en\"irotiment of the phagolysosome, vsiiere the> encounter different degradaii\e enzvines and other 
toxic ox> gen metabolites. Handman and Greenblatt (1977) provided the first evidence thai a parasite 
excreted factor may be important for the intracellular survival of Leishmania parasites. They 
observed that addition of concentrated excreted factor from L enntti promastigotes cultures 
promoted the growth of this parasite in mouse peritoneal macrophages, which under normal 
condition are not permissive. 
It is found that LPG is required for intracellular survival of promastigotes. 
An avirulent clone of L.nwjor which lack LPG is phagocMized b\ macrophages and killed within 
18 hours (Handman et al, 1986). Passive transfer of purified LPG from a viruleni strain of I., major 
into the avirulent promastigotes confirmed oo them the abilitv to survive in macrophages. LPG 
deficient variants of L donovani selected for resistance to the ricin agglutinin lectin are phagocytized 
but can not survive in human monocytes (King and Turco. 1988, McNecly and Turco, 1990). It is 
therefore suggested that intact LPG molecules is neccssarv for successful intracellular survival. LPG 
epitopes can be visualized by immunofluorescence with anti-LPG monoclonal antibodies on the 
surface of macrophages, as early as, five to ten minutes postinfection and are localized to the 
immediate area of internalization of the promastigotes (Tolson et al, 1990). 
Inhibition of Hydroljtic enz}ines ; 
Adaptation of life in a jAagolvsosome requires the ability to resist, inactivate 
or inhibit host hvdrohlic enzvines. It has been suggested that survival of Leishmania parasites mav 
depend on their ability to inhibit lysosomal ctizv-mes (Alexander e/o/., 1975) or resistance to 
lysosomal cnzvmatic digestion (Change et al., 1976) 
Activity of purified LPG against four hydrolvtic enzymes from peritoneal 
macrophages of mice, has been observed The activitv of acid phosphatase, ^ -^ucuronidase and N-
acetyl-P-glucosaminidase have not been affected but activitv' of B-galactosidase is highlv inhibited 
aflcr 3 hr of incubaiioa The suong negative charge of LPG nK>lecule may account for the observed 
inhibitor.- effects. Competitive inhibition b>' the abundant pho^^rvlated disacchande Gal(Pl->4) 
Man in LPG provides an alternative explanation. 
The role of LPG in i^ -otccting the parasite from digestion b) lysosomal 
enzymes are fiirther shown by measuring the rate of cylolysis of eryihrocjtes coated and 
•59-
uncoaled wiih LPG (Eilam et al., 1985). LPG coaling significantly diminished ihc rale of c\1olysis 
by macrophages, suggesting that LPG may indeed enable Leishmania parasites to suAive in the 
presence of hNdrolylic enzymes. 
Inhibitor of Protein Kinase C: 
Protein Kinase C (PKC) is a muliifunctional proiein kinase that specifically 
phosphorylates serine and threonine residues (Nishizuka, 1986). This enzyme is characterized by a 
catalytic domain containing an ATP-binding site and a regulatory domain that contains the sites 
involved incalcium, diacylglycerol and phospholipids binding. . 
The enzyinaiic activity of PKC is inhibited by about 50% in presence of a very low 
concentration of LPG (K,<1 uM). LPG is the competitive inhibitor with respect to diolein 
(diacylglycerol) and noncompetative inhibitor viith resj)ect to phosphatidylserine (McNeely and 
Turco,1987). LPG docs not affect the catalytic fragment of PKC (called protein kinase M) and 
cAMP dependent kinase (protein kinase A). The l-Oalkylglycerol portion of LPG is more 
effective inhibitor of PKC as compared to carboh\drate portion of LPG, complete LPG molecule, 
phospbosaccharide-PL on the basis of molar ratio. The phosphosaccharidyl-PI fragment also hasa 
greater inhibitory effect than intact LPG and PG (McNeely et al, 1989). The phosphoniated 
disaccharide fragment (P-Gal pi->4 man a -1) does not affect PKC activity. 
In resting cells, a large amount of PKC is cytosobc and inactive. Redistribution and 
membrane association in general, is a critical step in the regulation of PKC activity. In the 
presence of ele\-ated intracellular Ca*" levels, translocation of the enzyme from the cylosol to the 
membrane takes place normally in the presence of LPG, indicating thai the LPG does not interfere 
with PKC translocatioa In contrast, LPG prevents the phos|Aory laiion of specific PKC substrates, 
(proteins) in response to DAG. Thus, the inhibitor) effect of LPG on PKC ma\ be mediatedb\ 
defective protein phosphorylation (Descoteaux and Turco. 1993) (Figure 12). During 
phagocytosis, PKC is the initiator of the oxidative burst, wiiile LPG inhibits PKC activity in the 
macrophages. Phosphorlyation and membrane assosiation of the NADPH-oxidase complex 
components represent the first step of this iwocess (Dewald et al., 1988). The active NADPH 
oxidase amiplex catalyzes the one»<lectron transfer from NADPH to oxygen, generating siqjeroxide 
ani(m that is released at the outer sur&ce of the i^ asma membrane into the extracellular space or into 
I i^agocytic vacuoles. Further reduction of the siq)eroxide anions results in formation of hydrogen 
peroxide, hydroxyl radicals, and singlet oxygea These products are involved in physiological 
functions of macrophages, wluch is elimination of microbes. 
- 6 0 -
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Figure 12: A hypothetical modd for the inhibition of PKC -mediated events by LPG (Dcscotcaux 
and Turco, 1993). 
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Producte of oxidative burst are deleterious for Leishmania promastigotes, in particular H^Oj 
(Murrzf>', 1981; Pearson et al., 1983; Reiner and Kazura, 1982). Therefore, inhibition of PKC 
activity is important for ttie parasite to escape from flic toxic metabolites of oxidative burst. 
Inhibitor of Oxidative burst: 
A role of LPG in the impairment of respiratory burst has been su^^, l ie 
inhibilofy property of LPG on purified PKC may be of major significance, considering the role 
of PKC in flie induction of respiratory burst. Therefore, inhibition of PKC activity leads to Ac 
inhibition of oxidatiw burst. In tfus regard, phyagocytosis of LPG coated beads inhibits oxygen 
consumption in monocytes stimulated with phoibol myristateacctate, a synthetic activator of 
PKC (McNeely et al., 1990; Glew et al., 1988). Using indirect immunofluorescence, LPG or 
a LPG fragment is detected in the outer membrame of monocytes containing LPG coated 
beads.Thus, LPG may effectively interact with the monocytes PKC ^lich is involved in 
induction of oxidative burst. 
Scavengers of toxic oxygen Metabolites: 
In addition to inhibiting PKC- mediated enzvirutic induction of the oxidative 
burst, LPG may protect promastigotes by scavenging toxic o.x>'gen metabolites generated 
during the burst, (Chan et al., 1989). LPG is highly effective in scavenging hydroxyl 
radicals and superoxide anions. The scavenging activit\ of LPG is largely conferred b> 
the repeating phosphorylated disacchaiide units. This propert\ has been explained b> 
oxidation of the hydroxy! groups of sugars to Ketones (Green, 1980). Inhibition of 
chemiluminescence has also been observed with nmocytes treated with LPG but not with 
the glycosylinositol phospholipid antigens (Frankenbuig et al, 1990; El-on et al, 1990), 
which hasconfirmed the scavenging property of repeating phosphoiyiated disacchandes. 
Thus LPG protects the parasite from the damaging effects of oxidative burst ^ o u ^ at 
least two distinct mechanisms: a) attenuation of the PKC- mediated induction of Ae burst 
and b) scavenging of die cytotoxic products of tfie burst 
Inhibitor of c-fos gene expression: 
Activation of PKC also tesubs in tibe expression of several genes, like c-fos gene. The 
fos-gene function as a nuclear third messenger molecule diat regulate gene expression in 
rc^xxise to environmental signals. In macrophageSjC-fos gene e?q)ression is inducible tfarou^ 
a PKC or a cAMP-dependent pa&way. Activation of PKC results in a rqnd and transient 
increase in c-fos mRNA levels (Radzioch et al., 1987), whereas elevation of c AMP stimulates 
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a stable and long lasting expression of the t-fos gene (Bravo et al, 1987). 
The incubation of macrophages with LPG or its delipidated version resulted in the 
inhibition of PKC-depcndent C-fos gene cjqiression. In contrast, LPG did not inhibit 
macrophages to express the c-fos gene in response to c-AMP (Dcscoteaax et al, 1991). This 
observation is in agreement with tfie selective inhibitoiy effect of LPG on purified enzyme 
(PKC) activit}' (McNeely and Turco, 1987). 
LPG inhibits signal transduction in macrophages: 
LPG is involved in several aspects of the parasite macrophage interactions (Turco, 
1988). In macro{^u^es, the PKC-dqxmdent signal transduction pathway stimulated by bacterial 
LPS has been characterized in detail (Hamilton and Adams, 1987). After e)q>osure to LPS, 
{^ K)^ )holq>3se C is activated to catalyze ttie hydrolysis of phosphoinositol 4,S-bisphosphate into 
inositol triphosphate and diacylglyccrol. The latter jM-oduct activates PKC (Berridge, 1984, 
>5shizuka, 1984). Activaticm of PKC results in the phosphoiylation of a group of a proteins and 
in tfie rapid expression of a set of "eariy con^tence" genes, such as ttie c-fos protooncogene 
(Homilton and Adams, 1987). C-fos gOK expression is tightly coupled to tfie activation of PKC, 
as activators of PKC stimulate a rapid and transient increase in c-fos mRNA levels (Radzioch 
et al, 1987). Therefore, in macrophages c-fos gene expression represents a stimulus-specific 
reqxjnse dq)endent on the activation of PKC (Radzioch et al, 1987). It has been observed 
that LPG stimulated the expression of flie c-fos gene in a rapid and dose-dependent manner, and 
to lesser extent it stimulated the TNF gene. This suggest that tfie initial interaction between LPG 
and its receptor triggers a ceDular response that mi^t influence tfie subsequent interaction 
between tfie parasite and macrophage receptors. Recentfj', it has been demonstrated that the 
binding site for L. mexicana LPG is conferred, by tfie a-chains of botfi CR3 and p'***' 
(Talamas-Rohana et al, 1990), belonging to the CD18 famil>' of intigrins. From competitive 
expoimcails, it is also conchjded tfiat L. mexicana LPG and E. coli LPS share tfie same binding 
site on the CD18 femil>' of integrins. Therefore, it is also possible tfiat the cellular response to 
L donovarv LPG iosKivt CR3 md/ot P**^. Prctrcatment witti L. donovani LPG is cjqwble of 
irinbfting in a dose dependent manner subsequent LPS-induced c-fos gene e)q>ression, but not 
tfie LPS-induccd TNF gene expression (Descoteaux et al., 1991). They demonsti^ted tfiat 
pretTBatrnait wifli LPG intofoed witfi tfie signal tmasduction patfiway leading to flic expression 
oftfie c-fos gene in a sdective rather than a general manner. The LPG is a competitive inhibitor 
witfi respect to diolein (McNecly and Turco, 1987) winch suggest tfiat LPG, or a fragment of 
tins molecule, interferes witfi the physiological process of PKC activation upon generation of 
diacylglyccrol. Hence, LPG of Leishmania parasite appear io inhibit tfie PKC-dq)cndent 
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signaling pathway, which plays a major role in the acti\'ation process of macrophages (Fan et 
al, 1988; Schuhz et ai, 1990; Descoteaux et al, 1991). 
Inhibitor of Chemotaxis: 
L. donovani LPG and its delipidated counterpart are potent inhibitors of 
monocyte and neutrophil chemotactic locomotion. Inhibition of inflammatoiy reactions 
in the lesion sites may contribute to tf\e chronicitj- of the disease. (Frankenburg et al., 
1990). Chemotaxis activity of neutrophil or monocyte is inhibited due to aheration of 
PKC activity. 
Inhibitor of Viral Fusioiv. 
LPG of L. donovani is ^ t e n t inhibitor of viral fusion. The LPG used for viral fiision 
is introduced into human crytfirocyte gjiost (HEG) membrane. When LPG is 
incorporated in a very low concentrations into intact human erythrocyte membrane, it 
strongly inhibited sendai virus and induced hemoI>'sis. LPG incorporated in HEGs, 
reduced the binding of botii sendai and influenza virii&es to HEG. There fore, it strong}) 
inhibited over all viral fusion (Ling et ai, 1995). It has been suggested that LPG 
stabilized the bilayer structure of phosphatid>1ethanolamine against the formation of an 
inverted-hexagorul structure. LPG may give rise to an effective 'steric repulsion'between 
the viral and HEG membranes, thereb) modulating some specific modes of interaction 
between viral tai^ get membranes in the overall fusion process. LPG may also modulate 
the binding rigidity of the HEG membrane in tfie direction of making tfie destabilization 
and rearrangement of the underlying Iqnd bilayer (Ling et al, 1995). 
Inhibitor of IL-I Productioni 
LPG has been implicated as an inhibitor of interleukin-1 (lL-1) production. 
Two macrophage accessory functions regulate T-helper lymphocyte activation: a) the 
expression of major histocompatibility complex class n molecules and b) the production 
of interieukin (IL -1) (Unanue et al., 1987). In L. donovani infected macrophages, these 
two functions are defective (CSivier and Tanner, 1989; Reiner, 1987; Reiner et al., 
1987). Incubation of monocytes with purified L. donovani LPG inhibited 
Iqx^lysaccharide (LPS) induced IL-1 secretion (Frankenburg et al, 1990). 
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Chelalor of Calcium : 
Calcium jrfays an important role in the regulation of ceDular functions, mainly as an 
intracellular second messenger and as an enzyme cofactor. It has been shown that L. major 
infected macrophages contain approxin\atel>' 40 % more exchangeable calcium than uninfected 
controls, as well as macrophages engulfing LPG-coated etythrocjies have increased levels of 
calcium compared to macrophages engulfing control eiythroyles (Eilam et a!., 1985). 
In recent studies using NMR the effect of calcium on the tertiary structure of tfie glycan 
moiety of LPG was examined. The investigators concluded that calcium does not perturb the 
tfirce dimensional structure of the gfycan and it binds to LPG in the vicinitj- of the phosphate 
groiqK. Tharforc, the ability of LPG to chelate calcium may have important implications with 
respects to the ability of Leishmania parasites to survive within macrophages (Homans et al, 
1992). 
Modulator of TNF a Receptors: 
LPG also modulates TNFa recqitors. TNFa activates macrophage cytotoxic fiinctions 
and the subsequent destruction of tiie invader. It also plays a role in reducing the ability of 
macrophages to bind TNF a. Althou^ the Leishmania parasites stimulates macrophages to 
secrete TNF a (Green et al., 1990), a down regulation of TNF a receptors may play a role in 
the survival of Leishmania, particularly during the initiation of infection (DescoteaiLX et al., 
1991; Greene/a/., 1990). 
- 65 -
LPG as a Candidate Vaccine: 
LPG is the most abundant surface molecule of Leishmania promastigotes cell 
membrane. Purified L. major LPG when administered to geneticall> resistance mice, in which 
cutaneous lesions resolve spontaneous^, induced fiiD protection against a challenge with 
promast^otes, wliereas partial protection was achieved in the susceptible mice (Handman and 
Mitchell, 1985). This observation suggested that LPG might be considered as a condidate 
vaccine antigen against cutaneous leishmaniasis. 
Incorporation of LPG into liposomes proved to be an efficient way to immunize mice 
against L. mexicana without causing an>' exacerbation of the disease (Russell et al, 1988). 
Adaptive transfer of T-cells isolated fi^om immunized mice into syngenic mice provided 
protection against a challenge with L. mexicana promastigotes, indicating that protection is a 
function of antigen specific T-cells. 
Sevoal researchers have demonstrated that T-Kmphocytes play a dominant role in the 
acquired resistance to Leishmania parasites. Xfice vaccinated with L major LPG contained an 
increased frequency of L. mcgor reactive T-ccDs (Moll el al., 1989). Furthermore, LPG induced 
a specific delayed t>pc hypersensitivit>' in L. major infected mice, which also produced T-ceD 
dependent IgG to LPG. It has been suggested that T-ccD can recognize and respond to LPG, 
althou^ it did not respond in vitro. 
Moidonca et al., (1991) hav« rqxwted that T-lymphocytes fi-om cutaneous leishmaniasis 
patients respondsd to hi^ il>' purified L. brazilensis LPG, whereas proteinase K treated LPG did 
not stimulate any response. This important observation indicated that stimulation of T-ceD 
Kspcx\sss by LPG ma\' infact be induced by tighth' associated protein contaminants. Purification 
and partial characterization of the LPG associated protein contaminants revealed the presence 
of sevwal proteins. It has been demonstrated that peptides are potent stimulators of T-cells in 
vitro as well as, fi-om mice immunized with protein contaminated LPG for leishmaniasis 
(Jardim etal, 1991; Russo et al., 1992). Whereas protein fi^c LPG failed to stimulate any T-
cdl responses. Thiis, LPG does not appear to be able to elicit T-ceD response, it may act as a 
natural adjuvant for the proteins with v\iiich it is tigjitly conq)lexed. 
LPG used for Serotyping: 
Several polyclonal and monoclonal antibodies generated against Leishmania 
strains react witfi epitope present on LPG (De barra et al., 1982; Greenblatl et a!., 1983). 
These antibodies have proved usefiil for serotyping Leishmania strains which selectively 
precqiitate the excreted form of LPG. However, monoclonal antibodies Aat arc iiutiaD}' 
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believed to recognize the core region of L. donavani LPG are subscquenth found to 
react with protein contaminants (Jardim et al, 1991; Tolson et al., 1989). It has been 
shown that an anti-LPG mAb (CA7AE) binds specificiall>- to the repeating 
phosphot^ 'Iated disaccharide epitope of the LPG molecule. The repeating phosphor^lated 
disaccharide epitope of L. donovani LPG appears on the surface of infected macrophages 
as carl)' as S to 10 min post infection. Thus, LPG epitopes are detected on the 
amastigotes and the infected macrophages by a number of monoclonal antibodies. 
Although, these infected macrophages expressed LPG epitope which is distinct than 
parasite LPG expressed on promastigotcs and amastigotes (Handman, 1990; Tolson et 
al, 1990), The kala-azar patient scrum contained antibodies which are specific for 
surface components, especially LPG. These antibodies bind to live promastigotcs in 
absence of LPG expression which suggest that LPG is a mask for tfie surface antigen 
(Karp et al, 1991). The antibodies against LPG are detected in 45 kala-azar serum out 
of 50 samples (Krut^ials et al, 1992). Antibodies are purified fi-om kala-azar serum by 
affinit> chromatography. These antibodies strongh reacted with LPG of L. major 
amastigotes and to a lesser extent wiA the LPG of promastigotes (Osbom et al, 1994). 
This type of rcactivit)' could be directed against pi~>3 galactos}! determinants shared 
common epitope for promastigotes and amastigotes. Hence, LPG is used for serot>ping 
of leishmania fi-om serum. 
CHAPTER 3 
PARASITE MAINTAINANCE AND 
INFECTIVITY 
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LNTRODICTIOX 
The species of genus Leishmania are a biologicalh" diverse group of tr\panosomatid 
flageDales. All of them are transmitted by Phlebotomme sandflies. The> live extraceUularh' in 
the insect's digestKt tract, ^viiere tfie> undergo a morphological change to form promastigotes. \\Tien 
inoculated into the mammalian host bv' the vector, thev' infect macrophages, and then differentiate 
into nonmotile amastigotes that multiph intraceDularh' (Chang. 1983). Regular availability of 
parasite is a prerequisite for anv' experiment. The promastigote stage has been wideh cultxired 
in vitro in a varietv of biphasic and monophasic media (Chatterjec, 1957; Trotter et ah 1980a; 
1980b; Bhatnagar^/ at, 1989) and the amastigote stage, by regiJar passage in susceptible animal 
host (hamster or BALBc mice). The long term /nvZ/ro cultivation of promastigote decreases the 
virulence oi Leishmania (GiarminL 1974; NeaL 1984). The loss of infectivitv' of very old 
cultures may be due to the loss of the potential to form metacyclic promastigotes {6z SiKa and 
Sacks. 1987). For maintaining infectivitv during the course of in vitro culture, it is necessan to 
passage parasites in suscepliWe animal host. Recent culture techniques for Leishmania promastigotes 
offer a new and more confident opportunitv for diagnostics, biochemical metabolic, 
immunological and chemotherapeutical investigations. 
The parasite is exposed to growth conditions that differ significanth within vector and the 
host with respect to temperature, pH, nutrients and serum components. The parasite survival 
is facilitated by mechanism such as pH and temperature tolerance morphogenesis, resistance to 
con^anent h'sisand changes in surface molecule. CeDs from higher eukarvotic organism can 
not tolerate drastic changes in pH and temperamre. Despite the induction of stress responses 
such responses are traasient and camiot always prevent ceD death. In contrast Leishmania 
parasites encounter and survive extreme environmental conditions as an integral part of their 
life cvcle. Extreme variations both in pH and temperature can trigger changes in gene expression 
in Leislmiania that result in the development of new life forms (Zilberstein etal. 1991; Shapira 
et al, 1988: Bates, 1992; Leon et ah. 1995). 
Leishmania parasites are highly ad^table to the different environmental pH. .\s 
determined b\' various enzymatic assays promastigotes of Z.. donovani metabolize glucose, proline 
and nucleotides most npdly at pH 7.0-7.5. On other hand, amastigotes catabolize these substrates 
at an optimal pH of 4.5-5.0 (Mukkada et al., 1985). 
.AUKX^ ttie pH of the extracellular and intracellular environments of Leishmania 
parasite differ by upto 2 pH units, the intra ceflular pH of flie parasites remains constant 
Aroug^out flieir life cycle. The observations that promastigotes and amastigotes function best 
at ttieir corresponding environmoital pH values suggests, ttiat they have developed mechanisms 
to sense changes in environmental pH (Zilboistctn, 1991; Zilberstein and Gebstein, 1993). 
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It has been suggested that the adaptation of surkival of Leishmania parasites in 
various pH unit during the growth is phenot}pic rather than genot\pic (Zilberstein and Shapiro, 
1994). pH of dK grovMh modiiim significanth influences various important function of parasite like, 
induced gene expression or DNA and protein SNnthesis, low pH induced metacyclogenesis, 
transport of \arious ions. Recent studies demonstrated that the abilit}' of Z,. dono\'am promastigotes 
to regulate their intracellular pH depends on tfie presence of chloride ions in their cytosol 
(Vieira et aJ., 1994). Glascr et al. (1988) found, using phosphate NMR and 5,5-dimethyl-2-
4-o\azolidinedione (DMO), that promastigotes and amastigotes maintain similar intraceDular pH 
values of 6.8-7.4 ^oughout an extracellular pH range of 4.5-7.5 (Zilberstein and Shapiro. 
1994). 
Exposing promastigotes of species that transform morphologicalh into amastigotes like 
cells at 35*C causes a reduction in Iheir metabolism (Biegel et al, 1983; Hunter et al, 1984). 
This reduction is probably due to reduce, cell proliferation although the cells remain viable for 
adeast 72 hre. Proliferation of promastigotes that transform morphologically m vitro occurs onh 
at temperature less than 33-34'C (Bates. 1993). Although amastigotes are usualh obligator* 
intracellular orgonisms and can be cultivated under a.xenic conditions using some combinations 
of temperature, pH, and semm concentration (Bates, 1992; 1993; 1994; Pan, 1984; Doyle et 
al, 1991: Eperon and McMahon-Pratt 1989). The exposure of cultured Leishmania 
promastigotes to tranperatures typical of human hosts leads to an accumulation of hsp 70 and hsp 
83 transcripts (Shapira et al., 1988; \'ander Ploeg. 1985). The combined effects of temperature 
elevation on parasite morphologj. protein synthesis, and pattern of specific transcripts suggests 
that temperature is a factor for differentiation in Leishmania (Zilberstein and Shapnra, 1994). 
The past few years have witnessed a surge in interest in lectin-parasite interactions. 
The lectins have become valuable tools to stud\ tfie insertion, fate, distribution and functions of 
gjscoconjugates on and in parasites. The lectins are carbohydrate binding proteins or gl> coproteins 
other than cnz>Tnes or antibodies (Goldstein and Ha>es. 1978) and have been used in the 
identification of e.xposed surface gj> coconjugates because of their abilit} to nonco\ alenth and 
rdatKeh qjedficalK' binds to sacdiaride residues (Jacobson and Do>1e, 1996). All parasites have 
carbohydrates on their surfaces as part of their cytoskeletons or in their internal structures. 
These cell surface mdecules bind witii lectins and a^utinate the organisms. The agghitination, 
defined as decreased number of fi^c promastigotes or increased clumping of promastigotes to 
each other as compared to control, occurs with lectins like, Con-A, RCA, SBA and PN'A. 
The agglutination of Leishmania by carbohydrate-binding lectins has been 
extotsKdv'stiKfed. Lectin binding studies of L^wAm j^ma species (Dwycr, 1974; 1977: Doran 
and Hennan, 1981; Hernandez, 1982; Schottelius, 1982; Gueugnot et al, 1984) have found in 
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gt;ncTalthal promastigotes of L. dc»v7i'aru, L. major. L. mexicana. L. tropica, L. braziUensis and 
L aethiopica are ^ g)ulinated by Con A and RCA. An increase in promastigotes infectrvih has 
also been observed with developmental change from logarithmic phase to stationan phase during 
gixjvslh in axenic cuhurcs (Giannini 1974; Franke et al, 1985; Sacks et al.. 1985). The development 
of such infective or metacyclic promastigotes in axenic cultures is associated with changes in 
lectin binding ceD surface molecules (Sacks et al., 1985), altered mobilitv and increased resistance 
to killing by normal human serum (Franke et al., 1985; Sacks et al., 1985). These changes 
demonstrated bv- the work of Sacks et al (1985) with culture of I . major but comparable 
differences in lectin binding were not observed in L. donavam. The log phase promastigotes of 
L. major were 100% agglutinated, whereas stationarv' phase (metacvclic form) or infective 
promastigotes failed to bind PNA due to some alterations in surface carbohvdrates accompany 
the development of promastigotes into an infcctK'c stage. It has also been demonstrated that 
lectins reacted with a broad band of membrane-associated components (Jaffe and McMahon-
Pratt 1988). which is similar to that observed for a phosphorylated galactosvl-^- mannose 
poh-saccharide from L. doncr^ani (Turco et al. , 1984); for isolated excreted factor from L. major 
(landman e/a/., 1984), a polysacchride containing glucose, gabctose, mannose. phosphate 
and sulphate ( Pabtnik et al., 1985) and for a lipopeptidophosphomannan containing mannose 
and galactose isolated from L. adleri. 
M4TER1ALS AND METHODS: 
. \ M M \ L S : 
Healthy rabbits (CDRI strain) 3-4 months old, weighing 2.5-3.0 kg. were used for 
bkxxl coDection for the preparation of bi-phasic culture media. B.ALB c mice, weighing 20-22 
g. reared and in bred at the animal house facilitv at CDRL Lucknow, were used for isolation of 
peritoneal macrophages. Male Syrian golden hamsters (Mesocricetus auratus), 35-45 gm in 
weight were used for in vivo studies. 
PARASITE STRAINS: 
Leishmania donovani strain UR6 (MHOH/TN 1978''UR6) was isolated from kala-
azar patients in India and obtained from Prof A.N.Bhaduri of Indian Institute of Chemical 
Biologv, Calcutta, India. It was cultured on Brain Heart Infusion Agar with rabbit blood 
preferabl>' in semi-solid and biphasic media, as well as in liquid monophasic medium (L^f). 
Parasite L. donovani (strain MHOMTN/80 DdS), originalK isolated from Bihar, 
India, in 1979, was subsequently obtained throu^ kind courtesv of Prof P.C.C. Gamham of 
Imperial College, Lx)ndon in 1981. This strain is being regulariv maintained in vitro in 
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monophasic and biphasic media and in in vn^o, in golden hanister (Mesocricetxis auratiis). 
Maintainence of parasites: 
Parasites: The Leislwiania donavani promastigoles, (strain UR6) presenth nonpathogenic. 
(Ghosh eld., 1985; Mukheijee et al, 1988) was cuJnired at 2? -^  1*C on brain heart infusion 
2^ si^emenled with rabbit blood as solid media (Chakrabort> et al.. 1988; Mukheijee et al, 
1988) and maintained by subculturing at 72 hr intervals. (Chakrabort>- et al, 1988) 
The L donovani promastigotes of Dd8 strain (MHOMlN/80T)d8) was grown at 
26-^  1^ in nK>nofrfvasic and bijAasic media (Chatterjee, 1957; Bhatnagar et al, 1989; Mandwal 
et ah, 1988; Anuradha et al, 1992; Gupta et al, 1992) and maintained routine!} in this 
Uborator>-. Af^ er every few subcultures, the strain is passaged through hamsters in vivo to 
retain its infectivit\\iabilit\' which is quite often diminishedb\' continuous in vitro culture. 
PREPARATION OF MEDIA; 
Semi-solid medium: 
The composition of solid medium was: 
Brain heart infusion powder 24.0 g 
Agar powder 9.0 g 
TDW 600.0 ml 
I>g!ucose 10.8 g 
Preparation of medium in brief, is as follows: Brain heart infusion and agar powder 
were dissoK^ into 5(X) ml TD\\' and autoclaved at 10 lbs pressure for 10 min. The medium was 
allowed to cool vqjto 50-55°C, pH was adjusted to 7.4+0.2 with NaOH. D-Glucose was dissoK'ed 
in 100 ml of TDW'. The medium and D-gJucose solution were sterilized at 15 lbs pressure 
(121.^ for 15 mia Fresh rabbit blood (5-6 ml) was taken under sterilized conditions and added 
to warm D-^ucose solution. To this was added 501.U./ml of bcnz>l penicillin (30.OCX) I.U.) 
and 50 >ig''ml (30 mg) of streptomycin. The glucose solution was then added to the medium, 
mixed Ihoroi^ih and poured into sterilized petri dishes or culture tubes. These were then kept 
at room toipoature for 2 dajs. The sterility was checked after 24 hr at 37° and finalh stored 
al 4° C tin use (Saha et al, 1986). 
Liquid medium: 
The composition of liquid media is: 
Medium 199 or Medium 11.0 g 
RPMI-1640 
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HEPES buffer (25inM) 
KaHCOj 
TDW 
D-glucose 
Gentamycin 
Fetal Calf Serum (PCS) 
5.95 g 
2.25 g 
900 ml 
2.0 g 
40 mg 
100 ml 
AH the abo\e ingredients, were dissoKed in 900 ml of water and stirred for Ihr on a 
magnetic stirrer at room temperature. The pH of the medium was adjusted to 7.2 +0.2 with 
the help of IN HCl or IN NaOH. The medium was then filtered through sartorious milliporc 
filter (0.2 >im pore size) and kept at 37° for 24 hours for sterilit> checking. The medium was 
finall) supplemented with lO^o PCS and gentamycin (40;ignil) and stored at 4'C till use. 
Lciboitz (Ljs) medium: 
The compositiom of Lj, medium 
Leibovitz medium powder 14.8 g 
D-glucose 2.0 g 
Tryptose phosphate broth 2.95 g 
TDW 900 ml 
Serum (PCS) 100 ml 
Gentamycin 40 mg 
The Leibovitz medium (L,,) (Sigma) and 2.0 g D-glucose were dissoKed in 8(X) ml 
of TD^\' to which 100 ml of tr>ptose phosphate broth was added as an extra supplement. 
Toptose phosphate broth was prepared separateh, dissoKing 2.95 g of ti>ptose phosphate 
broth in 1(K) ml TDW and autoclaved at 15 lbs for 15 mins. The pH of the medium was adjusted 
to 7.2-0.2 and filtered through sartorious millipore filter (0.2pm pore size) and kept at 37°C 
for 24 hours for sterilit>- checking. The filtered Lj, medium was finalh supplemented with 
autoclaved TPB(Hi-media), 1(X) ml of PCS and gentamycin. It was stored at 4''C, until use. 
Biphasic media (IWN Medium): 
This medium consists of four parts of salt bactoagar and one part of defibrinated rabbit 
blood. 
Preparation of N-N.N. medium: 
Bacto - Agar (Difco) 15.5g 
Sodium chloride 6.6g 
Trq}le distilled water 1000 ml 
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Bacto-Agar and sodium chloride were mixed thoroughI>' by warming at 60-7(rC 
and the pH adjusted to 7.2. The mixture was finally' autoclaved at 1S !bs pressure for 15 min. 
Antibiotic, i.e. gentamycin was added to a concentration of 40 ;jg'ml and stored at 4'C till use. 
Defibrinated rabbit blood was mixed in a ratio of 4:1 (4 ml of molten agar: 1 ml 
of defibrinated rabbit blood) in screw capped vials at temperature not more than 60°C. The 
bactoagar and deJSbrinated rabbit blood was mixed thoroughly' b>' gently rolling the vials between 
tfie palms (Chatterjec, 1957). 
The vials were kept at 37°C for 24hr to generate water of condensation. These 
NNN medium vials were finally stored at 4'C until use. 
Overlay of Medium: 
RPMI-1640 medium: 
RPMI-1640 powder 10.4 g 
HEPES buffer 5.94 g 
NaHCOj 2.25 g 
D-Ghicosc 2.00 g 
TDW 900 ml 
Powdaed RPMI-1640 medium (Sigma) with gjutamine but without bicarbonate 
ion was used. AD the above ingredients were dissolved in 900 ml of TDW. The solution was 
stirred for 1 hr on a magnetic stirrer. The pH of the medium was adjusted 7.2i0.2 and 
sterihzed by filtering through a millipore filter of sartorious (0.2 pm pore size). Gentamycin was 
added at a concentration of 40 )ig ml after sterility' testing and stored of 4''C till need. 
Lock's solution; 
Sodium chloride 8.0 g 
Potassium chloride 0.2 g 
Calcium chloride 0.2 g 
Potassitmi dihydrogen Phosphate 0.3 g 
EKHucosc 2.5 g 
TDW 1000 ml 
All the above ingredients were dissolved into 1000 ml of water and stirred on 
magnetic stirrer for an hour. The pH of Ae solution was adjusted 7.2+0.2 with the help of IN 
HQ or IN NaOH. The solution was sterilized by passing dirou^ 0.2 yatv sartorious membrane 
fitter. 2.0 ml of stock solution was poured in thiogjycolate medium (3 g in 100 ml) and kept at 
3TC for 24 hr for sonSty test RnaD '^ to it was added 1.0 ml of gentamycin (40 ;ig''ml) and stored 
at 4'C until use. 
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In vitro maintenance of the parasites: 
promastigotes of both the strains UR6 and DdS were grown in vitro in various media. 
Semi-Solid media: 
To die culture tube containing approximate!) 5 ml of solid media, 6-8 colonies of L. 
doncMJTu promastigotes (UR6) were inoculated and 10-16 colonies were inoculated on the petri 
dishes for soBd media. These colonies were gentl>' spread on the slant b\- culture loop. The culture 
tubes and petri dishes were incubated at 22+rC in a BOD incubator for 72 hr or 3 dav's. The 
viabflitv' of the organisms were routineh' checked by taking few parasites from culture tubes or 
petri dishes on tfie g^s slide in nonnal saline or phosphate bufifer and observing under the 
microscope (Saha et al., 1986) 
Liquid media: 
Leishmania doncA'oni Promastigotes (DdS) were maintained in (monophasic)liquid 
media. 0.2 ml of l.OxlO' ccUs^ ml were inoculated into the culture vials or tubes containing 4-5 
ml of liquid RPM1-1640 or L,, media. Thus each vial contained 0.5x10* promastigotes ml. 
Tubes wCTe incubated at 26+rC for 4-5 days in a BOD incubator. The subcuturing was carried 
out afkT5da>'inLi,and7daysinRPMI-1640medium. Monophasic media are primarih'used 
for mass cultivation of promastigotes. 
Biphasic media: 
Prior to subculture, RPMI-1640 and NNN medium (Bactoagar base) tubes were 
brougjit to room temperature and 3-4 ml of overlay (RPMI-1640) was added in each vial or 
tubes. Positive axenic cultures containing 1-2x10* promastigotes of stationarv' phase (matacyclic 
form) were inoculated in each vial asepticaDv'. These culture vials were incubated at 26±1 °C 
for 4-5 days. These parasite passes throu^ four different growth phases during the coxirse of 
cultivation viz. (i) lag phase (ii)logariAmic growth phase (iii) stationary' phase (iv)decline phase 
(Chang and Hendricks, 1985). Subcultures of the parasites were carried out cverv week for 
continuous maintenance. 
In vivo maintenance of Parasites: 
The parasites woe maintained in vivo in hamsters through amastigotes to amastigotes 
by syringe passage or at times by inoculating the stationary phase promastigotes. 
Preparation of infective inoculum : 
Heavily infected hamsters (50-60 days post iitfection) were sacrificed, their spleen 
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rcmoved asepticaUy in RPMI- 1640 medium and cut into small pieces. These were 
homogenised lightl) in sterile RPMI-1640 medium with ttie help of motor driven tissue 
homogenizer, consisting of a glass tube and a teflon pestle. The smpension was initiaD)' 
centrifligcd at 500Xg for 10 min at 4'C to settle all tissue debris. The supernatant was collected 
and recentrifugcd at 1500Xg for 30 min at 4'C. After tfiis the supernatant was discarded and 
the sediment containing amastigotes was resuspended in RPMI-1640 medium. The number 
of amastigotes were counted in Neubaur's haemocjlometer. The inoculum size was adjusted so 
as to contain 1x10^  para.sites in 0.1 ml of suspension. 
Inoculation of auiimals : 
Male hamsters weighing 35-45 g were inoculated with 1x10^  amastigotes 
intracardiaD)' (Stauber et al., 1958). The infection gets established in the spleen in about 20-25 
daj-s post inoculation. But when 1x10^ promastigotes was used for inoculation the infection 
in the spleen of hamsters occured in about 45-60 dajs post inoculation. 
Growth curve: 
For ascertaining flie growth of Z.. donavani promastigotes in culture, the growth 
studies of p-omastigotes of different strain were carried out. Four strains of L. dono\>ani Dd8 
(MHOM1N'8aDd8). Ag83 (MHOM/IN'83/.Ag83), R.MRI (MHOM'IN'90RMRI168) and SS 
(isolated from Patna. India, and received from RMRIMS, Patna. India) were used in this 
studied. 
1.9 ml of complete medium was put into a sterile screw capped 15 ml vial (Borocil 
India). It was inoculated with 0.1 ml of inoculum, in which the parasite count was adjusted to 
lO^parasitesUl mL Hence, each vial contained 0.5x10* parasites'ml. The same ratio of mediimi 
to parasite was maintained for mass cultivation of parasites. 
Harvesting and storage of parasites: 
Leishmania <kmo\'ani promastigotes (strain UR6) cells were removed from the petri 
dishes as well as from culture tube using culture loop after 3-4 days of inoculation and 
suspended into PBS(0.1M, pH 7.4) or normal saline. Leishmania donavani promastigotes 
strains Dd8, Ag83, RMRI168 and SS were cultured in Lj, monophasic medium with 10% 
FCS in presence of gentamycin (40 >ig'ml). These cells were harvested after 4-5 days of 
inoculation. The growdi of the parasite was checked under microscope. The culture media 
containing the parasites or parasites suspended in PBS (O.IM, pH 7.4) were centriftiged at 
1500X^ for 10 min at 4'C. The wpecmXasA was removed and the pelleted ceDs were collected 
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^ d washed three times with PBS (0.1 M,pH 7.4) of normal saline. These parasites were used 
for evperiment immediatel) or stored -20*0 according to requirement of the experiments. 
The dode smear v\ as prepared b> overtay di l3nt paiasht on TSotamn coaled ^lidt and 
j^ried. The smear was fixed in methanol for 5-10 min. The staining solution (10"bGiemsa 
jlain) was la>ered on the sKdc and left for 30 min. The slide was then washed with rumiing water 
foDow'ed b> TDW. The stained smear was examined under oil immersion with a microscope. 
^Agglutination studies: 
Stock solution (1.0 mg ml) of lectins PNA, PRVP. Con-A and RCA ,20 were 
prepared in TDW. 
RCA,2o lectin was prepared in 0.005 M sodium phosphate and 0.2 M sodium 
chloide pH 7.2, attaining 0.1% sodium azide. These solutions were diluted to 1 pg ml of final 
cone, b)- serial dilution method with PBS (5 mM phosphate, 0.2 M NaCL pH 7.2). 
50 pi of parasites suspension (1x10' cclls'mJ) was added to 50 yl of lectin sohitions 
and niixcd thorough!} and then incubated at 25°C for 30 min. Controls were prepared in the 
absence of lectins solution or in the presence of specific inhibitor of lectins. Agglutination was 
observed for different strains at various concentrations of lectins by counting on 
haanocytometer under microscope. Permanent slides were prepared as smear on the slides and 
fixed in methanol and dried. The slides were stained with 10<*t) Giemsa stain for 30 min.. 
washed, dried and examined under light microscope in presence of oil immersion and 
photographed. 
RESlXTS AND DISCUSSION; 
To culture promastigotes in vitro conditions it is neccssar>" to start the primar>' culture. 
b\' sacrificing a hcavih' infected animal and removing its spleen, under asceptic conditions. The 
primar>' culture was started fi^om the infected spleen pieces into biphasic media at 26 :!: TC. 
Approximateh- 5x10' promastigotes per ml were obtained fi-om each culture mbe in log phase 
which were added to fi^h culmre medium. If slight haziness was observed in any tube it was 
discarded because it indicated the presence of contamination. From time to time, small amount 
war takoi ascqiticalh and examined under higher power of a light microscope for accessing their 
mortalit). The parasites multiply by longitudinal binar>' fission producing a large number of 
flagellates which were subcultured weekly. 
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In vitro culture and maintenance of promastigotes: 
In vitro culture and maintenance of L. doncn'ani promastigotes were carried out in the 
following media. 
1. Semi-solid media: Leishmania dono\-am promastigotes (strain UR6) were cultured on the 
brain heart infusion agar supplemented with rabbit blood in semi-solid as well as liquid media 
(Chakravorty et al., 1988; Saha et al., 1986). Plate 1 shows the grov l^h of the parasite in semi-
solid medium. These parasites developed as colony like structures on the petridish plate. The 
shape and size of colony of L. doncn-ani were undefined. The)' were oval, round and other 
shaped containing dimensions 2 x 4 mm. This strains of Z,. donovani had a propert) of growing in 
clusters. All surface area of the petri dish containing parasites looked like a colon>' or cluster 
on the petridish plate due to tfns ^ ecific property- of strain. The purit>' of the culture and the growth 
of parasites were checked after 72 hrs. The yield of parasite culture was found to be 
comparativeK' much more in semisolid media as compared to that in the other liquid media. 
Hence, semi-solid medium was preferred over the liquid or biphasic medium for cultxire and 
maintenance of L. dono\'ani promastigotes (strain UR6). 
2. Biphasic media: This medium consisted of four parts of salt bactoagar and one part of 
defibrinated rabbit blood. Positive axenic cultures containing 1-1.5 x 10* promastigotes from log 
to stationary phase were inoculated in each \ials or culture flasks ascepticalh. For contineous 
maintainance of culture. weekN' subculture of parasites or fresh addition of o\erla> medium was 
essential Tield of promast^ otes varied considerabh- in the same medium when different agar base 
were used RPNII-1640 medium as overlay and Bacto-agar witti 20<'/o defibrinated rabbit blood 
has been reported to be the most suitable combination for bulk cultivation of promastigotes 
(Singha, Ph. D. thesis. 1990). This is due to the fact, that bactoagar provides food for 
pfiomastigotes and at same time it absorbs the motabolic waste products released by promastigotes 
into the medium (Simpson, 1968). 
3. Liquid media: The mass cultivation of promastigotes were carried out in liquid media. The 
promastigotes were inoculated into the medium and incubated at 26 - TC for 4-7 da} s depending 
on use of liquid medium. Studies using different medium showed that if same inoculum (1 x 10^  
promastigotes/ml) were inoculated into different medium like Lj, , RPMI-1640 and Ml99; tfien 
stalionaiy phase culture is reached 4-5 dav-s in L^, 6-7 dav-s in RPMI-1640 and 8- 10 dav's in 
M 199, respectively. The growth of promastigotc was alsofound to be further enhanced by 
additon of tryptose i^ Kx i^iate broth in L,,. Although ver) rapid miihiplication of promastigotes 
was observed in RPMI-1640 medium but it is some how less as comnare to I „ medium Hence 
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Figure 1: The growth of the Leishmania donavani in semi-solid media. All surface ar 
pctridish containing die parasites looks like colony or clusten. 
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L^  medium may be used for large scale production of promastigotes. Plate 2 shows the 
gyowlh of promastigotes of strain Dd8 in Lj, medium and promastigotes of strain UR6 in liquid 
medium. 
//I vivo maintlnance of Ldshmania parasites,' 
The parasiles were maintained in VAC in hamsters through amastigotes to amastigotes 
In syringe passage or at times by inoculating the stationan* phase promastigotes. The amastigotes 
innoculatian has definite advantage over promastigotes inoculation as it takes relatively lesser time 
for establishment of infection (20 to 25 days for amastigote innoculation and 30-40 da> s for 
promastigote irmoculation. 
The assessment of flie inlasty of infection was carried out by examining dab smears 
of ^leen; stained with 10**/o Giemsa in PBS, pH 7.2 for 30 minutes. The slides were cxmained 
under a microscope and classified according to the number of amastigotes 100 cell nuclei. 
+ =1-10 amastigotes.' 100 ceD nuclei 
++ = 11-50 amastigotes 100 cell nuclei 
•>-^+ = 51-300 amastigotes 100 cell nuclei 
+-^ ++ = more than 300 amastigotes'100 cell nuclei 
In vivo infecti\ity of L donovani promastigotes of strains Dd8 and LT^6', 
In \ivo infectivit\'/palhogenidJ\' of I. dono\-ani promastigotes of strains Dd8 and UR6 
was examined b\ inoculating 1x10" promastigotes in stationar>' phase of growth to susceptible 
golden hamsters. Animals inoculated with L. donovaw E>d8 promastigotes showed a high levels of 
infection as observed by the high count of amastigotes in the dab smears of spleen on da> 45 
post inoculation (30-35 amastigotes 100 spleen ceD nuclei). Contrary to this, for hamsters 
inoculated wi^ promastigotes of L. donavam strain UR6, not even a single amastigotes in the 
dab smear of the spleen was observed over an observation period of 180 days post inoculation as 
in Figure 3. Hence, UR6 strain of L. dono\-ani is unable to establish infection in susceptible 
animals. Hence, non-pathogenicity of Z.. donovani is confirmed as reported by other workers 
(C:hakraborty et al, 1988; Mukherjee et a!., 1988; Saha et al, 1986). 
GROWTH CLTl\T. 
Since the ceD surface molecules and metabolic profile of die various developmental 
stages of the Leishmania promastigotes will be different, hence it is important to study the ceD 
saxfacc nx^cules of different strains under same developmental stage. E>ue to this reason growth 
curve of diffaail strains of Z,. donovani promastigotes under identical conditions were studied. 
F%ure 4 shows tfie growth curve of promastigotes of Dd8, SS, RMRI and Ag83 strains of L. 
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Figure 2: The promasdgotes of L. donovara growing in liqmd media (L,,). (4 
Promastigotcs of Dd8 strain (b) Promastigotcs of UR6 strain. 
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Figure 3: The Gcimsa stained sfidcs of ^leen macrophages of Z- donovani infected Sytue 
gcJdcn hamsters (a) infection from IMS promastigotcs on day 60 post infection (^  
infection from promastigotcs of UR6 strain on day 120 days post infection. 
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Figure 4: In vitro growth profile of Leishmania dcmovani promastigotes in Lj, medium. 
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dofvjvani in L,, medium. Unlike the promastigotes of strains Ag83, SS and RNIRI which reach 
the stationary phase on day 5 post inoculation the promastigotes of strain Dd8 reached the 
stationar>' phase on day 4 post inoculation. Hence, the growth of the parasites are depend on 
species and strain inspite of pH, temperature, nutrients, medium, vectors. 
AGGLUTIN.4TIO.\: 
The lectin ^^utination of L. dono\'ani promastigotes of strains UR6, Dd8, RMRJ68 
was carried out with the four pbnt lectins Con A, RCAuo- PHA-P and PN.'V and results are 
summarized in Figure 5. The Con A concentration causing 50°o agglutination were approximateh 
Ylyqlrt^ 14;^ ml and 40;;g'ml for UR6, Dd8 and RMRI strain preomastigotes, respectively. Both, 
Dd8 and UR6 strains were i^i^utinated complete^ with 62;jg ml Con A, while RMRI-68 required 
about more than 500 ^  ml. The RCAjjo lectin agglutinated about 50*Jb promastigotes of strains 
Dd8 and RMRI- 68 with 2 >igml wliereas 4 ;ig ml of lectin was required for promastigotes of 
strain UR6. 16 )ig'ml of RCAu^ was required for complete agglutaiuition of all strains of L. 
doncAxmi promastigotes. However, PNA and PHA-P showed different results. 500 pg'rcA PHA-
P was required for 50°o agglutination of promastigotes of Dd8 strain whereas 30°o agglutanation was 
observed for RMRI promastigotes. PHA-:P failed to agglutanate UR6 promastigotes. 
The PNA concentratioas of 125 ^ig'ml, 250 ;ig'ml and 500 pg/ml were require for 
50°0 ag^utination of RMRI-68 Dd8 and UR6 strains, respectrveh-. A smaD proportion of tite Dd8 
promastigotes C 25%) were found agglutinated even at low PNA concentrations (8 >igml) whereas 
the fffomastigotes of UR6 strain failed to agglutinate 3 1 ^ ml significanth lower C 10%) were 
found to be agglutinate with 125 >ig'ml. PNA agglutination was especialh inhibited by 
preincubation wth D-galactose suggesting the presence of galactose sugar on cell surface 
molecules. 
Cell agglutination with the various lectins was specific, and no spontaneous 
aggregation of cells occured in the absence of lectins. Lcctin-mediated cell agglutination was 
inhibited in the presence of specific, competitive lectin binding sugars. Agglutination of the 
promastigotes found to be lectin concentration dependent (D^yer, 1977). .\s demonstrated 
earlier (Wilson and Pearson, 1984), lectin- agglutinated cells were aggregated randomly, and 
occurred between all parts of the oi]ganisms, i.e. body to flageDum, bod>- to bod> and flageDum 
to flageUum, with no preference as to the pole. A number of parasites appeared to agglutinate 
within themseK'es as bod\' to flagelhun, but in our assay diese were counted as fi-ee parasites. 
There was no difference in agglutination at 4°C or 25*C. 
Agglutination was specifically inhibited b>' 10 mM galactose in the case of PNA, 
and by 10 mM mannose with Con A., RCA-mediated agghitination was not altered b}- galactose 
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Figure 5: Agglutination profik of L. donovani promastigotcs of strains UR6, Dd8, RMRI 
in the presence of four plant lectins Con-A, RCAuo, PNA and PHA-P. 
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bul was inhibited by 10 n\M lactose. Con A was found to bind to both parasite stages and to 
agglutinate promastigotes. The carboh>drate binding site of the Con A molecule is known to 
accommodate bofli D-mannose and D-glucose residues; inhibition of binding of D-mannose in the 
case of promastigotes, and by a -meth>'l mannoside in the case of amastigoles, thus impl}Tng that 
residues containing or resembling mannose were present on the surface of both parasite stages. 
Similarh, RCAjjo- which binds to galactose containing saccharides, also bind to both parasite 
stages, imphing the presence of a galactose containing ghcoconjugate on the parasite surface 
(Goldstein and Hayes, 1978; Wilson and Pearson, 1984). The PNA has a binding site that is 
most complementary to the carboh>drate sequence p-D-galactosc (l-->3)-N-acet>1-D-
galactosamine with galactose in the penultimate position, and that binds less avidly to D-galactose 
(GtJdstein and Ha>cs, 1978). Thus in contrast to the RCA binding gl\coconjugate(s), PNA may 
identify an internal galactose rather than one in the terminal position (Wilson and Pearson, 
1984). 
The structure of the neutral capping sugars on procyclic and metacyclic LPGs suggest that 
the proportion of various oligosaccharides ma} expresses p-glalactose, as well as mannose 
terminating oligosaccharide caps. The metacyclic promastigotes can be purified on the basis of 
their loss of agglutination by PNA (Sacks et al, 1985). which bind to I . donovani 
promastigotes via recognition of p-hnked terminal galactose residues on LPG (King and Turco. 
1988). Recenlh. il was suggested that PNA-negative forms were also COILA negative, and vice 
versea (Sacks et al. 1995). The structural modifications of L. major LPG during 
metacyclogenesis. are confirmed to the side chain substitutions terminating in P-linked galactose, 
whaeas the predominant Man al-->2Man capping structure remains unchanged and available 
for binding b> ConA. B> contrast, L. donovani metacyclics continue to synthesize LPG capping 
oligosaccharides which are common to procyclic forms, including those containing terminal p 
linked galactose, a-linked mannose. or both. These residues appear to become crvptic on the 
surface of metac> clic cells (Sacks et al, 1995). 
CRVOPRESER^'ATIO^ OF PARASITES: 
Ten percent ^'ccrol was used for cr>opresei\ation. It allows storing of 
fcishmania promastigotes at -^ CTC for upto 18 months. A gradual decrease in temperature of 
1-2TV30 minutes was carried out before storage in liquid nitrogen. Revival of stored parasite was 
done by thawing of the vials by rolling them between the palms. A gradual dilution of the 
sample with culture medium was carried out after thawing, followed b> centrifiigation and 
resuspension in fresh medium. 
CHAPTER 4 
LIPOPHOSPHOGLYCAN OF LEISHMANIA 
PROMASTIGOTE: 
ISOLATION, PURIFICATION AND 
CHARACTERIZATION OF LIPOPHOSPHOGLYCAN 
FROM NON-PATHOGENIC STRAIN UR6 
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INTRODICTION: 
Protozoan parasites of genus Leishmania causes a number of important human diseases, 
including \isceraL cutaneous and mucocutaneous leishmaniasis. During their digcnetic life cycle, 
these parasites ahemate between an extracellular promastigote stage in the digestKe tract of the 
sandfh vector and an intracellular amastigote stage that resides Nsithin the phagoKsosomal 
compartment of macrophages in the mammalian host. The Leishmania parasite has adapted to 
survive in such hostile environments. There arc specialized molecules present on the parasites 
cell surface which havt been inplicated for parasites survival. Three antigenic, surface components 
present in ttic proma.stigote stage that pla> a crucial role have been characterized. These are the 
surface metaDoprotease (a>63) (Bouvier et al, 1985: Etges et al, 1986; Russell and WUhelm. 
1986: Chaudhuri et al, 1989), a famih' of glycoinositol phospholipids (GIPLs) (McConville 
and Bacic, 1989; 1990; McComiDe et al.. 1990; McConville and Blackwell, 1991) and a complex 
glycoconjugate, termed lipophosphogKcan (LPG) (Turco et al., 1984; 1987; Turco, 1988; 
1990; Turco and Dcscoteaux. 1992; McConville et aL 1990; 1992). LPG is the major cell surface 
^'coconjugate of promastigote stage (Orlandi and Turco, 1987; McConville et al., 1987; King 
€t a/., 1987) and is activeh secreted into the culture medium in vitro (Handman ei a!., 1984; 
Dg et al., 1992). Although LPG is produced by all Leishmania spp. (Turco and Descoteaux. 
1992; McCon\iBe et al., 1992), other parasites have also been shown to express this molecule. 
RecentK, the presence of lipophosphogj) can in Entamoeba histolytica (Bhattachar\'a et al. 
1992; Stanehe/tj/., 1992; Prasad etaL 1992; Srivastava et al, 1995) and Trichomonads (Singh 
1993; 1994;Singh and Beach, 1994) has also been demonstrated. LPG molecule was also 
identified on tfie cdl surface of amastigote stage of I . major (KcUeher et al, 1995; Moodv- et al. 
1993; Glaser er al., 1991) and flagellar pocket of Z.. donav-ani and L. mexicano (McConville and 
BlackweH 1991: Bahr et al. 1993). LIKJ plays an important role in the complement activation 
and resistance to complement mediated lysis (Puentes et al, 1988; 1990; Sacks et al, 1995). in 
the attachment and entrv of promastigotes into mammalian macrophage (Handman and Goding. 
1985; Talamas-Rohana et al, 1990; da Siha et al. 1989), in survival in the phagoKsosomal 
compartment (NicNeeh and Turco, 1990; Elhay et al. 1990) and as a recognition molecule for 
tf»e T-lynq)hoa1c-dcpeiKJent immune response charactcristicof leishmaniasis (Moll era/., 1989). 
The promastigotes undeigo moij^ological and biochemical changes within the midgut of the sandfly 
vector wliich leads to an increase in flieir infectrvitv in tfie mammalian host (Davies era/., 1990; 
Sadcs et al., 1995). The alteration in pathogenic properties from logarithmic phase promastigotes 
to stationary phase promastigotes are due to the change in Ac LPG structure (McConville et 
al., 1992; Sacks e/a/., 1995). 
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In recent years, the promastigoie cell surface has recei\ed considerable aiieniion 
in view of its importance for interaction with the inuuune system and for parasite recognition. 
iqitake and survival in macrophages the cell surface glycoconjugaie. lipophosphogh can (LPG) 
has been isolated purified and characterized from Leishmania parasites of different species 
(McCon%ille etai, 1987; Turco etal.., 1984; 1987; Ilg etai, 1992) However, no attempt has been 
made to stud>' the LPG from nonpathogenic strains Hence. isolation, purification and 
identification of lipophosphoglycan from a non-pathogenic strain (UR6) of L. donovani 
promastigotes was attempted. 
MATEIUALS AM) METHODS: 
ISOLATION OF LIPOPHOSPHOGLYCAN: 
Leishmania doncnani promastigotes (strain UR6) cells were removed fi-om peiri 
dishes as well as from cultxire tube b\ culture wire and suspended in PBS (0.1 M pH 7.4). The 
cells were centrifuged at 1500xg for 10 min at 4 "C, supemaiani Vi^as discarded and the pelleted 
cells were collected The cells were \\'ashed with PBS three times The parasites were stored 
at -20'Xr in screw-capped antigen \ial until use, LPG was isolated using different organic soKent 
mixutre by the method of Turco et al, (1987). 
25 ml of packed cells (27.0 g) were taken in 75 ml of solution having CHCl jCH p H (3:2, 
v v) and 15 ml of 4 mM MgCl. solution. This was sonicated until the suspension became 
milk)', and then centrifuged at 2000xg for 10 minutes. A pellet m the interface of rvvo phases was 
obtained. The upper aqueous phase and the lower organic phase containing water soluble 
metabolites and non-polar lipids, nespectiveh. were discarded. The pellet, containing metabolites, 
polar lipids, proteins and LPG was collected To the pellet was added 120 ml of 4 mM MgCl; 
solution and sonicated followed b> centrifugation at 2(X)0xg for 10 mm at 4 T. The supernatant 
containing metabolites was discarded and again pellet was collected. To this pellet was added 75 
ml of CHClyCH30HH;0 (1010:3, v v) and 15 ml of CHCI3 CH.OH (11, v/v) vortexed and 
sonicated followed b\' centrifugation al 2000xg for 10 minutes ai 4 T?. The supemaiani coniainmg 
polar lipids was discarded and to the pellet was added 90 ml of CHClyCHpHWp (10:10:3, 
v/v) sohent mixture vortexed and sonicated followed by ccntrifiigation at 2000xg for 10 min ai 
4*t:. The supemaiani was discarded and 90 ml of soh'ent CHCI5 C H p H U p (10:10:3,v\) was 
added to the pellet, it was vortexed sonicated and centrifuged at 2000xg for 10 minutes at 41?. 
Supernatant was discarded and to the pellet was added 90 ml of water/ ethanol' diethylether 
pyridine'NH4OH (15:15:5:1:0.017, v/v) sonicated and centrifuged at 2500xg for 15 min at 
4*^ !. Stqxmatant containing crude LPG was effected in a clean and dried roimd bottom flask. For 
ctnnplete extraction of LPG, the above step was repeated three times and the solvent extract was 
combined (288-300 ml). The solvent extract was centrifuged at 30,000xg for 15 min at 4^? 
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and ttie supemalanl was collected. The discarded pellet contains proteins and gj> coproteins. The 
supernatant was evaporated at 35-40''C and finalh' hophilized to get powder form of ciiide 
lipophosphogjican (LPG). 
Determination of Carbohydrate Concentration: 
For estimating carbohydrate concentration in LPG, Dubois et a!., (1956) method 
was used. Glucose solution, (1.0 mg ml) was used as standard. 
Preparation of Phenol reagent: 
Phenol reagent was prepared by adding 20 g of glass dis tilled water to 80 g of 
redistilled reagent grade phenol. This 80**/o phenol solution was diluted to 5% for higher 
accuracy-, hence 1.0 ml of 80% phenol solution was mixed into 15.0 ml of TDW. 
0.2 ml of 5% of freshl>' prepared phenol reagent was added to the 50 ;il of crude 
LPG sohitioii. To ttiis was added 2.0mlof concentrated sulphuric acid (95.5%). The addition was 
made b>^  pouring the sulphuric acid against the liquid surface and not at the side of glass tube, for 
good mixing. The tubes were kept for 10 min at room temperature and then vortexed and 
incubated at 30°C for 25-30 minutes. Optical densir>-(O.D.) was measured at 485 rmi against the 
blank. 
Estimation of Proteins: 
The protein contamination in the LPG was anahsed b> estimation of protein as 
descibed b>' Lown- et al., (1951), using bovine seriim albumin (free of fatt\ acids) as standard 
(l.Omgml). 
Preparation of copper reagent: 
Copper reagent was prepared by mixing the following reagent: 
A scAition was made containing 2.0% w\ sodiimi carbonate in 0.1 M NaOH solution, 2.0*0 w'v 
potassium-sodium tartrate and 1.0% w\ copper sulphate in the ratio of (100:1:1, v/v). 
Preparation of Folin-phenol reagent: 
This is a solution of sodium tungstate and sodiiim mohbdatc in phosphwic acid 
and HCL Thus the reagent is phosphomohixlotungstate. The commercially' prepared reagent 
was used after dilution with TDW in 1:1 ratio. 
Frcshh' prepared copper reagent 5.0 ml was adde<i to 50 pi of sample solution 
(brou^t to 1.0 ml by addition of distilled water). This mixture was incubated for 10 minutes 
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at room temperature, then 0.5 ml of diluted folin Phenol reagent was added to each tube. The 
tubes were shaken vigoroash. After 30 minutes, the colour ijitensit> of the i^ eaction was read 
at 750 nm, using 160 U\V visible Simadzu spectrophotometer. 
PURIFICATION OF LPG: 
Gel filtration Chromatography: 
Packing of the column is the critical factor in achie\ing a optimum separation of 
any mixture b\' column chromatography. A clean and dried column was pluged by glass 
wocA Packing of a column was normally carried out by genth pouring a slurry of the stationary 
{rfvase (resin or gd) into a column after removing fines' of the gel. The column was genti>- tapped 
to ensure that no air bubbles are trapped and the packing settles evenh. The sluny was added 
until the required hei^ was obtained. Once the required height was obtained, the flow of the 
solvent tfirough tfie packed column was started and continued until the packing was 
completed. The viod volume and retention volume of the column was checked. 
The purification of crude Kpophosphogl) can (LPG) was carried out b>- column 
chromatogrz^ jh)'. The void volume and retention volume of the column were measured using blue 
dexlran and phenol red, respectiveh. The crude LPG was dissoKed in 2.0 ml of 40 mM NH(OH 
containing 1 m\4 EDTA and centrifiiged at 9000xg for 3 minutes. The supernatant was 
coDected and applied on Sephadex G-200 column (1.45 cm x 60.0 cm), equilibrated with 40 mXl 
NH4OH containing 1.0 mM EDTA. The fractions (1.0 ml) were collected and anahsed for 
carbohydrate bv the method of Dubois et al, (1956). The protein contamination in the partialh 
purified LPG, was checked by the method of Lovviy et al, (1951). The fractions containing 
LPG were poded and dried by lyophilization. The completely dried LPG was then resuspended 
in LO ml of 40 mM NH4OH and loaded on Sephadex G-25 column (1.3 x 45.0 cm) 
equilibrated with the same buffer at flow rate 30.0 mlTiour for desaltation. The LPG containing 
fractions were collected and lyophilized (Oiiandi et ah. 1987). 
The ammonia containing solution does not cleave ac\1 linkage, therefore, the 
dried LPG was resuspended in 10.0 ml of water/eAanol diethylether pyridine 'NH, OH (15:15:5:1: 
0.017, v\') and was precqiitated by addition of equal volume of methanol and chilling the sample 
at-20^ for 18-20 hours. After methanol precqritation solvent and methanol were e\'aporated 
under vacuum (Oriandi et o/., 1987). 
Proteinase K treatment: 
Dried LPG was treated with proteinase K enzyme for removal of tightly bound or 
assodated protdn to LPG (Jig et al.,1992). Dried LPG was dissolved in 2.0 ml of Tris-HQ buffer 
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(10 mM, pH 8.0) and added lOOyig'Tvi proteinase K enzvine. The solution mLxture was incubated 
at 42t: for 3-3.5 hr. After the treatment, LPG was extracted b> centrifiigation at SOOOXg for 
10 min at 4°C. Then, the aqueous phase was extracted with one volume of phenol saturated with 
10 mM Tris-HCl buffer, pH S.O.The phenolic phase was twice exiracted with one volume of 
10 mM Tris-HCl, pH 8.0. The bulk of the phenol in the combined aqueous phase was extracted 
twice with chloroform and 3-meth>l-l-butanol (24:l,v'v). It was concentrated by rotatory 
evaporation about 1/3 volume and ethanol precipitation was performed. The precipitation was 
carried out by addition of 1/10 volume of 5M ammonium acetate and 4 volume of ethanol and 
incubated for 3 hr at -70°C, precipitate was coDected by centrifiigation and dried under reduced 
pressure. 
Hydrophobic chromatography: 
A small cdumn was washed dried and packed with phen> 1 Sepharose CL-4P 
or octyi SejAarose CL-4B gd as described earlier. Preferably oct>'l Sepharose CL-4B was used 
as it is more h}'droirfK)bic than jAeml Sepharose CL-4B. The loading of the sample was carried 
out at room temperature with high salt concentration so as to ensure complete binding, wiiile 
ehaion of the material was performed at low temperature, high pH and reduced salt concentration 
for high recovery of the bound materials. 
Fmalh', dried LPG was resuspended in 1.0 ml of 0.5 M NaCl and 0.5 M acetic acid 
and applied onto octyl Sepharose column (1.5 x 10 cm). The column was initially equilibrated 
with 0.1 M NaQ in 0.1 M acetic add. .After 20 fractions(1.0 ml tube) were collected, the solution 
wasdiangedtoO.l M acetic acid wiiere 20 more fractions were collected. Finalh' column was 
washed witfi TDW. 
The lipid portion of LPG gets bound to the oct\ 1 or phem 1 Sepharose due to 
hydroiAobic interactions. Leaving PG and other carbohydrates to be eluted out. The boimd LPG 
was duted with scivsnt E (Turco el <3/., 1987) or a gradient 5- TO**© propanol in 100 mM, TES 
buffer, pH 7.0 (Dg et al., 1992). AD fractions were anahsed b> the method of Dubois et ah, 
(1956). LPG containing fractioas were pooled diahzed against distilled water and lyophiHzed. 
IDENTIFICATION OF LPG: 
Thin Layer Chromatography (TLC): 
The purified LPG was identified by Ain layer chromatography (TLC). The analysis 
of LPG was carried out on siHca gel-G precoated plate. The principle of separation on TLC 
is diat, tiie mdecules interact with botfi the si^ jport of silica gel and the solvent system. LPG was 
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djssolved in solvsnl E; water/ethanol/dieth>1ether/pyridine/KH,OH (15:15: 5:1:0.017, v/v). 5-
10;il of this was applied on the TLC plate and dried at room ten^rature. The plate was run in 
a soK^ ent mixture n-propanorp>"ridine'water (1:1:1, v/v) till Ae soK-ent reached the top of the 
plate. The plate was taken out from ttie chamber, and dried at room temperature and tfien in 
the oven. This was stained with iodine followed by 1.0% resorcinol in 10% sulphuric acid 
(Oriandi et a!., 1987 and Turco ei a!., 1987). The TLC plate was heated in oven 5-10 minutes 
as to cause charring of carbohydrate moieties of LPG. 
Preparation of SchifTs Reagent: 
SdtifPs ree^ent was prepared (Kora et al, 1973) by addition of 2.5 g of basic luchsin 
in 500 ml c^ distiDed boiling water. Stirred for 30 minutes and cooled to SCC and tfien filtered. 
40 nd of 1.0 N HCl was added to the filtrate, cooled to 25*C and then 3.5 g sodium metabi-
su^ phite was added. This was kept in tfie daric for 20 hours at 4°C. 2-3 g of actKated charcoal 
was added and shaken vigorous^, filtered and the pH was adjusted b)' adding IN HCl until a 
drop what dried on the glass slide does not turn red. This was stored at room temperature. The 
solution has to be diluted with TDW (1:1,v/v) before use. 
Procedure for PAS staining: 
The gel was transferred in 12.5% TCA for 60 min in dark and cool place. It was 
rinsed for 5-10 min in TDW and immersed in 1% periodic acid containing 3% acetic acid 
solution and incubated for 1.0 hr in daric and cool place. The gel was washed Aoroughly at 4 ^ 
with TDW wifli intermittent shaking and was left o\'emi^t in TDW after at least 6-8 changes 
of fi^h water. The gel was transferred into fiichsin- sulphite in dark for 30-45 min for staining 
and then washed 3-5 times with 0.5% sodium-metabisulphitc in 3% acetic acid solution. 
Fiiiall}, the gel was washed with HjO according to requirement and was stored in 3-5% acetic 
acid solution. 
Preparation of Silver stain: 
Silvw stain was prapared as per ^ meftod of Ookle> et al., (1980). AD solutions to 
be prepare fi-esh. 
(i) 0.36% (W/V) NaOH in H p 
(ii) 1.0 ml ammonia solution (25%) plus 1.05 ml H2O 
Solution (A): mixed 21.0 ml of solution (i) and 1.4 ml of solution (ii) 
Solution (B): l.Og AgNOj in 5.0 ml HjO 
Solution (C): Added solution (B) drop by drop to sohition (A) in a beaker with continuous 
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stirring.Thc addition of solution (B) was stopped on appearance of brownish colour or an 
insoluble precipitate. If precipitate was of much higher amount then it has to be prepared Qrsh, 
otherwise, it is transferred to a measuring cylinder and made upto'lOO ml and ^uscd 
immediately. 
Solution (D):(i) l.O '^o citric acid (w/v) in HjO 
(ii)38.0%HCHOinH2O 
2.5 ml of (i) and 0.25 ml of (ii) were added in 500 ml H^O and used forIde\'elopment of band. 
Procedure: 
The slab gel was fixed in 50% methanol and 10*^ 0 acetic Jteid solution for 3-4 hr 
or over n i ^ ll was transfesred in 5% mettumol, 1% acetic acid solution foj- Ihr and washed witti 
TDW for 30-45 min or more, so ttut the gel recovers its normal size. The staining solution (C) 
was added in fl»e plastic box containing ^ 1 . This box was then placed on to the shaker for 30 
min for proper staining. This gel was washed in the HjO for 5-10 min with gentle shaking. The 
stained gel was transferred in the devrlopcr (D) and was shaken gently until the bands were 
visualized. Finally, the gel was washed 3-4 times with HjO and storcid in 5% acetic acid 
solution. 
Coomassie brilliant blue stain: 
0.5 g Coomassie brilliant blue R-250 was dissoh-ed in 450 ml of methanol and 
stirred it for 30 min. Then 100 ml, of acetic acid was added and made the final volimie to 1.0 
b+er and stored at room temperature. 
Sodium Dodecyl Sulphate Polyacrylamide gel electrophoresis (SDS-F*AGE): 
For determination of mdecular weight of LPG, SDS- * pol)aci>'lamide gel 
electrophoresis (SDS-PAGE) was carried out according to the method of Guilian et a!., (1983; 
1985). The separating gel (pH 9.3) was( 15% T, 0.5%C) and the stacking gel was (5% T, 
4.8% QgeneraD)'used. LPG was dissolved in sample buffer to give a final concentration of 
0.1 % (w/v) SDS, 15% (v/v) glycerol (pH 6.8) and a trace amount of bromophenol blue as a 
tracking dye and dithiothreitol (DTT) was used. The sample was centriftged for 4 minutes at 
20,000xg. 30 ;il (1 mg^ 'ml) of sarofAc was loaded in a well and electrAphoressed at 15 mA 
constant current. Rumiing buffer containing 0.38 M glycine, 0.05 M Tri)5 and 0.1% SDS (pH 
8.5) was used. The molecular weight markers of range 66 kDa-14.1 '^ kDa were run for 
determination of molecular weight. Coomassie brilliant blue and periodic ^ id Schiffs (PAS) 
staining were carded out for detection of protdn and LPG, respectively (Korn and >)^ 'right, 1973; 
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Oriandi et cd., 1987X The gd was destained in A5% methanol 10°o acetic acid for protein and 
0.5% sodium metabisulphitc in 3.0% acetic acid for carbohydrate analysis of LPG. 
One dimensional 'H and 2D COSY Nuclear Magnetic Resonance spectroscopic 
studies: 
Sam}^ were prepared fxNMR studies b>- repeated dissolution in 99.98% D^O with 
cvc^oration and lyophilization. FinaH}', the sample was dissoNed in 500 yA of DjO (Aldrich). 
ID and 2D COSY-*H NMR experiments were carried out at room temperature (25 Q on a 
Brukcr WM 400 NMR spectrometer equipped with ASPECT 2000 computer using a "C/'H 5 
mm dual probe head. LPG was taken in D.O (99.98*'b) with sodium-2.2- Dimeth>1-2-
nk^KQtano-S-adfonate (DSS) as a refensnce standard. Typical Fourier Transformation conditions 
for one dnieasional 'H NMR were as follows. Sweep width (S W) was 6400, size 16k, Pulse 
width (PW) = 45* with a digital resolution of 0.77 Hz per point. 
The two dimensional (2D) COSY experiment used was N-tvpe phase cycling and a 90" 
mixing pulse. The free induction decays were acquired over 1024 data points and 2463.05 Hz 
for each of 256 values of evolution time. The second dimension (F,) sweep width (SW,) was 
1058.8 Hz. The raw data were zero filled in both dimensions prior to double Fourier 
Transformation. 
RESULTS; 
Isolation of LPG: 
LPG from UR6 strain was extracted essentialh by the method of Turco ei al, 
1984; 1987, usir^ diffwenl oiganic sohvnl mixture like, CHCl^  CJ^OH (3:2. v,V), CHCI^  ' Cf^OH' 
HjO (10:103, \f\\ CHCy CHpH (1:1, vV) and water ethanol' diethylether'pyridine ammonium 
hydroxide (15:15:5:10.017, v/v) solvent E followed b\- sonication and differential centrifugation. 
Whoi tx parasite cdl suspoision was treated with chloroform and methanol various metabolites, 
ipds and n o n i x ^ lipids were extracted. Delipidated residue which was obtained in the form 
of pdtet was extracted ef&aently at 4*C with soh ent E wiiich contains water /ethanol diethjletiier 
piyridine/ ammonium hydroxide in a propOTtion of 15:15:5:1:0.017. \'arious soKents ha\'e been 
tried for solubilization of delipidated materials. It has been observed by Turco et al (1984) that 
about 95-97 gjS'coconjugate is extracted from delipidated material with 40 mM NH4OH at 
lOOXl, frfde only 85-90% was extracted at 25*C with solvent E. Hence, considering this fact low 
temperature and optimum pH is required to extract ceO surface LPG's inorder to prevent its 
degradation. Thus, solvent E was preferred over NH,OH. This fact is also supported b\- v-arious 
oAer workers inchiding (King et al, 1987; Oriandi and Turco. 1987, Jaffe et al. 1990) 
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In the isolation of LPG fixMn UR6 promastigotes from 25.0 *ffll(27.0gm)of packed 
cdls (promastigotes) about 150 mg of crude LPG was obtained. The preifence of carbohydrates 
in CTude LPG was determined by phenol-sulphuric acid method (Dubois et al, 1956). Figure 
1 shows tf\e presence of carbohx drates in absorttancc spectrum of crude LP© in the w avelength 
region of 450-550 ran The absorbance maxima (?. ^ was observed at 480 nm, which indicated 
ftc presence of caibolndrales in the extracted LPG sample. The broad pcalJlof crude LPG was 
indicative of the fact that heterogeneous popubtion of carboh>drates was Resent in the sample. 
\\'hen tf)e crude LPG sample was subjected to SDS-PAGE, it migrated ^ as a broad band with 
an jpproximale mdecular wdgjit range between 35-10 kDa. PAS staining <ld not reveal presence 
of any other ^coconjugate in this extract Coomassie brilliant blue Ri250 staining of SDS-
PAGE gels showed dye positive bands indicating that d\e extract was ^bntaminated with a 
number of proteins. 
PLTUFICATION OF LPG; 
The partial purification of crude LPG was carried out !^ size exclusion 
chromalograph}. As reported earlier, gel filtration of ghcoconjugate on Slephadex or Sepharose 
cohmm equilibrated mth 0.2 M acetic acid, 0.1 M NH4HC03, 0.1 \ I NiajCOj or 0.1 M Tris-
HCl, pH 8.0, resulted in poor recoveiy of the applied materials on colun^. Purification of the 
glj'coconjugate on Bio-gel support or Sepharose equilibrated with any of above mentioned 
buffers or with 0.04 M NH^OH and 0.001 M EDTA soKmt failed to elute the material 
quantitK'eh. Therefore, it is suggested that gJ>'coconjugate is purified effidientl>' on a Sephadex 
gd equilibrated with 0.04M NH4OH containing 0.001 M EDTA solution. Sephadex G-200 gel 
was prefaed over Sephadex G-lOO (Turco et al, 1984; 1987; King et al, 1987) due to its high 
resolution and coverage of maximum range for separation. NH^OH solvent was useful for 
avoiding tiie precipitation of tfie LPG on the top of the column. Addition of the EDTA in the 
duting soKent was necessary to prevent aggregation of LPG, as without EDTA, LPG eluted 
much earlier as an aggregate on gel-filtration. 
The crude LPG was dissolved in 2.0 ml of a solution containing 40 mM NH,OH and 1.0 
mM EDTA. The particulates materia] was removed by ccntrifiigation and loaded (4.6 mg'ml 
carbohydrates as detaminedby' Dubois et al., 1956) on Sephadex G-200 column equilibrated with 
same buffer. The ehidon profile of LPG fi-om Sephadex G-200 is shown in Figure 2. LPG 
fractions eluted just after void volume, indicating ttiat it is a high molecular weight molecule. 
Sin^ broad peak was obtained indicating ttie heterogeneous nature of LPG. The desaltation 
of LPG mcdecule which is eluted fi-om Sephadex G-200 was ncccssar>' for removal of unwanted 
salts like, EDTA, NH,*, Mg*" etc. (King et al, 1987). Desalting of LPG sample was carried 
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Figure 1: The absoibance spcctia of crude LPG on reaction wMi phcnol-HjSO^ reagent (Dubois 
et ah, 1956). The absoibance maxima was observed at 480 mn, which indicated the 
presence of tibe carbohydrates. 
- 9 5 -
FRACTION NUMBER 
Figure 2: Ehition profile of LPG on Sq)hadcx G-200 column (1.5 x 20 cm). 2.0 ml sample in 
40 mM NHPH contarrang 1,0 mM EDTA was loaded Flow rate of the column was 
4 ml/hr and 0.8 ml fi^ictions were collected. Void volume of column was 7.0 ml. 
Fractions were monitored by the mctiiod of Dubois et al (1956). 
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Figure 3: Elution profile of LPG on Sq)hadcx G-25 cAhmrn (1.7 x 10 on). Flow rate of the 
column 36 ml/hr and 1.0 ml fractions were oWected. 
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out on Scphadex G-25 column. It is necessai^ to remove EDTA from the LPG sample, as it 
interfered in the NMR studies. The elution profile of Sephadex G-25 column is shown in 
Figure 3. A single broad peak was again obtained, which indicated singje type of populatioiL 
Protein contamination in tfie LPG sample was not detected by conventional methods such as. 
Ninh>'drin test, Lowiy method and coomassie brilliant blue-R-250 staining on gels. The absence 
of proteins, DNA and RNA was confirmed by UV-spectroscopy where the LPG preparations 
showed no absorbance at 280 nm and 260 ran respectiveh'. However, with 'H NMR and silver 
staining, protein contamination was observed. Therefore, further purification of LPG molecule 
was essential Thus, the LPG smaples were treated with proteinase K as described in materials 
and medK)ds for ranoval of ti^i^- associated protein&'peptides. Proteinase K treated LPG fraction 
was applied on octyl Sepharose CL-4B column for final purification. The LPG samples 
recovered from the column did not show any silver stain positive band on SDS-PAGE gel, 
suggesting that proteinase K treatment of LPG sample renders it free of an> protein 
contamination. The final confirmation of the absence of protein contamination was carried out 
by *H NMR spectroscopic analysis. No peak corresponding to -NH signal of the protein was 
observed. Hence, pure LPG was obtained, which was used for further studies. 
From 25.0 ml (27.0 gm) packed cells, about 150 mg of crude LPG was obtained. 
On further purification by column chromatography, 88.0 mg of partially purified LPG from 
Sephadex G-200 and 3L0 mg from Sephadex G-25 was obtained. After removal of tightly 
associated protdn contaminants and final purification by hydrophobic chromatography, 15.5 mg 
pure LPG was obtained. 
IDENTIFICATION OF LPG; 
Identification of pxirified LPG was carried out by thin layer chromatography 
(TIC), SDS-polyaa>'lamide gel dectrophoresis (SDS-PAGE) and 'H NMR spectroscop>. Purified 
LPG was dissolved in sdvatt E and applied on silica gel G precoated plates. Figure 4 shows the 
mobiHlj-of LPG in the solvent mixture l-propanolp>Tidine'H20 (1:1:1, v/v). A single diffuse 
spc/L diaracteristic of LPG molecules (Oriandi and Turco, 1987), was observed. The R^  value of 
LPG in ibis scrfvent system was found to be about 0.66 ± 0.02, wliich is close to 0.62 reported 
c^a^ for fte L. doncvani promastigotes LPG of pathogenic strain (Oriandi and Turco, 1987). 
Purity of LPG molecule was also assessed by SDS-PAGE. The SDS-poh acr>'lamide 
gd dectrophotesis fcjknved by periodic acid schifPs (PAS) staining and coomassie Imlliant blue 
R-250 and silver staining of purified LPG are shown in figure 5. As seen in Figure (5 A), no 
protdn contaminants were observed on coomassie or silver staining of SDS-PAGE of finally 
purified LPG, thus indicating that the purified UR6 LPG was devoid of any protein contaminant. 
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Figure 4: Thin layer chromatography (TLC) of purified LPG. An aliquot (5-10 ;il) of the L? 
sample was chromatograph on silica gel G in solvent (propanol/pyridine/HjO, 1:^  
vV). Detection was canied out by charring with 1.0% resorcinol in 10% sulphuric *> 
Lane 1 : Suc»ose, Lane 2 : Pure LPG, Lane 3 : Crude LPG 
w 
• 
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Figure 5: SDS-Pol>'acrylamidc gel profile of LPG purified from L. donovani promastigotcj i 
non-pafliogenic strain UR6. Shown in Figure A; Panel A is a coomassic brilliant bfc 
R-250 and Panel B is a periodic acid-Schifi& base stained geL Figure B; Pand 
is silver stained and Panel B is a periodic acid-Schiffs base stained gel. 
Lane 1 is molecular weight marker , lane 2 is purified LPG and lane 3 is partial 
purified LPG. 
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Tightly associated protein contaminants which were observed as positive bands on silver 
staining of LPG molecule on partial purification from Sephadex G200 were remoxed b) 
proteinase K treatment. On PAS staining of gel LPG was the onh' carboh>drate staining 
qxdes observed and it migrated as a broad band. The molecular weight of UR6 LPG, obtained 
h\ the migration of standards protein on SDS-PAGE, as shown in Figure (5B) was found to 
be in the range of 20-25 JcDa. The observed molecular weight of UR6 IJ*G is similar to that 
reported earlier for LPG of promastigote of L. doncn'ani (Turco et al., 1984; 1987). 
*H NMR spectroscopic studies wwe carried out to determine the structural features 
of LPG. 400 MHz 'H NMR spectrum of LPG molecule is shown in Figure 6. The signal at 
65.52 ppm corresponds to the H-1 proton of mannose. The signal at 6 4.94 ppm from the HOD 
and the signal from M.3 to 4.54 ppm correspond to anomeric protons of carbohydrate moieties. 
The doublet at about 61.0 ppm is of the terminal CHj of acvl chain of lipid moiet\ and that at 
61.3 ppm corresponds to the (CH2)n of the acyl chain of lipid moiet\. 
Two dimensional COSY NMR studies were carried out for structural characterization 
of the LPG molecule. A Uvo dimensional counter plot (COSY), below the normal one 
dimensional spectrum is shown in Figure 7. The signal at 6 5.52 ppm was unambiguous!) assigned 
to H-1 of mannose and cwmectivities could be traced out as cross peak to the sigjial at 8 3.71 
ppm for H-2 protons, respectiveh. The H-2. signal further gave cross peak al 63.53 for H-3 
prolon. Further assignments of other proton in mannose was difficult in the region 6 4.0-3.35 
RKn due to the in phase properties of diagonal peak. Furthermore the presence of three anomeiic 
protons at 6 4.47. 4.26 and 4.1 Rxn indicated that LPG was a vei^ complex structure. The signal 
at 6 4.47 can be unambiguousK assigned to H-1 proton of galactose. Similarh Lonnectivities 
could be traced out for H-2 (63.54 ppm). and H-3 ( 63.83 ppm), but due to the aforesaid problems 
further connectNities could not be traced out. 
DISCUSSION; 
The lipophosphogh'cans of L. doncn^ani (strain LT16) are a heterogenous famih' of 
molecules which having a tripartite structure, consisting of variable disaccharide phosphorvlated 
repeat units, phosphosaccharide core and a hsoalkyl-P! lipid moiety. As reporte(' earlier, the 
gfc'coconjugate is removed easfly from a delipidated residue fraction with several soK'ent at 
100°C, but extraction with solvent E at 25*C or less is preferred. The use of solvent E is desirable 
doing extraction of LPG at lower tenq)erature and optimum pH for avoiding its degradation. 
SdubibK- of the LPG in sdvenx E which contains etfianoL ether, and pviidine suggested that the 
LPG possesses hn^drophobic K^JK. This possibilit> was further strengthened by observation that 
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Figure 7: Counter plot of COSY spectrum of LPG in DjO at 2TC. The specfiK 
represented in ihe unsymmetrized mode. On the tope is the one dimensional spcs* 
of LPG under similar conditions. 
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the migration of LPG was enhanced on thin layer chromatography by increasing pyridine. It 
is suggested that the amphipathic nature of the LPG is due to tiie presence of covalently bound 
Iqjid, and tfiat the lipid served to anchor the glycoconjugate onto the parasite membrane. The 
LPG molecule behaved like phospholipids, wlien sohibilized in water. It produced a micellar 
structure shielding the hydrophobic portion from water, and oriented itself in a highly branched 
carbohydrate chain out wards (Handman et ah, 1984). Previous studies have shown tfiat 
migration of glycoconjugate on TLC plate is reduced in presence of high proportion of water in 
solvent system and usually a small amount of Triton X-100 (Turco et al, 1984). 
LPG is ehited from Sephadex G-200 column in the presence of NH^OH 
containing EDTA sohuion. It was observed that Nli, OH as eluting solvent was useful as it avoids 
the precipitation of the LPG on the top of the column. The addition of EDTA in the eluting 
buffer was essential for preventing any aggregation of LPG. The aggregate of LPG molecule 
ehited in void volume of the cohinm. King et al (1987) suggested that LPG released into the 
culture medium bound tighd)' to serum albumin and eluted in the void volimie following 
chromatognq)hy on Sephadex G-lOO, and the LPG-albumin complex could not be separated by 
separate treatment with 0.1 M EDTA, 2% deoxycholate and 6 M urea. A single broad peak of 
ttie LPG was obtained from cohunn indicating that there is a heterogenous population of LPG 
molecule in the sample. LPG purified by conventional methods failed to remove LPG-
associated protein contaminants as they were tighth' bound to LPG (MoD et al, 1989; Jardim et 
al., 1991). These associated proteins were removed by the treatment with proteinase K enzyme 
and protein/peptide free LPG is obtained after purification from octyl Sepharose column (Dg et 
al, 1992). 
From 25 vA of packed cdls about 150.0 mg of crude LPG was obtained. This 
on partial purification yielded 31 mg of partially purified LPG and on final purification on octyl 
Sepharose column gave a final yield of about 15.0 mg of pure LPG. This yield of LPG from 
non pathogenic strain was found to be less as compared to tfiat from pathogenic strain of L. 
donovani promastigotes (King et al., 1987; Oriandi and Turco, 1987). This observation is in 
concurence to flw eatii^ report where the yield of LPG from patfit^enic strain of Z,. donovani 
and L. major promastigotes is high- Furtiiermore, in a recent stu^ with L. major Kimsey et al 
(1993) have shown ttiat LPG obtained from a virulent (Vir 5) strain of parasite ejqjressed larger 
LPG as conpared to ttie cooespondtng LPG from an avirulent strain. This observation suggested 
flial vinilait strain parasites produced more LPG dian the avirulmt strain. The low e}q>ression 
of LPG in ttte avirulent parasite might be cither due to a defect in LPG Inosyntfiesis or due to 
its immaturation during metacyc^ogenesis of tfte parasite. Hence, it is also possible ttiat non-
paflwgmic strab (UR6) may contain a lesser copy number of LPG molecules/cell as compared 
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to tf»c padK)gaQC straia Biochemical properties of the LPG of pathogenic and non- pathogenic 
strain have been summarized in table 1. This table indicates that both LPG's are different in 
reference to >ield, presence of copy number/cell and structure but quite similar in molecular 
weight and mobilit>- on TLC. 
The pxirit>' of LPG was characterized by TLC. A single fused spot was achieved, 
suggesting that a single population of LPG molecule is present. The R| value of the spot was 
found to be similar to tfiat of tfie pathogenic strain (Orlandi and Turco, 1987) under similar 
conditions. It was observed that the LPG of a non-pathogenic strain (UR6) of Z,. donovani 
promastigotes have greater movement in hydrophobic solvent as compared to hydrophilic solution. 
It is suggested that UR6 LPG has more hydrophobic properties. Protein contaminants which 
were present in crude partially purified LPG, were removed by treatment with proteinase K 
a\zyme. tfiercfore, no positive siKer stain band was observed on SDS-PAGE, suggesting that 
proteinase K treatment of LPG devoids it of any protein contaminants. It was supported by the 
NMR spectroscop> thai no am -NL^ signal was found diuing nMR smdies except carbohydrates 
corresponding peaks were observed. Therefore, it was confirmed b>- 'H NMR spectroscopic 
studies, that the LPG molecule in the sample was pure. 
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TABLE 1: 
COMPARATIVE PmSIO-CHEMICAL PROPERTIES OF LPG OF L. donovani 
PROMASTIGOTES 
Properties Nonpathogenic strain Pathogenic straitf 
Molecular Weight 20-25 kDa 15-30 kDa 
Mobihn^ on TLC 0.66*0.02 0.62 
Yield Low High 
Structure Branched and more 
complex 
Unbranched and 
comparativeh simple 
Cellular 
copy number 
1.5-3x1 Cf 
molecule of LPG cell 
a: Literature report*-
CHAPTER 5 
EFFICACY OF LIPOHOSPHOGLYCAN 
AGAINST L. DONOVANI INFECTION: 
STUDIES IN MA CROPHA GE SYSTEM 
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INTRODUCTION 
Leishmama promastigotes are introduced into the host blood circulation during a 
successful bite by the insect vector, the sandfl>-. The> are then recognised and consequenth 
internalized by the host macrophages to complete the biological cycle. Recognition and 
intemalizalion into the macrophage is therefore, verT.' critical feature in Leishmania cell cycle. 
The recognition of parasite b>' macrophage invoK'es a receptor mediated mechanism. It is 
suggested th.it, both recognition and internalization of Leishmania parasite into macrophage is 
mediated by carbohydrate containing surface molecules (da SiKa et al. 1989; Puentes et a!.. 
1988; Talamas-Rohana et al.. 1990; Kelleher et al., 1992; 1995). In vitro studies suggest that 
promastigotes ma>' utilize several different macrophage receptors depending on the parasite 
species and developmental stage, and on whether serum is present. In the absence of serum, 
there is evidence that the two major macromolecules on the promastigotes surface, a complex 
carbohydrate lipophosphogh can (LPG) and a gh'cos>1-phosphatid> linositol (GPI) anchored 
63-kDa proteinase, gp63, are able to bind directh' to a number of lectin like receptors of the 
macrophage (Kelleher et al., 1992; Talamas-Rohana etui, 1990; \\%on and Pearson. 1986; 
1988). In the presence of serum, however, the promastigote surface is opsonized with 
complement components such as C3b and iC3b, and promastigote uptake occurs via the 
complement receptors CRI or CR3 (Mosser et al., 1992 da SiKa et al.. 1989), 
It has been demonstrated that manose-fucose receptor (MFR) or mannan plays an 
important role in the attachment and internalization of Z.. donovani promastigotes to human 
monocvie derived macrophages (\^ "ilson and Pearson, 1986). Two of the gh coconjugate. fiicose-
marmose ^ 'o^ote in bgand (FML) and phosp'. .ate mannogalactan ligand (PMGL) purified fi^om 
promastigotes were found to be potent inhibitors of promastigotes phagocylosis (Palatnik et al. 
1989). As reported eriier. the attachment and internalization of Leishmania parasites is inhibited 
b>'low tonperature, cviochalasins; and mild fixation of macrophage with formalin, suggesting 
that parasite uptake is dependent on the integrity' of the macrophage phagocviic mechanisms 
(Qiang. 1979). It has been shown that the promastigotes deri^ed LPG epitopes are identified 
only by parasite infected macrophages, when incubated at 37"C. None of the other cell tvpes 
expressed LPG epitopes after incubation with IKe promastigotes. However. all of the cells 
including macrophages are strongh bound to LPG or PG at either 37"C or 4°C (Tolson et al, 
1990). It has been shown that disaccharide repeats of LPG of I . donovani accumulate on the 
surface of infected macrophages during parasite internalization. The LPG epitope is recognized 
by the monoclonal antibodv- CA7.AE, found to be a phosphorvlated GalpI">4Man a 1 
disaccharide unit (Tolson et al, 1989). Epitope interaction to infected macrophage is not 
dependent on lipid-tail interactions with the bila>er of tfie macrophage plasma membrane. 
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Ahhougji it ma>' occur via interaction betv, een carbohydrate portion of the LPG molecule and host 
ccH receptors such as, the CDl 8 famil> of the integrins that are present on man> cells including 
macrophages (Tolson et a!., 1989). LPG epitope could also be detected on the cell surface of 
amastigotes or its LPG and the infected macrophage using a number of monoclonal antibodies 
directed against several distinct determinants on the phosphogh can moiet\. Furthermore, the 
LPG expressed by the infected macrophage ma\- be modified because unlike the parasite LPG 
wfach is expressed on promasligoles and amastigotes. it couJd not be radio labelled by galactose 
oxidase or periodate treatment. 
Two fimctionalh- important LPG-domains invohed in the biolc^ of the parasite have 
been identified in L. major promastigotes. The repeat unit P3. P04-6[Gal(pi-->3)]GaI(pi" 
3)]Gal(pi—>4)Man a 1-, has been shown to be invoK-ed in the attachment of procyclic 
promastigotes to the midgut epithelium of the sandfl}' vector. P. papatasi (Pimenta et al.. 
1992X wide the repeating unit P5b PQ,-6[Gal(p] ->3) Gal(pl->3)Gal(pi->3)]Gal(pl-->4)Man 
a 1 - . is shown to be involved in attachement of infective L major promastigotes to 
macrophage cell line .T774 (Kelleher et al. 1992). The interaction of P5b with macrophages 
aj^ jeare to be Z.. major specific, su^esting that other Leishmania ma> use different domains ol 
LPG or different surface molecules for host recognition. The epitopes on P3 and P4a recognized 
by the four MA* -s wWch arc e?q)ressed in LPG fi-om both proc>'clic and metac> cbc promastigotes. 
HowevTsr, expression is low in amastigotes. as expected fi-om the structure of amastigotes LPG 
(Kellehereta]., 1994). P3 and P4a are also expressed at different relati\e abundance in the LPG 
of procyclic and metacyclic promastigotes. P3 decreases fi-om 52 mol"© in proc\cIic 
promasfigotes to 31 mol'^ o m the metac>clic form while P4a increases from 9 to 45 mol°o. 
respectiv^h'. Howewsr, the combined amount of P3 and P4a increases only slighth from 61 to 
76 mol ^b in procyclic and metacyclic promastigotes. respecti\'eh. The intact LPG is a more 
cffectKe inhibitor (30-100 fold) of 4A2-A2 and 2G] \-A3> than P3 and P4a (Kelleher et al.. 
1994). A much higher affinity of antibodies for intact IJ'G has also been shown for M\bs WIC 
79.3 (Kdkher et aL 1992). CA7,AE and BF9CC (Tolson et al. 1989). The M4b UTC 108.3. 
which recognizes the unsubstituted repeat unit P2. PO4-6 Gal (pi~>4)Man a 1-. revealed a 
H^CT ejqyession in the amastigotes than in the promastigotes. This is due to amastigote LPG 
containing 70 mol**© of P2, while proc>clic and metacyclic promastigotes contain only 7 and 15 
mol% of P2, respectively (Kelleher et al, 1994). Recently, the P3 repeat unit is shown to be 
irnxjlved in the attachement of procyclic promastigote to the epithelial cells of midgut (Pimenta 
et al., 1992X while P3 is present in bofti procylic and metacyclic LPG's, onh' procycUc LPG could 
inhibft birtdiiYg of parasite to epithelial midgut. This is thought to be accounted for by procyclic 
LPG having clusters of repeat units with side chains of p-Gal units. Metacyclic LPG on the 
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odierfvand has a hi^ ^er numbo- of repeat units terminating ^ith p Ara (P4a and P5a), reducing the 
KkeHhood of chistCTs of repeat units with terminal p Gal residues. Hence, P3 in procyclic LPG 
is an attachment ligand for epithelial cells of the sand fly midgut (Kelleher et al., 1994). 
A rec«il report shows tfiat LPG is capaiAs of blocking the attachment of amastigotes 
or promastigotes to macrophages and also inhibit internalization of Z.. major promastigotes by 
macrophage (Kelleher et al, 1995). This inhibitory effect has been shown to be mediated by p 
(1—>3) Gal residues specific to L. major. The amstigotes LPG also binds to primary 
macrophages and cell Kne. The binding of amastigotes to macrophages could be blocked by intact 
LPG from L. major amastigotes as well as LPG from promastigotes to serveral ofter 
Leishmania species, suggesting invoN-ement of a conserved binding domain and not a species-
specific domain (KeDehere/o/., 1995). 
The protective potential of L. donovani LPG, isolated from promastigotes of i . 
donovant (strain UR6), against L. donovani infection in peritoneal macrophages has been 
studied. The studies demonstrate that UR6 LPG inhibits binding of promastigotes of Dd8 strain 
to peritoneal macrophages in a concentration dependent manner. Furthermore, UR6 LPG 
provided a significant protection (about 85-90*'/b) in peritoneal macrophages against promastigotes 
infection. 
MATERIALS AND METHODS; 
Mouse Peritoneal macrophage culture: 
Three month cW BALB'c mice, in bred at the animal house facility at Central 
Drug Research Institute, Lucknow, India, were used to obtain peritoneal macrophages. 0.5 ml 
of 2% tfiiogK'colate was injected intraperitoneal!}' to each animals. Thc>' were sacrificed b>-
overdose of clher or dtiardonn after 48 hr of thioglycolate injection. Animals were washed with 
70°/o ethanc4 and the epidermis was cut exposing the dermis. Five milliliters of cold RPMI-1640 
medium containing 100)i/ml of penicillin and 100 ;ig/ml of streptomycin was injected into tfie 
peritoneal cavit}. The abdomen was massaged gend> and the peritoneal fluid was aspirated under 
sterile conditions, and stored on ice. The peritoneal fluid was centrifuged at lOOOxg for 30 min 
at 4*C. The supernatant was discarded and the peQet was resuspended in warm medium, 
washed two times by centrifugation at lOOOxg for 20 min at 4*C. The pellet cells were 
rcsu j^ended in 5.0 ml of complete RPMI-1640 medium containing 10% FCS (v/v) and 40 >ig'ml 
gentamycin. A small drop of ceQ suspension was transferred on haemocytometer and counted 
under lOOOx magnification. Complete medium was added to required amount for adjusting cells 
count 1x10^ ceOs^ 'ml. The viabibtv' of &e cells were checked by tiypan Uuc staining. 
Circular g ^ cover slips were cleaned with sulfochromic acid, extensively washed 
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in tiipk clistilkd waler, sterilized by 70% cthano! then flame and placed in 24- well tissue culture 
costar traj-s (Coming, New York). In each weD 1.0 ml of ceU suspension was plated on to tfie 
cover slip and to it was added 1.0 ml of complete medium. The cells (0.5xl(f/ml) were 
allowed to adhere at ST'C in an atmosphere of 5% COj for 5 hr or more. Nonadherent cells 
were removed by rinsing the plates wifli complete RPMI-1640 medium twice. Approximately 
2x10' cells were obtained in each well. Adherent peritoneal cells were incubated for an 
additional 18 hr under the same conditions and used for studies. 
Trypan blue staining: 
50>il of trypan blue (0.01%) in PBS was added to the cell suspension and placed in 
ice. Tiypan bhic stains dead cells (blue colour) only by entering through their ruptured plasma 
membrane, leaving the viable cells-intacL 
Phagocytosis assay: 
Mondayas of peritoneal maaofiiigcs were prepared on glass cover slips in a 24 well 
costar trays. Eadi COVCT slip was coated with 2 x 10* macrophages in each well contaiiung 1.0 
ml of RPN'fl-1640 medium, supplemented with lO'^ o Fetal calf serum (FCS) and were incubated 
at 3TC in 5% COj atmosphere. Living promastigotes of L.donox'ani strain Dd8 or UR6 obtained 
(from 4 and 3 days culture respectively), were added to macrophages after two washing in an 
jqjpropriate concentrations (2,5,10 and 25 parasite per macrophage) and incubated for 18 hr 
at ST'C in at 5% COj atmosphere. 
Promastigotes oiL.donavani strains UR6 or Dd8 were added to monolayers of 
peritoneal macrophages in a constant ration (10 parasites per macrophage) in each well. The 
tissue culture i^ ates were incubated for periods ranging from 15 min, to 24 hr at BTC in 5% CO^ 
atmosphere in CO2 incubator (Heraeus, Jouan, IG 150). Each well was washed after its 
incubation periods, three times with RPMI-1640 medium to remove free promastigotes. Cover 
slips were fixed in methanol for 10 min and stained with 10*?o Giemsa stain (E.Merck \G, 
Darmstadt, Federal Republic of Germany) for 30 min, dried, mounted, and anahzed micro-
scopically. The phagocytic index was determined by counting the percentage of all 
macroph^es ii 10-12 miaoscopic fidds under \000K magnification (a total of approximately 500 
cdSs) fitat had piugocytosed at least one Leishmania parasite and multiplying tfiis count by the 
avenge nndxr dLeishmania parasites per macrofrfu e^ observed in 100 macrophages (Palatnik 
et al., 1S>89). For determination of adhesive index, tfie experiment was carried out at 4 \Z: 
keeping ttie odier experimental conditions same as above (Bianco et al., 1975). 
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InrectJon of Macrophages: 
Pronnastigotes harvested in die late log to stationar>' phase were used to infect culture 
of adherent macrophages on cover slips at a ratio of 5 parasites per macrophage. Infection was 
performed at 3TC in 5% COj atmosphere. The percent infected cells and the number of 
amastigotes in these cells were counted at specific intervals by removal of all nonadherent or 
extraccDular promastigotes by washing with PBS. 
Liposomes Preparation form vitro studies: 
Lipid film was prepared as mentioned in Chapter VI. Dried film was dissolved in 
RPMI-1640 medium without PCS and LPG at required concentration (10, 50, 100, 1000 and 
2000 ng^ wcD) was added to it. AD preparations were vortexed and sonicated in the presence 
of ice, pulse cycle of SO/sec. arid 3 Hz fi^equcncy was maintained for 15-20 min with a time 
interval of 2 min. It was centrifuged at 30,000 x g for 15 min. Supernatant was collected in the 
fi«h tubes. AD pr^uralions of LPG or lqx)somised LPG were filtered with 0.2 pm membrane 
filter (Sartonous) in the sterilized (autoclaved) tubes and made upto 3 ml in each tube by adding 
conpfcte medium, le., PCS supplemented medium. The same phospholipids to cholesterol ratio 
was maintained for aD experiments. 
Macrophage binding assay: 
Monolayers of peritoneal macrophages (2x10^ cells'ml) were grown on cover sHps 
as desoibed above. These macrophages were incubated with LPG alone and with hposomised 
LPG (LPG in SUVch) for 2 hr, prior to the addition of parasites to the macrophages. 
Promastigotes of strain Dd8 were added to macrophage monolayers at ratio of 5 parasites per 
macrophage and incubated for 45 min at 37°C in 5% CO, atmosphere. The binding assay was 
terminated b>' tfiree gentle washing witfi PBS, for removal of fi-ee promastigotes. The cover 
s6ps were fixed in methanol, stained with 10% Giemsa for 30 min, dried mounted and examined 
microscopicall}' by counting number of macrophages with bound promastigotes. A minimum of 
500 macrophages were coimted fi^om each cover slq). 
Inhibition of Ldsh/rumia internalization in macrophages by LPG: 
Monolayers of peritoneal macrophages (2x10'cells^ml) were grown on cover slips 
and incubated with LPG or lq>osomised LPG (LPG in SUVch) of difiFerent concentration for 
2 far prior to the addition of parasites to the macrophages. Promastigotes of strain IMS obtained 
fix)m 4 da>'s old culture were added to macrophage monolayers at a ratio of 5 parasites per 
maai)iAf^andincubatedfor6,12,18and24hrat37'Cin 5% CO^ atmosphere. Extracellular 
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promastigotes were removed b> washing with RPMI-1640 medium after 6 hr. 
After incubation period, experiment was terminated by three subsequent washes with 
PBS (0. Wi, pH 7.2), for removal of firee organisms. The cover slips were fixed in methanol 
for 10 min, stained with lO^b Giemsa stain for 30 min, dried, mounted and examined 
mJcroscopicaU)'. Number of the infected macrophages and amastigotes were counted for each 
cover slip. 
Pre and Post treatment of LPG: 
Monolayers of peritoneal macrophages (2x10* ccHs'ml) were grown on cover slips 
as desoibed above. The ceQs were incubated with promastigotes'(5 promastigotes/macrophage) 
for 6 hr at 37°C in 5% COj, 93% Nj and 2% Oj in a CO^  incubator. Extracellular promastigotes 
wwe removed by dKxxx^ washing. LPG (100 ng/well) was added in each weD and incubated 
for 2 hr in Ac same environments. After washing the plate was incubated for 18 hr in CO^ 
incubator. 
In another set of experiment, the macrophage monolayer was incubated with LPG 
(100 ng'wtffl) for 2 hr, prior to the challenge with promastigotes for 6 hr in 5°o CC^  atmosphere. 
Extracellular promastigotes were removed. Fresh complete medium was added and incxibated for 
18 hr as described above. Controls were prepared in the absence of LPG. 
RESULTS: 
Infecti\ity of promastigotes of Dd8 strain in peritoneal macrophages. 
The macrophage culture system was used to evahiate the in vitro infectivit> of Z. 
donovani promastigotes (Dd8). The infectivity of L. donovani promastigotes of strain Dd8 wa.s 
examined by incubating promastigotes in stationary phase of growth with mouse peritonea] 
macroiAages. Z.. dbncA'om promastigotes showed a h i^ levels of infection as observed by the 
h i^ count of amastigotes in the glass slides after 24 hrs of incubation period. Further increasing 
the time of incubation showed the number of amastigotes increased inside the infected 
macrojrfi^ cs and rdeased of some amastigotes from the macrophages due to ruptured die plasma 
membrane. 
Phagocytosis assay: 
In vitro phagocytosis assay using promastigotes of strain Dd8 and UR6 with 
paitoneal macrophages obtained from B ALB/c mice was carried out. The cfifect of incubation 
of promastigotes of Dd8 and UR6 strains of L. donovani with peritoneal macrophages under 
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sirrribr conditions showed that tfie infectiviU' of Dd8 promastigotes was more compared lo UR6 
promastigotes (Plate 1). 
The effect of promastigote&'macroirfiage ratio on phagocytosis was ako studied. The 
lrfiagoc)1ic index (PI) as shown in figure 2A was found to be proportional upto a ratio of 10:1 
with respect to promastigotes macrophage ratio. Increasing ttie promastigotes macrophage ratio 
further upto 25:1, did not show any significant changes in phagoc>'tic index. The adhesion 
contributed onh' 7% or less to the phagocytic index as observed by carrying out the assay at 
4*C. Thus, the observed internalization of promastigotes was indicative of a norma! physiological 
phenomenon. 
Time dependent phagoc>tosis of promastigotes by macrophages was also studied. 
Rgure 2B shows the time dependent internalization of promastigotes of strains E>d8 and UR6. 
The phagoc>lic index w as found to be directl)' proportional to the incubation period upto 6 hrs, 
when ma.ximum number of promastigotes per macrophage were internalized and their 
phagoc>tic capacit\' seemed to be saturated. The examination of infected macrophage culture 
after 18 hrs post challenge with promastigotes should a large number of amastigotes in the 
infected ccfls, for both strains. The percentage of infected peritoneal macrophages withDdS 
promastigotes was found to be higher as compared to UR6 promastigotes. These observations 
suggest that promastigotes of non-pathogenic UR6 strain of Z-. donovanf are able to bind, infect 
and proliferate in the peritoneal macrophages. 
LPG blocks attachmentof promastigotes to peritoneal macrophages: 
Studies were carried out to evaluate the potential of UR6 LPG in inhibiting the 
attachmoil of I>d8 promastigotes to peritoneal macrophages. With increasing ratio of parasite to 
macrophage, a concomitant increase in the percentage of cells with attached promastigotes or 
number of promastigotes attached to each cell was observed. At the ratio of 5 promastigotes 
per macrojrfi^es, with an incubation time of 45 min, onl) one or two parasites were found to be 
attached to each cell. 
The effect of pretreatment of peritoneal macrophages with varing concentrations 
of UR6 LPG on the macrojAage promastigote interaction is shown in figure 3. A concentration 
dependent increase in LPG's abilit>' to inhibit binding of Dd8 promastigotes to peritoneal 
macrofjuigcs. For 10 ng^ml LPG about 50% inhibition of attachment to peritoneal macrophages 
was observed. This inhibitory activity was enhanced fi-om 60^o to 78?o, when the LPG 
concentration was increased from 50 ng/ml to 100 ng'ml, respectively. A maximum inhibition 
of about 85-90**'o was observed for 1000 ng/ml of LPG. No fiirthcr enhancement in inhibition 
with increase m LPG concentration to 2000 n^ml was observed. Similar results were obtained, 
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Figure 1: bifcctivily of promastigotcs of L. donavani strains UR6 and Dd8 strains in pcritono 
macrophages. 
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Figure 2: E£fect of promastigote/inacrophage ratio (6 h incubation) (a) and effect of time at a 
ratio of 5:1 promastigote/macrophage (b) on phagocytosis. 
Values are mean ± SD for three experiments. 
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Figure 3: Inhibition of attachment of L. donavani promastigotcs to mouse peritoneal 
macrophages in presence of UR6-LPG. The number of macrophages with parasite 
tfadiod was counted and expressed as percent adheraice compared to control In the 
fjgure Ac abbreviation L-LPG stands for LPG incorporated in cholesterol containing 
gmall unilameDer vesicle. Values are mean + SD for four experiments testing each 
condition in triplicate. 
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when the LPG was incorporated into small unilamellar vesicles (SUV) with cholesterol. These 
results demonstrate that UR6 LPG inhibits attachment of promastigotes of E>d8 strain to 
peritoneal macrophages in a concentration dependent manner. 
Protection of peritoneal macrophages against Leishmania infection using LJR6 LPG 
Peritoneal macrophages were incubated with UR6 LPG for 2 hrs followed by 
challenge with L. dono\'ani (Dd8) promastigotes. The intensity of infection in macrophages was 
assayed by counting the percent cells with amastigotes, and the results shown in (Figure 4 and 
summarized in Table 1). A dose dependent protection in macrophages against Leishmania 
infection was observed when macrophages were preincubated with LPG. A subsequent decrease 
in infected cells with increasing concentration of LPG or Hposomised LPG molecule was 
observed (Tabk 1). A maximum protection of about 85 percent was observed for 1000 ng nJ of 
LPG. iicoiporation of LPG in liposomes did not show any substantial difference as compared 
to LPG alone treatment. 
Pre and Post Treatment: 
In order to look into the possibility' whether LPG mediated protection in macrophages 
gainst L doncA>ani was either due to inhibition of attachment of promastigotes to macrophages 
or killing of amastigotes inside the macrophages, studies with pre and post treatment of 
macroph^es with \JK6 LPG were carried out. Peritoneal macrophages were either challenged 
with Dd8 promastigotes for 6 hrs followed by the removal of free promastigotes b> washing with 
PBS and incubating with LPG for 2 hrs or incubating macrophages with LPG for 2 hrs 
followed b> the removal of unbound LPG and challenging with Dd8 promastigotes for 6 hrs. 
TaWe-2 shows the intensit\' of infection in different groups of animals at 18 hrs post infection. 
Figure 5 also shows protective cfiBcacy of LPG molecule against L. donovani infection. 
Pretreatment of macrophages with LPG showed a substantial inhibition of infection but no 
inhibitory effect on infection was observed when macrophages were incubated with LPG post 
establishment of infection. These observation suggests that LPG dependent inhibition of 
attachment of promastigotes to macrophages is the primar}- mechanism responsible for LPG 
mediated protection of peritoneal macrophages against L. donovani infection. 
Thus, above presented results demonstrate that LPG of I. donovani promastigotes 
(strain LJR6) inhibit tfie attachment of promastigotes of pathogenic strain (Dd8) to the peritoneal 
macrophages. Furtfiermore, preincubation of peritoneal macrophages with LPG provided 
significant protection against L. donovani infection. 
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Figure 4: Effect of pretreatment with IJR6-LPG on intensity of Ldonavani promastigotes 
infection (strain Dd8) in BALB/c mice peritoneal macrophages upto 18 h post 
infectian. The number of macrophages wi& parasite internalized was counted In the 
figure the abbreviation L-LPG stands for LPG incorporated in cholesterol containing 
small unilamellar vesicle. Values are mean + SD for four experiments testing each 
condition in triplicate. 
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Table I: 
Dev elopment of I. donovani promastigote Infection In peritoneal macrophages in presence and 
absence of pretreatment with UR6 LPG. 
Treatment % Infected cells after No. of parasites/100 cells 
Groups 
6h 18 h 6 fa 18 fa 
1. Control 69-2.02 
2. lOngLPG 35-2.16 
3. SOngLPG 27zl.l3 
4. lOOngLPG 22t0.9 
5. l)ig LPG 11.9±0.3 
6. 2 >ig LPG 10.6±0.4 
7. lOng LLPG 30-2.04 
8. SOngLLPG 26-0.2 
9. lOOngUPG 18±1.01 
10. l>igLLPG l l r l 
11.2)jgLLPG 10.8r0.4 
Values represent mean iSD for four experiments testing each condition in triplicate. 
Peritoneal macrophages were incubated ^ i^th LfR6 LPG for 2 h followed b\' remo\'al of free LPG! 
^-ashing as described in materials and methods. Tbe> were then challenged with L donovani {M"omastigot 
(strain DdS) at a ratio of 1:5. The infectivit>' of promastigotes was checked at 6 and 18 h post infectic 
In the table the abbreviation LLPG stands for LPG incorporated in cholesterol containing unilamell 
liposomes. 
80±3.1 
36+1.2 
32±2.01 
23-1.03 
11.5+0.4 
11.1+0.2 
31±1.2 
30-0.12 
19+1.09 
10.8-0.3 
10.2-0.2 
191+5 
44-1.7 
33rl.3 
33-0.7 
27+1.2 
25+1.2 
44-1.82 
36+2.1 
36-1.9 
19^1.2 
17+0.62 
239^18 
74+5.03 
56+3.08 
45r2.5 
32-0.4 
28-0.6 
56i2 
49-1.32 
32+1.5 
30.7+0.9 
28+0.7 
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TABLE 2: 
Protection against L. donovani infection in BALB/c mice peritoneal macrophages on pre and 
post treatment with l'R6 LPG. 
Treatment % Infected cells Amastigotes/100 cells 
1. Control 76±2.5 226 ±49 
2'. Post treaiment 7512.9 215 + 5.3 
3\ Pre treatment 24.5 ±0.7 59 ± 7.3' 
Values represent mean-SD for three experiments testing each condition in duphcaie. 
a; Peritoneal macrophages were incubated with promastigotes of strain Dd8 for 6 h followed by 
incubation with LPG (100 ng well). The data was collected 18 h post infection. 
b: Peritoneal macrophages were incubated with LPG for 2 h followed b\ incubation with 
promastigotes of strain Dd8 for 6 hrs. The data was collected 18 h post infection 
• p \'alue as determined by student t test p< 0.001 
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Figure 5: Protec&on ^^inst L. dcmovani infection in BALB/c mice peritoneal macrophages on 
pre and post treatment with UR6 LPG:(a) untreated peritoneal macrophage chaUcnged 
with promastigotes (control) (b) peritoneal macrophages were incubated i^ik 
promast^tes of strain Dd8 for 6 h followed by incubation with LPG (100 ng'ml) ^  
paitoneal macrof^ iages woe incubated witti LPG for 2 h followed by incubation wilfc 
promastigotes of strain Dd8 for 6 hrs. The data was collected 18 h post infectioo. 
?/•;>••: #.•: 
4 9 
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DISCUSSION: 
I J*G is an attachmcnl bgand for promastigotes which is invoKed in a direct interaction 
with macrophage receptors (Talamas-Rohana et al, 1990) or it can be opsonized with 
complen>ent components to interact with macrophage receptors (da SiKa et al, 1989). LPG from 
aU the species of Leishmania examined share the same tripartite structure comprising of a 
backbone of disaccharide repeat units, which are linked b) a phosphosaccharide core to a lyso-
alkyl phosphatid}1inositoI anchor (Turco and Descoteaax, 1992). Recent studies have 
demonstrated that binding of amastigotes to macrophages could be blocked by intact LPG from 
L. major amastigotes, as well as by LPG's from promastigotes of Z,. major, L. donovani and 
L. mexicana (Kelleher et al., 1995) indicating tfie possibility of involvement of conserved non 
species-qjecific LPG domain in LPG-macrophage binding. In the presence of complement, tfie 
attadimoit of amastigotes to macrophages is not ahered, siiggesting the LPG interacts directly 
with macro{rfiage recqjtors (Kelleher et al., 1995). It has been demonstrated that the gljcan core 
of LPG can reduce the attachment of amastigotes to macrophages (KcDeher et al., 1995). This 
inhibition has been shown to be dose dependent and decreases with increasing ratios of 
amastigotes to cells. (Kelleher et al., 1995). 
Studies were carried out to evaluate the eflScacy of heterologous LPG in providing 
protection against L. donovani infection. The reason for choosing LPG of promastigotes of 
strain UR6 for Aese studies was that, Ae>' can be grown in large quantities in the semisobd 
medium as described in the materials and methods. Hence, large amount of pure LPG can be 
obtained easil\' from promastigotes. 
The interaction between Leishmania promastigotes and BALB c mice peritoneal 
macrophages was studied m vitro. The effect of infectKit> of botfi strains of L. donovani 
promastigotes (Dd8 and L'R6) was checked. It was found that the Dd8 promastigotes had greater 
infectivit)' than UR6 strain. The effect of ttie promastigote macrophage ratio on phagoc)tosis 
was also studied. The rate of phagocytosis increased upto 10 promastigotes per macrophage and 
beyond that the phagocytic capacity of die macrophages seemed to be saturated. The 
intonabzation of promastigotes by flie macrophages was a physiological phenomenon representing 
a normal phagocytic macrophage activit}'. The morphological changes in internalization of 
promastigotes during tfie course of stud)- was not observed and the plateau was not an 
equihlnium between internalization and digestion of parasites in macrophages. 
The effect of time on promastigotes internalization by peritoneal macrophages was 
assessed The phagocytic inde.x was found to be proportional to the incubation period upto 6 hrs, 
where flie maximum number of pronfiastigotes per macrophage were internalized. After 6 hrs, 
q>proximately 80-85 percent of macrophages were capable of internalizing the promastigotes, 
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and after vsWch Ihcir capacit> seemed to be saturated. Therefore, the phagoc>1ic index indicates 
that the nuvimum internalization occurs upto 6 hrs. Hence, it could be suggested that the ratio 
of 5-10 promastigotes per macrophage and an incubation time of 6 hrs is the suitable condition 
for in vitro assay. 
Previous studies have shown that promastigotc LPG from L. major inhibited L major 
promastigote binding to macrophage cell line J774 (KeOeher et af., 1992) and LPG from L. 
mcgor amastigote is also inhibited the attachment of amastigote to flie macrophage ccD line J774 
(Kelleher et aL, 1995). The potential of UR6 LPG in providing protection against L. donovani 
mfectJon was also studied. Purified LPG from L. donavani promastigotes (strain UR6) was able 
to inhibit the attachmoit of promastigotes of L. donmani strain Dd8 to peritoneal macrophages. 
It was evident from the studies conducted, tfiat inhibition of attachment of promastigotes to 
peritoneal macropha^ was concentration dependent. These results support the earlier observation 
(Kdldier et al., 1995) that domain of LPG which is involved in binding of promastigotes to ttie 
macrophages, is conserved in the promastigotes LPG of both Ae Dd8 and UR6 strains of L 
donavani. 
Two mechanisms of binding of Ae ghcoconjugate to cells may be postulated: a 
^jedfic mechanism, b>' which the carbohydrate part of the molecule binds to macrophages, and 
a non-^)ecific mechanism by which a hydrophobic (probabh- Hpid) part of the molecule binds 
to aD cells. It is therefore, interesting to note that the gjvcoconjugate bound to macrophages 
(presumabh' via a ^ Jedfic recqMor) was capable of cappring, wWle the gl>'coconjugate, which was 
maeh' inserted into the membrane of other cells bv hydrophobic interaction, was not (Handman 
and Goding, 1985). B has be«i suggested that L. major ghcoconjugate is the parasite molecule 
involved in macrophage recognition and attachment, and that this interaction occurs via the 
carbohydrate part of the molecule (I^andman and Goding, 1985). In many other ceD-cell 
interactions studied the process of attachment has been demonstrated to be a muhistep process. 
For example, attachment of leukocytes to endotiielial cells may be mediated initialh by a low -
affmit} binding interaction to the endothelial surface via selections and the Sial>'l Lewis 
saccharide, followed bv high a£5nit>' interaction with CDl 8 integrins of the endoAelial cells 
providing stable association before transmigration (Lasky, 1992). Evidence also suggests that the 
attachmait of Plasmodium falciparum merozoites to human er>throc}1es is mediated b)- a two 
stage binding process utilizating two distinct binding domains of the 175-kDa eiy1hF0c>te binding 
ntaffn (Kain et al, 1993). Similar interaction rosy also occur for the attachment of Leishmania 
amastigote s to macrophages via two binding domain of LPG or two different ccD surface 
mt^ecules (Kelleher et al, 1995). The involvement of two ccU siirface molecules in a muhistep 
infection process has already been demonstrated for attachment of Leishmania promast^ote. 
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Beads coated v^ t^h promastigotes gp63 were not internalized by macrophage, although 
atl3chment of these beads to the surface of the cells was observed (Russell and ^^  right, 1988). 
In contrast, beads coated with LPG attached and were phagoc)tised. Recentlj, Love et al. 
(1993) have also suggested that the interaction of L. mexicana amazonensis amastigotes with 
niammafian cdls via interaction with heparin sulfate proteoghcans may be a general mechanism 
to bind to host cells. However, in the present stud>' binding of promastigotes to peritoneal 
macrophages was inhibited by about 85-90% when pretreated with LPG, suggesting additional 
mechanisms for promastigote recognition by macrophages. This smd>' is also supported by 
previous study (KcDeher et al.^ 1995) that LPG was unable to completeh' block attachment 
suggesting the involvement of other ligands support the earlier observation (KcUcher e/ca/., 
1995) that domain of LPG which is involved in binding of promastigotes to the macrophages, is 
conserved in tfie promastigotes LPG of both the DdS and UR6 strains of L. donavani. 
After demonstrating tfie capabilit>' of LT16 LPG in inhibiting the attachment of Dd8 
promastigotes to macrophages, it was necessary* to see whether this can render any protection 
against L. donovani infection. It was observed tfiat LT16 LPG is capable of providing significant 
protection (about 85 percent) in peritoneal macrophages against promastigotes upto 18 hrs post 
infectioa The long term protection against L. donovani infection in peritoneal macrophages was 
also found to be concentration dependent. About 85 percent protection was obtained at 1000 
ng'rtil which foiled to iiKrease subsequenth' increasing the LPG concentration upto 2000 ngml 
This long term protection could ha\'e been obtained due to an inhibition of attachment of 
promastigotes to peritoneal macrophages or by killing of the amastigotes inside the macrophages. 
In order to destinguish between the peritoneal to processes macrophages were treated with LPG 
before arid after challenge witfi promastigotes. It was observed that the peritoneal macrophages 
which were treated with LPG before being challenged with promastigotes provided significant 
protection i^ainst L. doncxani infection. However, those which were challenged with promastigotes 
and then treated with LPG provided similar pattern of infection as observed fliat for control 
Tliese observations, suggest that pretreatment of j)eritoneal macrophages is necessary condition 
for achieving protection which is dependent on the inhibition of attachment of promastigotes 
to peritoneal macrophages. The protective efiScacy was not enhance furtfier by using LPG 
incorporated in SUV containing cholesterol. The interaction of peritoneal macrophages with 
promastigotes is receptor mediated. A number of studies focusing on the macrophage side of 
fte interaction wifli Leishmama spKX& showed that several host receptor raay be involved (Wyler 
et al, 1985; BlackweD et ah, 1985; Guy and Beloscvic, 1993; Straus et al, 1993). The LPG 
molecule of Leishmama parasite gets attached directly to the macrophage recqjtors and blocks 
these receptors resulting into inhibition of ingestion of promastigotes into macrophages. 
CHAPTER 6 
EFFICACY OF LIPOPHOSPHOGLYCAN 
AGAINST EXPERIMENTAL VISCERAL 
LEISHMANIASIS 
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INTRODUCTION: 
Protozoan parasite of the genus I^ishmania affects mammalian hosts, and causes a 
wide spectrum of diseases, depending on the host and on the LewAmamt? species in\'ohed. In 
humans, ttie infection rar\ges from self healing lesions to disseminated cutaneous disease or highh 
destructive mucosal lesions and from as\-mptomatic ii\fection to fatal visceral dissemination, causing 
one of the W'orid's major health problems. 
, Lqwpho^ho^'can (LPG) is one of the major Leishmania cell surface ghcoconjugate 
and has been rqxjrted to exist on tfie surface of aD Leishmania species of promastigote stage (Turco 
and Descoteaux, 1992) and also on the surface of L. major amastigotes (Glaser et al., 1991, Mood> 
etcd., 1993) and the flagellar pocket of L. mexicana (Bahr et al., 1993). The abundance and 
preserKC of LPG thoughout the various stages of the life cycle of parasite suggest that it plays an 
important role in the biology and infectivity of Leishmania organisms. (Tokon et al., 1990). 
Several studies have examined LPGs potential as a chemicalh define<l vaccine against cutaneous 
leishmaniasis. Administration of immunoa£5iiit> purified L. major LPG along with adjuvant C. 
parvum, to geneticalh' resistant mice was found to induce fuU protection against challenge witfi 
promastigotes whereas, partial protection was observed in smceptible mice (Handman and 
Goding 1985; Handman and Mitchell, 1985; McConville et al, 1987). Similar protection against 
L. mexicana in CB.VCa mice was also reported using homologous LPG reconstituted into 
lqx)somes (Russell and Alexander, 1988; Kahl et al, 1990). However, it has been recenth found 
tfiat LPG purified b\ immunoafi5nit> is heavih' contaminated with peptide. Mendonca et al 
(1991) reported tfial T-htnphocjIes from cutaneous leishmaniasis patients respond to purified L. 
brazihensis LPG. whereas jxxrteinase K-treated LPG did not stimulate an} resporise. Subsequent 
T-cell proliferation studies showed that the LPG-associated proteins were potent stimulators 
of T-ccQs in leishmaniasis patients (Moll et al., 1989; Jardim et al. 1991; Russo et al. 1992) as 
weD as in mice immunized with protein contaminated LPG (Jardim et a/, 1991). In view of 
these observations the mechanism of protection and use of LPG as a vaccine against leishmaniasis 
is open to question. Furthermore, use of LPG in protecting against visceral leishmaniasis has not 
yet been evaluated. 
Studies on the potential of promastigote LPG in providing protection against L. 
chnovarv infection in suscqitibk golden hamstcis was carried out. The results demonstrate tfiat 
pr^reatment of hamsters with IPG provides significant protection against L. donavani infection. 
Furdiennore, the protective cfBcacy of UPG imdecules was foimd to be significanth enhanced 
on its incorporation in cholesterol containing phosphatid>1choline liposomes. 
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NL\TERL\LS AND METHODS,' 
Isolation and purification of egg phosphatid>1choline (PC): 
The egg yolk was collected in grinder from one dozen egg and to this acetone (150-
200 ml) was addded This was mixed proper!) and filtered. Filtrate was discarded and solute was 
again treated with acetone. This step was repeated 9-10 times until filtrate became colourless or 
materials looked like white powder. It was dried in vacuo for 1.0 hr. The dried material was 
taken in round bottom flask and added 1.0-1.5 btre of absolute alchohol and kept on magnetic 
stirrer for 1-1.5 hr, filtered it and filtrate was evaporised at 40 - 45°C. The residue was 
dissolved in minimum amount of petrolium ether (b.p 60-80'C) and precipitated with chilled 
acetone. The solvent from precipitated material was removed by decantation. The precipitate 
was dissolved again in petrolium ether immediateh' to avoid oxidation of egg phosphocholine. 
Finally, it was precipitated with chilled acetone and all precipitate was dissoKed in miiumum 
amount of dilorofomt and rotav^porised, dried under vacuum and stored at -20^0. This dried 
material v\as passed through column chromatography over neutral alumina (Grade lU) using 
increasing amounts of methanol in chloroform as the elucnt. Ehition with 7-10*!o methanol in 
chloroform ga\'e pure egg PC. Fractions were anahzed by thin la>er chromatograph>' using 
silica gel G-60 TLC pbtes. The plates were developed in chloroform methanol water (65:25:4) 
and tf>e spot was identified by staining them with iodine vapour followed by moh bdenum-blue 
spar\ (Goswami and Frey, 1971). 
Preparation of lipid liposomes: 
Liposomes were prepared by the method of Gupta and Bali, 1981. using egg 
I^ wqjbochdine in presence or absence of cholesterol. Egg PC and cholesterol were taken 
in the round bottom flask and dissoKed in minimum amount of chloroform. The solvent was 
evaporated in a rotavapor resulting in formation of a lipidfilm. For complete drxTiess, it was 
kept under vacuum for 1.0 hr. A ratio of 1 )ig LPG to 1.0 mg phospholipid and 15°o 
cholesterol of lipid was maintained in all experiments. 
Neutral liposomes: Neutral liposomes were prepared using neutral phospholipid and 
cholesterol. 
Multilamellar vesicles: Multilamellar vesicles (ML\') were prepared as described eariier 
(Senior and Gregoriadis, 1982; Woeff and Gregoriadis, 1984). lipid film was prepared as 
iDOilioned above. The film was dissolved in 50 mM PBS (pH 7.4) vortexed and sonicated at 
2ff\Z for 30 min using water bath sonicator. The MLV was used inunediateh' for immimization 
cjq)criment. 
Small Unilamellar vesicles: Small unilamellar vesicles (SU\') were inepared through probe 
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sonication of ML\' in the presence of ice for 30 min or more, with 50 pulse cycle in 3 Hz 
frequency. Then preparations were ccntrijfuged at 30,000xg for 15-20 min and collected 
supernatant. Again small unilamellar vrsicles were washed with PB5 (50 mSi, pH 7.4) by 
ccntriftigation at 30,000 x g. These preparations were used immediately for immunization, 
although storage at -ZOT did not appear to alter their stability. 
Negatively charged liposomes: Multilamellar and unilamellar vesicles were prepared as 
described above. 7% dicetylphosphate to phospholipid was added during the preparation 
of film A ratio of 1 ;ig LPG to 1.0 mg phospholipid (egg PC) and 15% cholesterol of lipid was 
maintained in all preparations. 
Positively charged liposomes: AD preparations were prepared as mentioned above. 
Stearylamine (14^o) of lipid (w/w) was added during the preparations of film. AH preparations 
were used immediately for immunization. 
Incorporation of LPG into liposomes: 
LPG was incorporated into the liposomes by dissoKing ttie film in 50 mM PBS (pH 
7.4)foUowed by adding LPG stock as required amount before sonication. LPG incorporation 
was different in various Iqwsomised preparations. Small unilamellar vesicles were incorporated 
more LPG as compared to mult^ )lamellar vesicles. The percent of incorporation varied 
between 85-95%. 
/A yil'O EFFICACY OF LIFOSOMISED LPG: 
For evaluating immunization immunoprophylactic efiBcacy of hposomised LPG, 
various protocols were tried, which are summarized below. 
Protocol-1: 
Male s}Tian golden hamsters (35-45 gm) were gK'cn intraperitoneal injection of 
LPG alone (10 >ig of LPG/animal) and in \'arious liposome incorporated forms, like (SLW) 
and (ML\') bposomes. Each group was subdivided into two groups, which consisted of 5-7 
animals group. On da> 21 post LPG administration, the hamsters were challenged with IxlO' 
promastigotes of infective L. donovani strain Dd8. One set of subgroup was immunized again 
after 14 da\s (booster dose). The animals were sacrificed on day 45 and or 60 post infection 
and the percent infected splenic macrophages were counted and percent protection was 
calculated. 
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Percent protection (PP) = X 100 
\\'here Kj is tfie number of amastigotes 100 cells in control N^ is the number of amastigotes^ 100 
cells in the treated group of animals. 
Protocol-Il: 
Initial!} three groups were taken and subdivided into two groups. Each sub group 
contained 7 animals. Different concentration of LPG (10, 20, 30 )ig animal) incorporated in 
smaD unilammellar vesicles in presence or absence of cholesterol were inoculated into hamsters 
b^ inlr^jeritoneal route and challenged with 1x10'promastigotes 21 days after LPG challenge. 
Percent protection was calcxJated as mentioned above. 
RESULTS: 
LPG pro ides protection against L donovani infection in susceptible golden hamsters: 
The potential of LPG in protecting susceptible golden hamsters against L. donavam 
infection was studied b> administration of a singe dose of 10 ;ig animal of purified LPG alone 
or incorporation in various liposomised preparations, 21 da}.s prior to infection. The percent 
protection s^ainst L. dona\.-am infection in susceptible golden hamsters on pretreatment with LPG 
and its IqxKomised preparations is sunmiarized in figure 1. Pretreatment of animals with LPG 
alone or in various liposomised form provided significant protection against L. donovani 
infectioa The groq) of animals recerving LPG alone showed a relatrvel) low protection of about 
22 percent. This protective efiBcac> of LPG was found to be significant!) enlianced on its 
incorporation into liposomes. For LPG incorporated in cholesterol containing multilamellar 
IqxTsomes about 35 percent protection was observed. Incorporation of LPG in unilamellar vesicles 
enhanced the protecting eflScac}' to 41 percent. A ma.\imum protection of about 48 percent was 
observed for LPG incorporated in cholesterol containing unilamellar liposomes, which is more 
than double of that observed for LPG alone. These observations suggest that smaD unilamellar 
VKides (SL~\) in presence of cholesterol responed better as compared to other preparations. 
Optimization of conditions for pretreatment with LPG: 
Effect of variation of pretreatment schedule with liposomized LPG on the 
protection against L donovani infection in hamsters was studied. Figure 2 shows the protection 
con^iared to control observed in animals treated with a constant dose (10 ;jg animals) on day 2, 
10,14, 21 and 28 prior to infectioiL A low protection of about 32 percent compared to control 
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Figure 1: Protection against JL donovani iofection in Syrian golden hainsteiiB on pretreatment 
with LPG alone and its various Uposomised forms. The LPG concentration in all the 
pRparations was kept constant at 10 i^animaL Values are repr^ented as mean +SE 
(n=20). "Hie various abbreviations used arc as follows: LPG MLV = LPG incorporated 
in cholesterol containing multilamellar vesicle; LPG SUV = LPG incorporated in 
unilamellar vesicle and LPG: SUVCH = LPG incorporated in cholesterol containing 
unilamellar vesicle. 
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Figure 2: The effect of various pretrcatment schedules using liposomiscd WG (10 
^animal) on the protection against L. donovani infection in susceptible golden 
hamsters. The protection was compared to control with treated animals on day 2-28 
prior to infection. Values are represented as mean_+ SE (n=15) 
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was observed for day 2 pretreatment vsith liposomised LPG. This was found to be enhanced 
significanlJ>- to aboul 41 and 48 pCTcent on increasing the LPG pretreatment time to day 10 and 
21, respectively, prior to infection. The resuhs indicate that pretreatment of animals with 
Hposomised LPG anx-where between 20 to 30 days is optimum for getting maximum protection 
against L. donavani iitfection. 
The dOfect of multqJe doses of LPG alone or its various liposomised preparations was 
also studied. Two doses 10;ig' animal each of LPG was administered in a gap of 14 days. The 
results of the studies are summarized in Fig. 3. Although, tfie booster dose of LPG incorporated 
in \'arious liposomised preparations showed a slight enhancement in percent protection but 
almost no change was observed in case of LPG alone. The percent protection observed with 
IqxKomised pr^arations by the administration of booster dose was increased about 1.15 fold. 
The stud) si^gests that sin^e dose of LPG administration prior to challenge with promastigotes 
was sufficient in pro\iding optimum protection ^ i n s t L. doncn^ani infection. 
Effect of intraperitoneal and intracardial administration of LPG preparations on 
efl5cac\- was also studied A higher percent protection b>' intracardial administration as compared 
to intraperitoneal route was observed. Althoiigh administration by intracardial route was foimd 
to provide better |»x)tection than intraperitoneal route but intraperitoneal route is preferred because 
the intracardial administration of any vaccine'chemoproph> lactic agent is risk>, difficult as well 
as it requires expertise hand to perform it. Furthermore, the intraperitoneal administration is 
easy to perform. weU accepted by others and risk factors are low as compared to intracardial 
route. 
Dose dependent LPG mediated protection against L donovani infection in hamsters: 
Studies cm concentraticHi dependence of liposomised LPG in protecting hamsters against 
L. dona\rani infection was carried out for optimization of dose required to give maximum 
protection. 10, 20 and 3 0 ^ LPG was incorporated in liposomes and administered intraperitonealh 
in golden hamsters 21 dav-s prior to infection. A dose dependent protection by liposomised LT16 
• 
LPG was observed (Table 1 and Figure 4). For increase in concentration of LPG incorporated 
in SL^' from 10 to 20 )ig animal an increase in percent protection from 50 to 68 percent was 
observed. Further increase of LPG concentration to 30 ^ig'animal showed no significant 
enhancement in percent protection. These result indicate that single administration of 20 )ig of 
LPG incorporated in cholesterol containing S\J\ is the most effective dose for achieving 
maximum protection b\ UR6 LPG against L. donovani infection in susceptible golden hamsters. 
Liposomes injected intravenously into &e blood circulation are readily taken up by 
the mononuclear phagoc>le s}stem (Gregoriadis, 1988; Raz et aJ., 1981; PerezSolar ei a!., 
- 1 3 1 -
- 10 po single doso 
IDA'S ^ach double dose 
! ^ 
^ 
LPG LPG MLV CH LP6 SUV LPG SUV CH 
Figure 3: The effect of multiple doses of LPG alone or its various liposonused preparations. 
Susceptible golden hamsters were pretreated with LPG and its various liposotnised 
prqnndionsonday Kpdortonfectionwi&Z.. tiTnovani promastigotes of strain Dd8. 
The percent protection compared to control in these treated group of animals was 
caicuiated on day 45 post infection. Values arc represented as mean ±SE (n=10). The 
various abbreviations used are as follows: LPG MLV = LPG incorporated in 
cholesterol contaiiung multilamellar vesicle; LPG SUV = LPG incorporated in 
unilamellar vesicle and LPG SUVCH ~ LPG incorporated in cholesterol containing 
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Figure 4: The protection against L. donovani infection in susceptible golden hamsters on 
pretrcatnicnt with various dose of liposonuscd LPG incorporated in SUV in presence 
and absence of cholesterol. Syrian golden hamsters were administered a single dose 
of desired concentration of LPG in SUV, 21 days prior to infection with L. donavani 
promastigotes of strain Dd8. The results presented were obtained on day 4^ post 
infection bj' sacdfidng animals. Values are rqnesented mean +SE (n=l S).The various 
abbreviations used are as fc^ows: LPG SUV = LPG incorporated in unilamellar vesicle 
and LPG SUVCH = LPG incorporated in cholesterol containing unilamellar vesicle. 
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TABLE 1: 
Protection against L donox'am infection in susceptible s>Tian golden hamsters on pretreatment 
v«itb varying dose orUR6 LPG incorporated in unilamellar liposome. 
LPG concentration 
in liposomes 
Mean number of amastigotes Protection 
/lOO splenic macrophages (%) 
1. Control 
2. lOpg'animal 
3. 20 >ig animal 
4. 30 pg animal 
25.38±3.2 
12.56±1.22 
8±0.92 
7.56-1.13 
50 
68 
69 
Values represent meaniSE (n=15). 
S>Tian golden hamsters were given single i.p. injection of desired concentration of LPG 
incorporated in cholesterol containing unilamellar liposomes 21 days prior to infection with L. 
donorani promastigotes of strain DdS. The results were obtained on day 45 post infection by 
sacrificing animals 
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1985). It has been suggested that negatKeh charged MLVs are more readih taken up by murine 
peritoneal macrophages (Mehta ?r a/., 1982) and human peripheral blood monoc>les (Alehta 
et aJ., 1984). Hence, studies using negatneh and positi\-eh charged liposomes were also carried 
ouL 20 and 30;^ of LPG were incorporated both in negathrlj- charged (Dicet>'lphosphate) and 
positiveh, charged (strea>lamine) egg PC SU\' and ML\' liposomes. The results of these studies 
are summarized in Table 2. With negativeh' changed liposomes showedno significant change 
in percent protection a.s compared to neutral liposomes was observed. 
DISCUSSION: 
The importance of T-cell responses in reco\'er>' and resistance to leishmaniasis is well 
demonstrated. It is therefore, of considerable importance to use these responses to evaluate the 
immunostimulatorv' potential of Leishmania antigeits. LPG is the major surface ghcoconjugate of 
aD Leishmania promastigotes and has been reported to be both immunogenic and antigenic. Hence 
the induction of immune re^xinses using LPG might be an effective approach to inhibit parasite 
survival and repbcation in the nuffranahan host. LPG has been used successftilh to inimunize mice 
against cutaneous infection with L. major (Handman and MitcheDL 1985; McConville et al, 
1987), as weD as to elicit T-ceD response in leishmaniasis patients (Kemp et al., 1991; Mendonca 
et al., 1991). Mice immimized with LPG produce LPG specific ^ G and increases firequenc> 
of Z_ mcgor reactive T-ceDs, although these cells do not respond to LPG in vitro (MoD et a!.. 
1989). Mendonca et al. (1991) have demonstrated that LPG stimulated PBMC in cutaneous 
leishmaniasis patients, but that treatment of LPG molecule with proteinase K abolished its 
stimulatory activity. It has been demonstrated that protein copurified with LPG was responsible 
for the observed T-cell stimiilation (Russo et al., 1992). LPG wliich is associated with protein 
contaminants elicited in vitro proliferative responses and IFN-^oduction in cutaneous, 
mucocutaneous and cured visceral leishmaniasis patients. However, protein free LPG and 
repeating disacdiaride units of LPG did not stimulate LPG specific T-ceU (Russo et al.. 1992). 
Similailv', purified gKcoIipids are weak stimulator whereas, the protein associated glycolipid was 
found to be high stimulator of T-Cell response. A LPG associate protein (Mr 11000) was 
isolated and it was found that lymphoc>le stimulation was associated with fte protein 
component of LPG and not Ae glycan (Jardim et al., 1991; 1995; Pimenta et al., 1994). 
After establishing that LPG from L donavani prmnastigotes (strain LT16) inhibits 
attachment of promastigotes of strain Dd8 to macrophages and also provides protection to 
macrophages against L. donavani infection (AK et al, 1995X we set out to cjq)lore wliether 
pretreatment of hamsters wS&i UR6 LPG can jM'ovide protection against I . donovani infection. 
Pretreatment of hamsters with UR6 LPG or its Hposomized prqiaration anywhere between 10 to 
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TABLE 2: 
Protection against L dottovani infection in susceptible s\Tian golden hamsters on pretreatment 
v»itb 20jjg/aniinal single administration of 1116 LPC alone or on incorporation in liposomes. 
A: 'Neutral liposomes 
Groups Mean number of amastigotes 
'100 splenic macrophages 
Day 45 Da\ 60 
Protection 
(%) 
Dav 45 Da\ 60 
1. Control 
2 LPG alone 
3.MLV 
4. MLV LPG 
5. SUV 
6. SUV LPG 
26-2.2 
19-1.7 
25-1.9 
15.5-2.0 
25-1.2 
9.5-1.6 
41.22-2.8 
26.3-1.2 
17.66+1.3 
27 
40 
63 
39 
59 
B:^egatr» ely charged liposomes; 
Groups Mean number of amastigotes 
100 splenic macrophages 
Dav 45 Da\ 60 
Protection 
(%) 
Dav 45 Dav 60 
\ Control 
2. MLV 
4. MLV LPG 
5. SUV 
6. SUV LPG 
28-3.2 
28-1.9 
19.2-1.2 
27.3+1.7 
9.5-1.6 
42.33- 2.8 
30.33+1.24 
15.66+L6 
32 
66 
28 
63 
a: Egg phosphatid>lcholine liposomes containing cholesterol. 
b: Egg phosphatidylcholine liposomes containing cholesterol and dicet>'l phosphate 
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Valuesare represented as mean-SE (n=20) 
The \-arious abbrexialions used are as follo\\'s; MLV= multilamellar liposomes; SUV= unilamellar 
liposomes; MLV LPG = LPG incorporated in cholesterol containing multilamellar liposomes and 
SUV LPG= LPG incorporated in unilamellar liposomes. 
Susceptible Syrian golden hamsters were pretreated with LPG and its various 
Uposomised forms on day 21 prior to infection with L donoN-ani promastigotes of strain Dd8 The 
percent protection compared to control was calculated on day 45 (by spleen biops)) and on day 60 
post infection by killing the respective animals of the groups. 
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SUMMARY 
Lipophospho^can (LPG) is a major cell swface gjycoconjugate of Leishmania 
parasites. This unusual ^coconjugate is present dvoug^out the various phases of growlh in 
Leishmaia parasites. The promasligotes plasma membrane contains about 1.25 million copies/cell of 
LPG, accounting for aflcast 25% of its cell wall Structurally, LPG is composed of a neutral «q) and 
a variable composition of a repeating phosphorylated disaccharide units attached via a conserved 
f^osphosaccharide core to a phosphatidytinositol (PI) Iqnd anchor. M LPG molecules contain 
multiple unit of a backbone structure of P04-6-Gal(P l->4)Man a 1-. 
LPG plays an in:q>ortant role in tfie biology of die parasite due to its surface location, 
its developmental regulation during the life cycle and the reduce virulence of the LPG-^ficient 
organisms. A variety of functions and activities of LPG in the mammalian host have bean 
experimoitaDy demonstrated or siiggested. These inchide, involvement in attachment and mtiy of 
promastjgotes into mammalian macrophages, protection of parasite witftin i^iagolysosomal 
comparlmait and as a recognition molecule for die T-lynqihocyte dependent immimc responses 
charactovtic of leishmaniasis. LPG is an inhilMtor of protein kinase C, inhibitor of oxidative burst, 
infaibitar of vbal fusioa, signal transduction and scavenger tii oxygen free radicals. Lipophosphog^can 
has also bom proposed to induce a protective immune response in mice and tfaerefOTe, is considered 
to be a candidate vaccine against leishmaniasis. 
In recent years, the promastigote ceO surface has received considerable attention 
in view of its importance in interaction with the immune system and for parasite recogration, 
uptake and survival in macrophages. The ceO sur&ce g^coconjugate, lipopho^hog^can 
(LPG) has been isolated, purified and characterized from Leishmania parasites of dififerent 
^>ecies. However, no atten:^ >t has been made to ntody the LPG frtxn non-pathogenic strains. 
Hence, LPG frxnn promastigotes of non-pathogenic strain UR6 was isolated purified, 
characterized and its potential as immunopropfayiactic t^geat and/or candidate vaccine gainst 
experimoital visceral leishmaniasis was evaluated. Isolation of LPG was carried out unng 
di£ferent organic solvent mixtures. Crude LPG was purified b>' size-exclusion, n d 
hydrophobic afOnity chromatogn^rfry. From 25.0 ml (27.0 gm) packed cells, about 150 mg 
of crude LPG was obtained. This on partial purification yidded 31 mg of partially purified 
LPG «iuch on octyl Sq>harose CL-4B cdumn gave a yield of about 15.0 mg of pure LPG. 
Characterization of purified LPG was carried out by ttun Isycr diromatogrq>hy (TLC), SDS-
polyacfylamide gel dectrophoresis (SDS-PAG£) and NMR qtectroscopy. A sinj^e fiiaed qwt 
widi Rf value similar to the LPG of pathogmic strains was observed on TLC. The purity of 
LPG molecale was assessed by SDS-PAGE foflowed by periodic acid schiffs (PAS) stainii^ 
On PAS itaining of gdl, LPG was the only cart>ofaydrate stainii^ species observed and it 
miizrated as a sinfik dififiised band. The molecular wd&ht of UR6 LPG. obtained bv the 
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migration of standard proteins on SDS-PAGE, was fouiKl to be in &e range of 20-25 kDa. 
The protective potential of L. ehncvani LPG, against L. donovaru infection in 
pcritonf al macrophages has been studied. The studies demonstrate that UR6 LPG inhibits 
binding of promastigotes of Dd8 strain to peritoneal macrophages in a concentration dependent 
maimer. A maximimi inhibition of about 85-90% was observed for 1000 ng^ ml of LPG. No 
further enhancement in inhibition with increase in LPG concentration upto 2000 og/vnl was 
observed. Similar results were also observed when LPG was incorporated into small 
unilamellar vesicle (SUV) containing cholesterol Furttieroaore, UR6 LPG provided a 
significant protection (about 85-90%) in peritoneal macrophages against promastigotes 
infectioa. 
In order to look into the possibility whether LPG mediated protection in 
macrophages system against L donavani was either due to inhtbition of attachment of promastigotes 
to maotiphages or killing of amastigotes inside the macrophages, studies with pre and post treatment 
of macrophages with UR6 LPG were carried out It was observed ^A\s!L the peritoneal macrc^hages 
which were treated witfi LPG before being chaDoiged wiA promastigotes provided significant 
protection against L. donavani infectioiL Howevn-, fhose macrophages which were first challenged 
wifli pnxnastigotes and thai treated with LPG provided similar pattern of infection as observed that 
for contnoi These observations, suggest that pretreatment of peritoneal macrofrfiages is necessary for 
achieving protection which is depend on the inhibition of attachment of promastigotes to peritoneal 
macrophages. 
In vivo efficacy of LPG molecules gainst visceral leishmaniasis was evaluated in 
suscqjtible goklenhamstEn using LPG alone or incorporated in liposomes. Pretreatment of hamsters 
witti LPG anywhere between 10-28 days prior to infection did provide significant protection against 
L dbrKMTQ infection. The protective efficacy of LPG was enhanced ognificantiy on its incoiporation 
in ^xjsomes. LPG incoqwrated in cholesterol containing multilamellar liposomes provided 40 percent 
protection whereas LPG incorporated in small umUmellar vesicles (SUV) provided about 65-70 
porcoit protection. This protection was more than double as compared to LPG alone. Furthermore, 
for incorporation of LPG in negatively charged %osomes a similar percont protection as tiiat for 
neutral liposomes was observed. Studies on coocentration dependence of Kposomised LPG in 
protecting hamster against L. donavani infectkm showed that a sin^e dose of 20 i^g/'animal of 
liposomised LPG incorporated in SUV provided a maximum protection of about 68 percent. The 
effectiveness of Mposome itvxxporated LPG compared to LPG alone in ]»t>tection against L. doncroam 
in hamsfcn can be due to induction of an e£fective T<dl reqxMise. This possibility is indicated fixxn 
the fiKt that increased percent protection was obsovtd on increasing the pretreatment schedule with 
IqxKomised LPG fi-om 2 days to 21 days. 
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